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At	 the	 end	 of	 2010,	 the	 ORL	 department	 of	 CUF	 Infante	 Santo	 Hospital,	 led	 by	
Professor	João	Paço,	was	invited	to	participate	in	humanitarian	missions	in	one	of	
the	 Portuguese-speaking	 countries,	 former	 Portuguese	 colony	 -	 Democratic	
Republic	of	São	Tomé	and	Príncipe.	
Without	any	knowledge	of	the	main	ENT	pathologies	we	started	this	adventure.	
From	 research	 on	 sub-Saharan	 African	 countries,	 an	 increase	 in	 deafness	 was	







At	 the	end	of	 the	 first	mission,	 the	 results	 led	 to	 the	 curiosity	 to	understand	 the	
reason	 for	 the	 increased	 prevalence	 of	 sensorineural	 deafness,	 irreversible	 and	
with	socio-cultural	repercussions	important	for	the	development	of	a	country.	
The	absence	of	clinical	records,	 laboratory	exams,	 imagiologic	or	audiologic	 tests	
led	 us	 to	 a	 greater	 clinical	 challenge	 of	 etiological	 cause	 of	 hearing	 loss	 in	 this	
country.	
The	present	doctoral	project	was	born	at	the	end	of	the	first	mission.	








In	 June	2013,	 in	the	scope	of	 the	doctoral	course,	during	genetics	curricular	unit,	
and	due	to	difficulties	 in	carrying	out	complementary	examinations	 in	the	 island,	
born	the	idea	was	born	to	study	the	association	between	neurossensorial	hearing	






by	 Portuguese,	 we	 could	 hypothesize	 for	 the	 existence	 of	 an	 associated	 genetic	
factor,	 and	 for	 that	 reason	 the	 evaluation	 of	 the	 main	 mutations	 of	 our	 people	
should	be	investigated.	
Since	São	Tomé	and	Príncipe	is	an	island	that	has	been	colonized	for	many	years	
by	Portuguese,	we	hypothesize	 the	existence	of	 the	 same	genetic	 factors,	and	 for	
that	reason	the	evaluation	of	the	main	mutations	from	Portuguese	population	was	
investigated.	
In	 this	country,	 they	had	a	significant	 improvement	 in	primary	health	care,	 since	
the	 implementation	 of	 humanitarian	 aid	 by	 the	 IMVF	 in	 cooperation	 with	 the	
Camões	 Institute.	 São	 Tomé	 and	 Príncipe	 have	 good	 vaccination	 coverage,	 but	
some	 vaccines	 that	may	 have	 an	 impact	 on	 the	 appearance	 of	 deafness,	 such	 as	
rubella,	were	not	implemented	until	this	project.	






Knowing	that	 there	 is	not	only	an	etiological	 factor	 for	deafness,	 the	birth	of	 this	







Analyzing	 the	main	effects	of	 the	risk	 factors	evaluated,	 it	was	 found	 that	 female	
gender	 is	 in	high	risk	to	have	HL	than	male	gender;	rubella	disease	could	 lead	to	
HL	 if	 it	 is	 during	 gestational	 period	 and	 represents	 a	 double	 risk	 to	 HL.	 In	 this	
sample,	 self-report	 of	 malaria	 infection	 augments	 the	 risk	 of	 HL,	 around	 three	
times	 more;	 sickle	 cell	 disease	 (HbSS)	 have	 almost	 two	 and	 half	 folder	 risk	 to	
develop	HL	and	sickle	cell	trait	is	protecting	to	HL;	regarding	G6PD	non-B	variant	






Simultaneously	 with	 the	 etiological	 research	 project,	 there	 is	 a	 need	 to	 the	
diagnosis	 to	 minimize	 the	 effects	 of	 deafness.	 The	 acquisition	 of	 equipment	 for	
audiological	 evaluation	 (audiogram	 and	 auditory	 evoked	 potentials)	 and	 the	
acquisition	and	adaptation	of	hearing	aids	to	children	and	young	adults	with	work	
activity	 were	 born	with	 the	 help	 of	 patronage,	 in	 order	 to	 reduce	 the	 effects	 of	
social	isolation.	
This	project	gave	rise	to	another	humanitarian	project	-	"Projecto	sem	Barreiras"	
of	 the	 Fundação	 Calouste	 Gulbenkian	 with	 the	 IMVF	 and	 Universidade	 Católica	
Portuguesa	which	 included	 the	 national	 implementation	 of	 the	 Sign	 Language	 of	
São	Tomé	and	Príncipe	(LGSTP)	and	the	Neonatal	Auditory	Screening	of	São	Tomé	
and	Príncipe	(RANSTP),	with	the	acquisition	of	acoustic	oto-emission	equipment.	
Undoubtedly	 a	 project	 that	was	 born	with	Professor	 João	Paço,	 cherished	by	 all,	
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Underdeveloped	 countries	 are	 those	with	 the	 highest	 prevalence	 of	 deafness.	 In	
some	situations,	chronic	infectious	processes	would	trigger	this	hearing	loss,	 lack	
of	 hygiene	 and	 health	 care	 as	 well	 as	 medical	 therapy	 shortages.	 Actually	 we	
recognize	 numerous	 causes	 of	 hearing	 loss	 and	 identified	 some	 of	 the	 most	
frequent	and	most	of	them	could	be	prevented.	
São	Tomé	and	Príncipe	is	an	island	located	in	sub-Saharan	Africa,	discovered	and	
colonized	 by	 the	 Portuguese	 people	 (João	 de	 Santarém	 and	 Pedro	 Escobar)	 in	
1470.	 It	 was	 a	 Portuguese	 colony	 until	 12th	 July,	 1975,	 when	 it	 became	
independent.	 It	 is	an	underdeveloped	country	that	 is	 the	subject	of	humanitarian	
aid.	
In	humanitarian	aid	during	 the	project	 -	 "Health	 for	All	 -	Specialty"	promoted	by	
the	 Marquês	 de	 Valle	 Flor	 Institute	 (IMVF)	 and	 Camões	 Institute,	 a	 group	 of	















that	 these	are	prevalent	 in	these	regions	and	are	acting	as	a	protective	 factor	 for	
severe	malaria.	
Another	 possible	 causes	 of	 hearing	 loss,	 and	 considering	 that	 it	 is	 a	 country	
previously	 colonized	 by	 diverse	 populations	 and	 cultures	 including	 European,	 is	




According	 to	 the	 statement	 that	 the	 majority	 of	 causes	 of	 hearing	 loss	 are	
preventable,	 and	 assessing	 the	 main	 characteristics	 of	 public	 health,	 such	 as	
common	 diseases	 and	 preventive	 actions	 in	 the	 country,	 it	 was	 found	 that	







usually	 results	 from	 the	 interaction	 of	 numerous	 factors	 that	 influence	 the	
emergency	of	hearing	loss.	
The	deaf	people	 should	be	 integrated	 in	 society.	For	 this	 reason	was	created	 the	
sign	 language	 adapted	 to	 the	 country	 and	 also	 adapted	 hearing	 aids	 to	 promote	
hearing	and	stimulate	oral	language.	
	
This	 was	 an	 enthusiastic	 work	 developed	 during	 five	 years	 of	 humanitarian	


































The	 islands	 were	 uninhabited,	 and	 they	 were	 delivered	 to	 the	 captains	 of	 the	
















age	 of	 8	 embarked	 for	 São	 Tomé	 to	 learn	 Christian	 doctrine	 and	 become	 good	









During	 the	 period	 from	 1540	 to	 1710	 São	 Tomé	was	 the	 target	 of	 invasions	 by	
other	peoples,	namely	Angolans,	Dutch,	and	French.	All	this	political	turmoil	led	to	



















Figure	 1.1-3	 -	 Age-sex	 pyramid	 of	 Republic	 Democratic	 of	 São	 Tomé	 and	 Príncipe	 (Instituto	
Nacional	de	Estatística	2012).	
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Even	 all	 districts	 are	 dedicated	 to	 farming,	 Mé-Zóchi	 has	 a	 higher	 activity	 and	





















































The	 data	 presented	 has	 been	 published	 by	 Caroça	 C	 and	 Paço	 J	 (2016)	 as	 is	
possible	to	see	in	
	

















INTRODUÇÃO: Desde fevereiro de 2011, um grupo de Otorrinolaringologistas do Hospital CUF Infante Santo, tem sido 
convidado, por uma organização não-governamental, para integrar missões humanitárias em São Tomé e Príncipe. Esta 
equipa médica tem sob a sua responsabilidade a organização e disponibilização dos recursos humanos e dos equipamentos 
necessários para efetuarem procedimentos cirúrgicos, consultas e rastreios auditivos aos que têm patologias em Otorrino-
laringologia.
MÉTODOS: Este trabalho resulta de uma revisão retrospetiva de todos os casos de Otorrinolaringologia com que esta 
equipa contactou, entre 2011 e 2016 durante as missões humanitárias supramencionadas. É também o resultado de todas 
as atividades que foram desencadeadas no decurso das referidas missões.
RESULTADOS: No decurso destas missões encontrámos patologias comuns. Entre as mais recorrentes destacamos os 
casos de surdez e de patologias dos tecidos linfoides no contexto de uma orofaringe. Em 18 missões foram efetuados 1057 
rastreios em Otorrinolaringologia e as principais cirurgias foram efetuadas na cavidade oral com recurso a adenoidectomia 
e a amigdalectomia. Os resultados de todos os testes conduzidos, durante as 18 missões, revelam um aumento da surdez 
neurossensorial.
DISCUSSÃO: Estas missões pretendem promover o acesso a todos, na medida do possível, aos cuidados de saúde, no 
contexto da Otorrinolaringologia. Para tal, procede-se à identificação dos que têm problemas auditivos e/ou problemas rela-
cionados com a linguagem. Neste sentido, também procurámos adaptar próteses, quando possível, sobretudo em crianças 
e jovens adultos. Constatámos um bom desenvolvimento das crianças às quais foi efetuada uma adaptação das próteses 
existentes. Algumas regressaram à escola, fortaleceram amizades, tornando-se assim mais sociáveis.
Em última análise, concordamos que as missões humanitárias têm que ser adaptadas às especificidades do país onde decor-
rem, tal como temos feito nestes últimos cinco anos.
PALAVRAS-CHAVE: Missões Humanitárias; Otorrinolaringologia; Surdez Neurossensorial; São Tomé e Príncipe
INTRODUCTION
Since February 2011, a group of otolaryngologists from 
a private hospital in Portugal - hospital CUF Infante 
Santo was invited by a NGO to provide equipment and 
properly skilled professionals to help and treat otolar-
yngology diseases in São Tomé and Príncipe. These mis-
sions included surgical procedures, consultation and 
hearing evaluation. 
São Tomé and Príncipe is an archipelago in western 
equatorial Africa, near Gabon, Equatorial Guinea, Ca-
maroon and Nigeria. Was discovered by Portuguese ex-
plorers in 1470 (João de Santarém and Pero Escobar), 
who decided that these islands were good locations for 
bases to trade with the mainland. São Tomé and Príncipe 
have economic and political autonomy since 1975. The 
official language is Portuguese.1 
With a resident population of approximately 187.000 
inhabitants, this Country shows a low average age dis-
tribution (17-18 years) who have a low socioeconomic 
power and poor sanitary conditions. Many have also suf-
fered from Malaria, a public health infection.2-4 
The main hospitals in São Tomé and Príncipe are Hos-
pital Ayres de Menezes in São Tomé city, and Hospital 
Manuel Quaresma Dias da Graça in Príncipe island.
The IMVF (Institute Marquês of Valle Flôr) is an NGO 
(Non-Governmental Organization) with the objective of 
implementing in this country the “Health for All – Med-
ical Specialities”, supported by Portuguese Institute to 
Development Support – Camões Institute and Callouste 
Gulbenkian Foundation in partnership with the Ministry 
of Health of São Tomé e Príncipe.
Doctors from the University Clinical Center of Hospital 
CUF Infante Santo embraced this project, since February 
of 2011. At the very beginning an Humanitarian Mission 
in this Country consists of observing patients during a 
regular consultation, surgery and hearing assessments 
for one week and then three or four times per year.
The aim was to be part of the project Health for all - 
Medical Specialities and to implement at São Tomé and 
Príncipe assessments and surgical interventions. These 
were our top priority. Due to absence of audiological ex-
ams for more than 30 years in these islands, our team 
also brought them. Thus, this project’s global aim was 
not only to consolidate the Health System by bringing 
specialized medical care in São Tomé and Príncipe but 
also to complement its preventive and primary health-
care with specialized assistance for secondary and ter-
tiary care.







The first team of five arrived on February of 2011: two 
ENT doctors, two nurses and one clinical audiologist 
with audiometric equipment and one year after we initi-
ated speech therapy and hearing aids (Fig. 1). Each team 
of doctors tends to include one or two senior surgeons 
and one other in acadamic training. Nurses are special-
ized in ENT operating room.
Before arriving in São Tomé and Príncipe for these mis-
sions we were already expecting to find problems relat-
ed to ear infections, chronic otitis media and conductive 
hearing loss.
Before going, we need to prepare all equipment and ma-
terial. For the assessment, audiological evaluation and 
operating room. Surgical material, supplies and equip-
ment arrived in STP by plane and boat.
Before going to São Tomé we had acquired a microscope 
with possible connection to a monitor to allow showing 
and explaining the surgical intervention system, to the 
local professionals. 
As we arrive all mission members plan the activities for 
the week (Fig. 2).
The hospital has 2 operating rooms for the whole coun-
try. These are spacious, each has a large window and air 
conditioning (Fig. 3). Yet, the lack of reliable electricity 
and water supply compromises the proper delivery of 
oxygen and suction as well as cleanliness. The steriliza-
tion equipment is quite basic and it results on the instru-
ments gradual degradation. Besides, dressings are often 
washed and reused.
The post-surgical recovery area is located on the hall 
right outside the operating room and has no nursing 
staff.
FIGURE 1. First mission (February 2011)  
and five years later (February 2016).
FIGURE 2. Briefing when arrive, before work. 
(Feb 2011, Feb 2016).
FIGURE 3. Operating room – Hospital Ayres de Menezes.







FIGURE 4. Patients are referred for consultation 
by radio or television.
Otolaryngology assessments are held in a pavilion at Ayres 
de Menezes Hospital which shares a physical space with 
ophtalmology. All assessments take place on the arrival 
day and on the following 3 afternoons.
METHODS
This work is a retrospective chart review of all otolar-
yngology cases observed during these missions, which 
occurred from 2011 until 2016. It also includes all activ-
ities and actions taken in this context. 
RESULTS
During these missions, we have found some common 
pathologies (Table 1).
Deafness is the most prevalent pathology followed by 
the lymphoid tissue of oropharynx. 
After the first mission, we found that we needed to 
change our organization, because we found a high prev-
alence of sensorineural hearing loss. So, we needed to 
acquire auditory brainstem response to assess what we 
could not with pure tone audiogram. 
The  need  for  fitting  hearing  aids, also required speech 
therapy, to improve hearing and oral language. In some 
cases, it was impossible to acquire oral language and 
lead the necessity to develop a language for communi-
cation - sign language.
The mission grew after 1 year with one more audiologist 
for hearing aids and a speech therapist. After one year, 
a teacher of sign language has been associated to help 
them creating this language.
In these 18 missions 1057 otolaryngology assessments 
were conducted. Patients were referred for consulta-
tion by radio or television (Fig. 4).
Operating room activities are performed on the five 
working days during the morning and are always pre-
pared one day in advance. Before surgery and early in 
the morning, all patients were placed in a room next to 
the operating room for preparation - veins were chan-
neled (Fig. 5). All men and women, children and adults 
wait all morning for it. 
Only sixteen of eighteen missions were surgical and dur-
ing all missions we made 465 surgical procedures (Fig 6). 
Surgery of the lymphoid tissue and less complex surgery is 
done which allows larger number of patients. The main 
surgery is oral cavity with adenoidectomy and tonsillec-
tomy. Here we have also chronic otitis media surgery 
and otosclerosis surgery. The rhinologic surgery is main-
ly chronic rhinosinusitis with polyps, rhinitis and masses. 
The cervical surgery consists in glands surgery and bra-
chial masses.
After the mission all patients are re-observed by a local 
otolaryngology doctor who is on a temporary assign-
ment and not a native of São Tomé and Príncipe.
TABLE 1. Common pathologies found during missions.
ENT Assessment Audiology Operating Room
Chronic adenoiditis and tonsillitis Sensorineural Hearing Loss (NSHL) severe to profound Adenoidectomy 
Simple chronic middle ear disease 
and Cholesteatoma
Cofosis Tonsillectomy 
Otosclerosis Children and adults without oral language Ear surgery
Thyroglossal duct cyst Head and neck surgery
Branchial cyst and fistula Biopsies
Tumors


















São Tomé and Príncipe is a small country in extreme 
need. They have limited access to surgical expertise, 
otolaryngology and audiology evaluation.
These humanitarian missions try to make healthcare ac-
cessible to all as well as to identify people with earing 
and language problems so prosthetics can be adapted, if 
possible, mainly for children and young adults.
We mainly perform surgical procedures for the lymphoid 
tissue as we try to treat the vast majority of citizens.
By analyzing Chadwick J et al paper, we have the advan-
tage that an otolaryngologist lives in that country. This 
allows some surgeries that we couldn’t do if a colleague 
wasn’t available to take care of patients for the post-sur-
gical time. Yet for any doubt he has our contact to ask 
for help.6 
From our experience we agree that we are often unable 
to make the follow-up of a ear surgery as most patients 
do not return for the post-surgery follow-up. According 
to Horlbeck G et al, they got good results related with 
otology surgery but that is based on the follow-up of 
64% of cases only. 7 
The most complex cases we must evacuate to Portugal.
We have noticed a positive development in children to 
whom we have adapted their prosthetics. Some of them 
returned to school, have friends and became more social.
During the missions, clinical sessions were held, address-
ing the results of previous missions and clinical topics. 
FIGURE 11. Hearing aids adapted in children and young adults that are studying or working. This is a photo of a child in the left on February 
2012, when adapted to hearing aids and in the right in last mission (February 2016).
FIGURE 12. In speech therapy we try to have a caretaker present.
FIGURE 13. This project leads us to fulfill the need for sign 
language by creating a sign language alphabet. The sign language 
dictionary was created to widely spread the São Tomé e Príncipe 
sign language.
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RESUMO
Introdução: A audição é um importante sentido para a integração 
de um indivíduo na comunidade, por esse motivo é importante 
a identificação dos fatores associados à surdez. Neste trabalho 
propomos revelar os dados audiológicos verificados durante 
2 anos de missões humanitárias de Otorrinolaringologia e a 
identificação de eventuais fatores de risco para a surdez.
Desenho do Estudo - Material e Métodos: Avaliámos todos os 
indivíduos que procuraram a consulta de audiologia no decurso 
das missões humanitárias em São Tomé e Príncipe de 2012 a 
2014. Foram observados por um médico de otorrinolaringologia, 
onde para além de observação foi efetuado um questionário 
clínico onde foram pesquisados fatores de risco (história 
familiar de surdez, co-sanguinidade, história de malária clínica, 
terapêutica antimalárica, história gestacional e peri-parto, 
história otítica, história de traumatismo craniano) e realizada 
avaliação audiológica por um audiologista. Os dados foram 
processados e analisados numa base de dados da IBM SPSS 20.0.
Resultados: Dos 721 indivíduos observados, foram excluídos 77 
por não conterem registo de avaliação audiológica, obtendo 644 
registos clínicos para o estudo. Verificámos uma prevalência de 
surdez neurossensorial de 35,7%, surdez de condução de 2,9% 
e mista de 1,9%. Os restantes indivíduos eram normouvintes 
(59,5%).  Destes indivíduos normouvintes, 26% eram indivíduos 
apenas com um ouvido ouvinte – surdez unilateral.  Dos factores 
de risco analisados a história de malária clínica foi o único factor 
de risco que se revelou mais significativo. 
Discussão: A prevalência de surdez na amostra avaliada foi 
elevada, afastando-se dos valores esperados. Numa população 
de um país subdesenvolvido, e de acordo com os dados da 
Organização Mundial de Saúde, seria de esperar uma maior 
prevalência da surdez de condução e mista. No entanto, 
neste trabalho verificamos uma maior prevalência da surdez 
neurossensorial.  A malária ou mesmo a terapêutica instituída 
no seu tratamento podem estar a contribuir para os resultados 
audiológicos obtidos. 
Conclusão: A surdez nem sempre tem uma causa única. Existem 
um conjunto de fatores que ao interagirem podem desencadear 
o aparecimento de surdez. Neste trabalho a malária revelou ser 
o fator de risco mais significativo na associação com a surdez 
neurossensorial em São Tomé e Príncipe. Mais estudos estão a 
ser realizados na identificação de outros fatores de risco.
Palavras-chave: Malária; São Tomé e Príncipe; Surdez 
Neurossensorial
AbstrAct
Introduction: Hearing is an important sense for the integration 
of an individual in the community; therefore the identification 
of factors associated with deafness is important. In this 
work we reveal the audiometric data verified during 2 years 
of Otorhinolaryngology humanitarian missions and the 
identification of possible risk factors for deafness.
Study design - Material and Methods: We evaluated all 
individuals who have sought audiology consultation in the 
course of humanitarian missions in Sao Tome and Principe from 
2012 to 2014. All patients were observed by an ENT doctor, held 
earing evaluation by an audiologist and answered a clinical 
questionnaire in which risk factors were accessed (family history 
of deafness or co-sanguinity, previous clinical malaria, previous 
malaria treatment, gestational and peri-partum history, 
previous ear infections and history of head trauma). Data were 
processed and analyzed in IBM SPSS 20.0 database. 
Results: Of the 721 observed individuals, 77 individuals were 
excluded because they do not contain audiological registration, 
obtaining 644 medical records for the study. We found a 
prevalence of sensorineural hearing loss of 35.7%, conductive 
deafness of 2.9% and 1.9% mixed. The remaining individuals 
were normal hearing (59.5%). From the normal hearing 
individuals, 26% had a unilateral deafness. Of the risk factors 
analyzed, the history of clinical malaria was the only risk factor 
that showed more association. 
Discussion: Away from the expected values, particularly with 
regard to the type of deafness encountered, the prevalence of 
hearing loss in the study sample was high with sensorineural 
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hearing loss as the most prevalent type. According to WHO 
in developing countries, conductive and mixed deafness were 
expected to have a higher prevalence Malaria and antimalarial 
treatment may be contributing to the development of deafness.
Conclusion: Deafness does not always have a single cause.  A 
number of interacting factors may trigger the onset of deafness. 
In this paper, malaria seemed to be the most significant risk 
factor in association with sensorineural hearing loss in Sao 
Tome and Principe. Further studies are being made on the 
identification of other risk factors.




A audição é um dos sentidos importantes para 
a aprendizagem e integração do indivíduo numa 
comunidade ouvinte.
Em qualquer idade, a surdez tem um impacto profundo 
na comunicação interpessoal, psicológica, bem-estar, 
qualidade de vida e independência económica.1
De acordo com a Organização Mundial de Saúde 
(OMS) a audição na criança é um dos sentidos mais 
importantes para o desenvolvimento da linguagem. A 
criança com surdez apresenta um risco aumentado de 
baixa aprendizagem, abuso físico, social, emocional 
e sexual, podendo mesmo levar à morte.  Por outro 
lado, no adulto a surdez está associado ao isolamento 
social, estigmatização, abuso, distúrbios psiquiátricos, 
depressão, dificuldade no relacionamento com parceiros 
ou crianças, escolha de carreiras profissionais restritas e 
stress ocupacional.1
Em 2012, existiam no mundo cerca de 141 milhões de 
surdos e a maioria, cerca de 127 milhões, nos países 
em desenvolvimento.1 A incidência estimada de surdez 
congénita ou de início precoce nestes países é de 6:1000 
nados vivos, cerca do triplo da que ocorre nos países 
desenvolvidos.1
A surdez tem vindo a aumentar desde 1995 até 
2011. O grande peso deste aumento vem dos países 
subdesenvolvidos, sobretudo Ásia e África subsaariana.1 
O custo-eficácia da prótese auditiva, implante coclear 
e outros equipamentos auditivos tem-se demonstrado 
proibitivo para a maioria dos países subdesenvolvidos 
ou em desenvolvimento, devido aos custos na aquisição 
e manutenção destes equipamentos.1 Por esse motivo é 
importante atuar na prevenção e detecção precoce da 
doença.
A República Democrática de São Tomé e Príncipe (STP) 
é um país localizado na zona equatorial, próximo do 
Gabão, Guiné Equatorial e Nigéria. Ocupa uma área 
de aproximadamente 1000 km2, constituída por duas 
ilhas (Ilha de São Tomé e Ilha do Príncipe) e ilhéus 
adjacentes (Rolas, Cabras...), num total de sete distritos 
administrativos, sendo a capital a cidade de São Tomé.
Atualmente apresenta cerca de 187000 habitantes, 
com uma base de pirâmide populacional alargada, 
representando uma população muito jovem de acordo 
com os resultados do CENSUS 2012.2
O desenvolvimento socioeconómico é baixo, incluindo-
se a República Democrática de São Tomé e Príncipe no 
grupo dos países subdesenvolvidos. 
Devido à sua situação económica, STP é alvo de 
ajudas humanitárias, donde se destaca a atuação da 
organização não-governamental - Instituto Marquês de 
Valle Flor (IMVF), com o projeto - "Saúde para Todos - 
Especialidades".
Nunca esteve disponível em STP, avaliação audiológica, 
pelo que não é conhecido o perfil audiológico desta 
população.
No que diz respeito à saúde pública desta população, 
existe uma patologia que os assombra desde há longo 
tempo. A malária esteve praticamente erradicada há 
cerca de 40 anos atrás. Posteriormente houve um 
retrocesso com o aumento da incidência mas nos últimos 
anos tem-se verificado uma diminuição dos casos de 
malária clínica.3,4 
Em fevereiro de 2011, no âmbito do projeto “Saúde 
para Todos Especialidades” uma equipa constituída por 
médicos, enfermeiros e audiologista iniciou missões 
humanitárias de uma semana com periodicidade de três 
a quatro vezes por ano. 
Após a primeira missão verificámos um número 
aumentado de indivíduos que recorriam à consulta do 
Hospital de São Tomé por surdez unilateral e bilateral, 
ligeira a profunda.
A constatação de um número elevado de doentes com 
surdez, levou-nos à necessidade de insistir nos rastreios 
e iniciar medidas para tentar minimizar o isolamento, 
insucesso ou mesmo o abandono escolar. 
Perante a situação clínica encontrada, tornou-se 
importante caracterizar a população avaliada em consulta 
de audiologia, estudando a prevalência da surdez e 
identificando possíveis factores de risco associados ao 
aparecimento da surdez.
MATERIAL E MÉTODOS
Analisámos os casos avaliados durante os anos 2012 a 
2014, nas missões humanitárias de otorrinolaringologia 
(consulta de audiologia) através de um estudo 
observacional.
Os casos foram recolhidos na consulta de Audiologia, 
realizada em ambiente hospitalar (Hospital Ayres de 
Menezes – São Tomé, Hospital Manuel Quaresma Dias 
da Graça – Ilha do Príncipe) e em rastreios realizados em 
escolas e num hotel da cidade de São Tomé.
Este trabalho foi autorizado pela Comissão de Ética de 
São Tomé e Príncipe.
Todos os casos foram observados inicialmente por um 
médico otorrinolaringologista da equipa e submetidos 
a questionário clínico, para identificação de possíveis 
factores de risco para o desenvolvimento de surdez 
(história familiar, co-sanguinidade, história prévia de 
malária clínica, história gestacional e perinatal, história de 
infeções otológicas e história de traumatismo craniano). 
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Observámos 721 indivíduos na consulta, 77 dos quais 
foram excluídos por não apresentarem registo de 
avaliação audiológica (Fig. 1).   
Incluímos no estudo 644 indivíduos com uma distribuição 
etária do 1 aos 83 anos, sendo a média de idades 
observada de 20,21 anos e a mediana de 15.  O sexo 
feminino na amostra apresentou uma prevalência de 
52% e o masculino de 48%. 
Todos os distritos administrativos de São Tomé e Príncipe 
foram abrangidos pela consulta de audiologia, quer 
através do deslocamento dos indivíduos aos hospitais 
centrais, quer através da realização de rastreios em 
escolas e num hotel da cidade, sendo o distrito de 
Água Grande o que apresentou maior percentagem de 
indivíduos (52,6%).
Avaliámos por audiograma total 80% dos indivíduos e 
20% por potenciais evocados auditivos.  Considerámos o 
limiar auditivo electrofisiológico para a determinação do 
limiar auditivo do indivíduo quando não se conseguia a 
colaboração no audiograma tonal.
Destes 644 indivíduos, 47,1% consideravam que ouviam 
mal do ouvido direito, confirmando-se pelos exames 
audiológicos, 48,3% de indivíduos com hipoacusia. 
Apesar do ouvido esquerdo apresentar mais ouvidos 
normouvintes, apresentou maior prevalência de surdez 
profunda e severa. 
Foi avaliada a queixa subjetiva de surdez através da 
questão “acha que ouve mal?” tendo-se verificado de 
memória, mas perante a inexistência de registos clínicos, 
optámos pela colheita de informação, mesmo assumindo 
o viés.
Foram também registados os dados relativos à presença 
ou ausência de oralidade, observação na otoscopia, limiares 
auditivos e resposta à questão “acha que ouve mal?”.   
A avaliação audiológica foi realizada por um 
audiologista. Utilizámos como instrumento de medida 
a audiometria tonal, os potenciais evocados auditivos 
e a impedanciometria.  A aplicação de cada um destes 
exames dependeu do grau de colaboração do indivíduo e 
da própria idade.  Os exames foram realizados numa sala 
isolada, minimizando assim o ruído, tornando-o aceitável 
para a realização de avaliação audiológica fora de uma 
cabine insonorizada de acordo com o ANSI S3.1-1999 
(R2013). 
O grau de surdez foi determinado de acordo com a 
classificação adoptada na OMS, em que o indivíduo é 
classificado considerando o grau de limiar auditivo obtido 
no melhor ouvido.
Esta classificação considera normouvinte o indivíduo 
com um limiar inferior a 25 dB no melhor ouvido, surdez 
ligeira de 26 a 40 dB, moderada de 41 a 60 dB, severa de 
61 a 80 dB e se superior ou igual a 81 dB será profunda. 
Registámos todos os dados informaticamente numa base 
de dados e o tratamento dos resultados foi efetuado 
através do SPSS Statistics versão 20, utilizando a análise 
descritiva e de frequências para o estudo descritivo e o 
teste do χ2 para a avaliação da significância estatística.
FIGURA 1 
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acordo com a classificação no melhor ouvido (quando 
os dois ouvidos apresentavam hipoacusia) e os exames 
audiológicos, uma sensibilidade de 65% e 84% de 
especificidade, um valor preditivo positivo e negativo 
de 71,2% e 79,7% respectivamente.  A prevalência de 
indivíduos com queixas auditivas foi de 34,5 % e os que 
efetivamente apresentavam hipoacusia foi de 37,9%. 
O tipo de surdez encontrado foi diversificado, verificando-
se uma prevalência de surdez neurossensorial de 35,6% 
enquanto que a surdez de condução e mista apresentaram 
uma prevalência de 3% e 1,9% respetivamente (Fig. 2). 
maturidade suficiente para ter oralidade.
Quanto aos factores de risco elegíveis, analisamos a 
história familiar, co-sanguinidade e história prévia de 
malária clínica. Outros fatores de risco, tais como a 
história gestacional e perinatal, foram avaliados, mas 
devido à baixa taxa de resposta foram excluídos deste 
trabalho.
Ao serem questionados sobre a existência de surdez na 
família, apenas 14,1% responderam afirmativamente e 
outros 13,8% não se recordam ou não sabem. Os restantes 
72% responderam não ter história familiar de surdez.  Ao 
aplicar-se o teste do χ2 verificou-se que nesta amostra, 
não existe significância estatística entre a história de 
surdez familiar e a surdez (χ2 = 1,436; p = 0,231).
A relação entre a surdez e a co-sanguinidade nesta amostra 
revelou que apenas 2,8% responderem afirmativamente 
sobre a questão, tendo 20,8% optado por responder que 
não sabiam.  Não se verificou existir significância estatística 
pelo teste do χ2 (χ2 = 0,716; p = 0,398).
Ao questionar sobre a história de episódio de malária 
clínica, cerca de 53,4% responde afirmativamente que em 
determinado momento da vida sofreu infeção por malária, 
tendo realizado terapêutica antimalárica.  
A terapêutica antimalárica variou desde o quinino à 
terapêutica mais recente com artesunato e amodiaquina, 
mas nem todos conseguiram responder à questão sobre 
o tipo de terapêutica realizada, tendo sido excluída da 
análise o tipo de tratamento antimalárico instituído.
O grupo etário mais jovem foi o que respondeu mais 
negativamente sobre a história de malária clínica.  Cerca 
de 14% não se recordava de ter tido malária em algum 
FIGURA 2 
Tipo de surdez (n=644)
FIGURA 3 
Grau de perda auditiva (n=644)
Os restantes indivíduos eram normouvintes (59,6%).
Nos indivíduos normouvintes, 74% destes apresentavam 
os dois ouvidos normouvintes, o que significa que os 
restantes (26%) tinham uma surdez unilateral, apesar de 
serem classificados como normouvintes de acordo com a 
classificação adoptada.  
Avaliámos a perda auditiva por graus de acordo com a 
classificação da OMS, apresentando 60,2% dos indivíduos 
normouvintes, seguindo-se por ordem decrescente a 
surdez profunda (15,1%), ligeira (11%), moderada (9,2%) 
e por fim a severa (4,5%) (Fig. 3).
Calculámos a prevalência de surdez nos distritos. 
Verificámos que o distrito com maior prevalência de 
surdez foi Mé-Zóchi com 44%, seguido de Cantagalo e 
Caué com 42%, Lobata com 41%, Lembá e Água Grande 
com 35%. O distrito com menor prevalência de surdez foi 
Pagué (Príncipe) com 25%.  
Analisámos o desenvolvimento da linguagem oral na 
amostra global, havendo 14,4% sem oralidade e 73,8% 
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momento da vida.  A associação entre os episódios de 
malária e a surdez revelaram-se com um χ2 = 3,663 e 
p = 0,056 que apesar de não apresentar significância 
estatística, está mais próximo de obter significância.
DISCUSSÃO
A OMS estima que cerca de 5% da população mundial 
(360 milhões) apresenta incapacidade auditiva. A elevada 
prevalência é encontrada na Ásia Pacífica, Sul da Ásia e 
África Subsaariana.5
Tal como já foi referido, nos países subdesenvolvidos, 
a surdez é uma patologia frequente que leva muitas 
vezes ao abandono escolar, desinteresse, isolamento 
social e que por conseguinte leva ao agravamento do 
subdesenvolvimento.
O tipo de surdez mais frequentemente encontrado nestes 
países é a surdez de condução ou mista. A principal causa 
de surdez nas idades jovens, particularmente nos países 
de baixo e médio desenvolvimento é a infecção otológica 
não tratada, a qual apresenta otorreia crónica.5,6 Devido 
à carência de serviços e cuidados médicos é frequente a 
evolução de uma otite média aguda em crónica. Outras 
doenças infeciosas como a rubéola, a meningite, a papeira 
e o sarampo são também causas importantes de surdez. A 
sua identificação e estudo na população é particularmente 
importante pelo facto de poderem ser prevenidas através 
de um programa de vacinação.5
Em São Tomé e Príncipe não existe possibilidade de 
realizar avaliação audiológica a não ser durante as missões 
humanitárias, por esse motivo não há conhecimento da 
prevalência da surdez na população. No CENSUS 2012 foi 
realizada uma questão sobre a audição: “Tem dificuldade 
permanente de ouvir?” onde 97,09% responderam que 
não tinham nenhuma dificuldade e os restantes 2,91% que 
tinham dificuldade.  Estes resultados não são compatíveis 
com os dados da OMS.  Por outro lado, neste trabalho foi 
avaliado, no questionário clínico, a avaliação subjetiva da 
audição através da questão “acha que ouve mal?”, tendo-se 
verificado uma sensibilidade de 65% (na identificação dos 
indivíduos surdos) e especificidade de 84% (identificando 
os indivíduos normouvintes).
Perante o trabalho realizado durante as missões, 
destacamos uma prevalência aumentada de surdez 
neurossensorial (35,7%). Ao contrário do esperado a 
surdez de condução (2,9%) e mista (1,9%), em São Tomé 
e Príncipe, está pouco representada nos casos que 
recorreram à consulta de Audiologia.
A oralidade reflete o efeito da surdez na aquisição da 
linguagem oral, por essa razão é importante identificar os 
casos que não têm oralidade ou  a apresentam de forma 
deficiente.  Como seria expectável perante a prevalência 
de surdez neurossensorial aumentada, a existência de 
oralidade também está diminuída, neste segmento da 
amostra. 
A malária é uma patologia que afeta este país desde há 
vários anos, sendo responsável por um elevado índice de 
mortalidade e morbilidade.  Recentemente a incidência 
de malária clínica grave tem diminuído, assim como a 
mortalidade devido a esta patologia.  Não existem registos 
clínicos nos processos hospitalares sobre o diagnóstico 
desta patologia, pelo que o questionário se baseou apenas 
na resposta do indivíduo ou responsável pelo indivíduo. 
A terapêutica antimalárica instituída também chama à 
atenção como corresponsável pela surdez,7 mas neste 
estudo, foram poucos os que sabiam a terapêutica que 
tinham efectuado.
No país desde há alguns anos está implementada a 
terapêutica profilática antimalárica durante a gravidez, 
tendo sido verificado através do questionário que tem 
tido forte aderência. A malária clínica na ilha do Príncipe 
está neste momento erradicada, mas na ilha de São Tomé 
ainda está em fase decrescente de casos.4
Muitos têm sido os trabalhos apresentados sobre a surdez 
em países subdesenvolvidos, com vista à explicação para 
esse fenómeno.  
De entre vários trabalhos, salienta-se um trabalho de Lasisi 
et al  que fez uma revisão dos casos que recorreram à 
consulta no University College Hospital, Ibadan na Nigéria 
e onde 14% apresentavam surdez.8 Este estudo pretendeu 
identificar as causas de surdez na Nigéria, concluindo que 
nos países subdesenvolvidos cerca de 85 a 90% das causas 
de surdez nunca são conhecidas, levando a um atraso 
na intervenção e efeitos irreversíveis. Verificou-se que o 
fator genético contribuiu com 25% dos casos, seguindo-se 
infeções por sarampo (13%) e meningite (8%).8 
Sendo a Nigéria um país próximo de São Tomé e Príncipe 
com algumas semelhanças culturais e epidemiológicas, 
considerámos um trabalho útil para fazer alguma analogia 
com São Tomé e Príncipe. Neste, à semelhança do que 
se verificou no nosso trabalho, a inexistência de registos 
clínicos e de exames complementares de diagnóstico, 
laboratoriais e imagiológicos, era importante e limitava a 
investigação etiológica.
Numa meta-análise de artigos ingleses publicados entre 
1996 e 2002 tentou-se identificar o factor etiológico da 
surdez.9 Da análise constataram que a etiologia da surdez 
neurossensorial bilateral é desconhecida em 41,5%, 
seguindo-se a genética não sindrómica (27,2%), a pré-
natal (11,5%), a perinatal (9,7%), a pós-natal (6,6%) e a 
genética sindrómica em 3,5%. A surdez neurossensorial 
bilateral profunda está mais associada a surdez genética 
não sindrómica.9 Por outro lado, a surdez genética não–
sindrómica tem vindo a aumentar a sua relevância na 
causa da surdez, assim como a prematuridade e asfixia 
neonatal.
Os resultados sugerem que se devem adaptar instrumentos 
de diagnóstico médico (laboratoriais, neurofisiológicos e 
oftalmológicos) de modo a ajudar no diagnóstico das causas 
de surdez que são maioritariamente desconhecidas.10  
Em São Tomé e Príncipe, os cuidados médicos são 
limitados, não havendo exames complementares de 
diagnóstico laboratoriais disponíveis.  Por esse motivo as 
causas infeciosas na população não são completamente 
conhecidas.  A malária é a principal patologia conhecida e 
























REVISTA PORTUGUESA DE OTORRINOLARINGOLOGIA E CIRURGIA CÉRVICO-FACIAL10
diagnosticada.  Não existe possibilidade de realizar testes 
serológicos que ajudem na identificação de patologias 
infeciosas que possam estar implicadas no diagnóstico de 
surdez, nomeadamente as doenças que fazem parte do 
grupo TORCH (toxoplasmose, rubéola, citomegalovírus e 
herpes).11 
A rubéola tem vindo a diminuir o seu papel etiológico 
devido à implementação da vacina na grande maioria dos 
países,9 mas no caso de São Tomé e Príncipe, esta poderá 
ser uma causa importante, pois não está implementada 
esta imunização e não se conhece o perfil epidemiológico 
da doença no país (em estudo, dados não apresentados).
Nesta população existe um programa nacional de 
vacinação, com uma boa cobertura vacinal em todo o país, 
mas não contempla a vacina anti-rubéola.12 Esta poderá 
ser outra importante causa de surdez congénita, evitável.11 
Existem nomeadamente casos de patologia cardíaca e 
oftalmológica na ilha que podem ser enquadrados em 
casos de rubéola gestacional.
O quadro infecioso de meningite, devido à elevada 
prevalência de malária, por vezes é diagnosticado como 
malária cerebral, não havendo por esse motivo história de 
surdez associado ao diagnóstico de meningite.
É importante salientar, uma vez mais, que neste país não 
existem exames audiológicos a não ser durante o período 
em que estão as missões humanitárias.  Por esse motivo 
também não existe possibilidade de recorrer à realização 
de exames audiológicos a não ser nesse momento, o que 
limita o diagnóstico.
De acordo com a pesquisa bibliográfica, será de esperar a 
existência de vários fatores relacionados com o ambiente 
e o próprio indivíduo que possam estar associados ao 
desenvolvimento de surdez, dos quais se salientam: a 
malária13,14; a ototoxicidade7 e a terapêutica antimalárica 
que, apesar de em alguns artigos não ser considerada como 
ototóxica15,16, nas crianças17 como a dose frequentemente 
não é adequada ao peso da criança, poderá causar surdez 
irreversível; as infeções, nomeadamente a rubéola, apesar 
de desconhecida na população, poderá estar a contribuir 
para a surdez em São Tomé e Príncipe. Existem outros 
factores, nomeadamente as hemoglobinopatias que são 
prevalentes nesta região subsaariana e poderão estar 
associadas à surdez na forma homozigótica da doença de 
células falciformes,18,19 assim como o défice de glucose-
6-fosfato-desidrogenase (G6PD) em parte associado 
ao aumento de casos de icterícia neonatal grave e 
consequente surdez neurossensorial neonatal.20, 21 
Não podemos esquecer, que sendo São Tomé e Príncipe, 
um conjunto de ilhas no seio do Atlântico, com poucos 
recursos, poderá estar associado a mais casos de co-
sanguinidade e maior prevalência de surdez genética (em 
estudo por Cristina Caroça).
CONCLUSÃO 
Dos fatores de risco avaliados, a malária revelou ser o 
mais significativo. Neste momento estão a decorrer outros 
estudos tendo como objetivo a identificação de outros 
fatores de risco para a surdez neurossensorial em São 
Tomé e Príncipe. As causas genéticas e ambientais poderão 
estar a ser responsáveis pelo aumento de prevalência de 
surdez neurossensorial em São Tomé e Príncipe, sendo 
de salientar que poderá não estar implicada apenas uma 
causa isolada, mas um conjunto de fatores que em sinergia 
levam ao aparecimento de surdez.  
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The	 interaction	 between	 a	 person	 and	 his	 or	 her	 surrounding	 environment	 is	
mediated	 through	 sensory	 experiences.	 The	 sense	 of	 hearing,	 in	 particular,	
facilitates	 communication	 and	 faster’s	 social	 interaction.	 Hearing	 is	 the	 key	 to	




The	 function	of	 the	ear	 is	 to	 convert	physical	 vibration	 into	an	encoded	nervous	
impulse.	It	can	be	thought	of	as	a	biological	microphone.	Like	a	microphone	the	ear	

















The	outer	 ear	 transmits	 sound	 to	 the	 tympanic	membrane,	 it	 includes	 the	pinna	
and	ear	canal	(Alberti	2001).	
Anatomically	the	auricle,	pinna	or	outer	ear,	is	a	uniquely	constructed	organ.	It	is	













































a	milliliter.	 Uncoiled	 the	 cochlea	 has	 a	 length	 of	 3.1	 –	 3.3	 cm.	 The	 height	 of	 the	
cochlea	 is	approximately	0.5	cm	 in	humans	(Moller	2006).	 In	 this	space	 lie	up	 to	
30,000	 hair	 cells	 which	 transduce	 vibration	 into	 nervous	 impulses	 and	 about	
19,000	 nerve	 fibers	 which	 transmit	 the	 signals	 to	 and	 from	 the	 brain	 (Alberti	
2001).	
Vibration	of	the	footplate	of	the	stapes	vibrates	the	perilymph	in	the	bony	cochlea.	
This	 fluid	 is	 essentially	 incompressible.	 Therefore,	 there	 has	 to	 be	 a	 counter	
opening	in	the	labyrinth	to	allow	fluid	space	to	expand	when	the	stapes	foot	plate	
moves	 inwards	 and	 in	 turn	 to	move	 inwards	when	 the	 stapes	 foot	 plate	moves	
outwards.	 The	 counter	 opening	 is	 provided	 by	 the	 round	 window	 membrane	




























Physical	 characteristics	 of	 the	 basilar	 membrane	 cause	 different	 frequencies	 to	
reach	 maximum	 amplitudes	 at	 different	 positions.	 Much	 as	 on	 a	 piano,	 high	































Sound	 entering	 the	 outer	 ear	 is	 picked	 up	 by	 the	 tympanic	 membrane.	 The	




















Auditory	 messages	 are	 conveyed	 to	 the	 brain	 via	 two	 types	 of	 pathway:	 the	












Schematically,	 this	 pathway	 is	 short	 (only	 3	 to	 4	 relays),	 fast	 (with	 large	
myelinated	fibers)	and	ends	in	the	primary	auditory	cortex	(Choclea	2013).	




The	 main	 function	 of	 these	 pathways,	 also	 connected	 to	 wake	 and	 motivation	
centers	 as	 well	 as	 to	 vegetative	 and	 hormonal	 systems	 is	 to	 select	 the	 type	 of	
sensory	message	to	be	treated	first	(Choclea	2013).	
	
Conscious	 perception	 requires	 the	 integrity	 of	 both	 types	 of	 pathways.	 For	




The	 Central	 Auditory	 Processing	 is	 a	 network	 that	 permits	 some	 of	 the	

















The	ability	of	 localizing	 sources	of	 sound,	also	 referred	 to	as	directional	hearing,	






low	 frequencies	 and	 interaural	 level	 differences	 (ILD)	 at	 high	 frequencies.	 If	 the	
head	remains	stationary	neither	a	given	ITD	nor	an	ILD	can	sufficiently	define	the	
position	 of	 a	 sound	 source	 in	 space	 (Figure	 1.3-8).	 On	 such	 a	 theoretical	 basis	




















(the	 head	 shadow	 effect);	 b)	 An	 acoustical	 shadow	 (the	 head	 shadow	 effect)	 occurs	 for	 high	
frequency	sounds	because	their	wavelengths	are	small	compared	with	the	size	of	the	head.	
	
At	 the	 end	 of	 the	 19th	 century	 scientists	 already	 realized	 that	 occlusion	 of	 the	







Hearing	has	an	alerting	 function	especially	 to	warning	 signals	of	 all	kinds.	There	
are	 brain	 cells	 which	 respond	 only	 to	 the	 onset	 of	 a	 sound	 and	 others	 which	
respond	only	to	the	switching	off	of	the	sound,	i.e.	a	change.	These	cells	allow	the	




Sound	 stimuli	 produce	 interaction	 with	 other	 parts	 of	 the	 brain	 to	 provide	
appropriate	 responses	 (Alberti	 2001).	 Certain	 sounds	 can	 evoke	 anger,	 others	
pleasure.	The	point	is	that	the	sensations	produced	by	hearing	are	blended	into	the	















Conductive	 lesions	 impair	 the	 transmission	 of	 sound	 from	 environment	 to	 the	
cochlea,	so	the	signal	reaching	the	sensorineural	system	is	weaker	than	it	should	
be.	A	conductive	hearing	loss	is	the	amount	by	which	the	signal	is	attenuated	due	
to	 the	 disorder,	 and	 is	 expressed	 by	 the	 size	 of	 air-bone-gap	 (Figure	 1.3-9)	
(Gelfand	2009).	








Sensorineural	 lesions	 involve	 the	 cochlea	 and/or	 auditory	 nerve	 and	may	 affect	
sensory	receptor	(hair)	cells,	auditory	neurons,	and/or	any	of	the	many	structures	
and	 processes	 that	 enable	 them	 to	 be	 activated	 and	 to	 function	 properly.	 The	
resulting	impairment	of	auditory	functioning	is	called	a	sensorineural	hearing	loss	
(Figure	1.3-9)	(Gelfand	2009).	

















(9%)	 are	 children	 under	 15	 years	 (Figure	 1.3-10).	 Male	 gender	 presents	








Figure	 1.3-10	 -	 Distribution	 of	 disabling	 hearing	 loss	 in	 Adults	 and	 Children,	 Man	 and	 Woman	
(WHO	Media	centre	2012).	Legend:	m-million	
	









average	 life	 expectancy	 is	 increasing	 in	 the	 general	 population,	 as	 well	 as	








*Adults: 328 m.  
91% 
*MBD, WHO, 2012 DHL estimates; DHL adults (15+ years) threshold  





diagnostic	 tests	 are	 becoming	 more	 accessible	 and	 more	 early	 conducted,	






2:1000	newborns	 (Olusanya	 et	 al.	 2014).	 The	 importance	 of	 primary	 prevention	
should	be	strengthened	especially	 in	 those	countries	where	the	birth	rate	 is	high	
and	 where	 present	 prevalence	 of	 disabling	 hearing	 loss	 increases.	 According	 to	
WHO	 data,	 (WHO	 2013a)	 in	 the	 case	 of	 underdeveloped	 countries	 the	 type	 of	
hearing	 loss	that	usually	arises	 is	conductive	and	mixed	hearing	 loss,	such	fact	 is	
being	observed	in	countries	with	weak	medical	and	therapeutic	resources,	leading	




that	 can	 interact	 and	 trigger	 this	 change.	 Sensorineural	hearing	 loss	 is	 a	hearing	
disability	 classically	 irreversible	 by	 medical	 or	 surgical	 point	 of	 view.	 In	 this	
hearing	 loss	 type,	 the	 only	 possibility	 of	 recovery,	 in	 some	 cases,	 is	 the	 hearing	
rehabilitation	with	hearing	aids	or	even	implants	(osteo-integrated,	middle	ear	or	
cochlear).	 These	 types	 of	 rehabilitation,	 in	 addition	 to	 the	high	 economic	weight	
that	 involve,	 entail	 need	 for	 support	 by	 specialized	 professionals	 and	






children	 the	hearing	 loss	 prevalence	 is	 1.7%	and	 in	 adults	 (≥	 15	 years)	 is	 about	






per	 capita	 of	 the	 country	 increases	 (Figure	 1.3-12)	 decreasing	 the	 number	 of	




Figure	1.3-12	–	Relation	between	hearing	 loss	prevalence	 in	 children	and	Gross	National	 Income	
per	capita	(GNI).(WHO	Media	centre	2012)			
	
In	general	we	may	 lead	 to	 think	 that	 the	 cause	of	hearing	 loss	according	 to	ages	
will	 change,	 being	 at	 birth	more	 common	a	 genetic	 cause	 and	while	 in	 adult	 the	





These	 may	 be	 inherent	 to	 the	 individual	 himself	 or	 in	 association	 with	 the	
















The	 proportion	 of	 hearing	 loss	 due	 to	 preventable	 causes	 is	 much	 higher	 in	
middle-	 and	 lower-middle-income	 countries	 (75%)	 than	 in	 high-income	 areas	
(49%)	(Krug,	Cieza,	Chadha,	Sminkey,	Martinez,	White,	et	al.	2016).	This	situation	
is	 probably	 explained	 by	 the	 high	 prevalence	 of	 infections	 in	 the	 middle-	 and	
lower-middle-income	 countries	 and	 the	 better	maternal	 and	 child	 health	 care	 in	


























Epidemiological	 studies	 provide	 insight	 into	 the	 modifiable	 and	 non-modifiable	
risk	 factors	 associated	 with	 hearing	 loss	 and	 into	 the	 mechanistic	 pathways	
underlying	 ARHL.	 Risk	 factors	 to	 ARHL	 are	 classified	 into	 four	 categories:	 1	 -	










is	 contributing	 in	 any	way	 to	 this	 phenomenon	 especially	 among	 the	 30	 and	 50	
years.	Usually,	women	present	a	better	hearing	than	men	particularly	in	the	higher	
frequencies,	whereas	hearing	degradation	in	men	is	two	times	faster	(Figure	1.3-
15).	 The	 hearing	 threshold	 of	men	begins	 to	 decline	 around	 the	 age	 of	 30	 years	





Figure	 1.3-15	 -	 The	 gender	 reversal	 phenomenon.	 Average	 audiograms	 of	 341	 males	 and	 346	
females	in	age	range	50	to	89	years.	Adapted	from	J	Am	Acad	Audiol	(1993;4:42-49)	
	
First	 signs	 of	 ARHI	 in	 males	 may	 already	 be	 evident	 at	 an	 age	 of	 30–39	 years,	
beginning	 at	 the	highest	 frequency	 range	 of	 10–16	kHz;	 by	40–49	 years	 hearing	
impairment	 has	 progressed	 to	 frequencies	 of	 6–8	 kHz.	 Presbycusis	 in	 females	
generally	 begins	 a	 decade	 later,	 and	 the	 principal	 speech	 band	 (0.5–4	 kHz)	 is	
affected	 in	 both	 genders	 by	 60–69	 years.	 Besides	 gender	 differences,	















Melanin	 in	 derma	 is	 proportional	 to	 melanin	 in	 inner	 ear	 (cochlea).	 There	 are	
studies	that	associate	the	higher	levels	of	melanin	to	higher	protection	to	hearing	
loss	(Sun	et	al.	2014;	Murillo-Cuesta	et	al.	2010).	
Melanin	 in	 inner	 ear	 is	 produced	 by	 melanocytes	 derived	 from	 neural	 crest	
progenitors.	In	stria	vascularis,	melanocytes	are	called	intermediate	cells	(IC),	and	
play	 a	 role	 in	 producing	 endolymph.	 In	 mice	 they	 had	 revealed	 that	 is	 also	





In	 the	 study	of	Sun	et	al.	African-American	 individuals	have	been	shown	 to	have	
odds	of	hearing	loss	40%	to	60%	lower	than	Caucasians,	and	this	difference	exists	
even	 after	 adjustment	 for	 noise	 exposure	 and	 socioeconomic	 status	 (Sun	 et	 al.	
2014).	
Also	another	study	(Mujica-Mota	et	al.	2015)	involving	melanin	revealed	that	eye	
color	may	be	 an	 indicator	 of	 inner	 ear	melanin	 content	 and	has	been	 associated	
with	 hearing	 loss.	 Evidence	 suggests	 that	 melanin	 can	 be	 protective	 against	










on	 questionnaire	 leading	 to	 a	 bias.	 According	 to	 Driscolland	 and	 colleagues,	 the	
degree	 of	 parenting	 influences	 the	 prognosis;	 siblings	 and	 mother	 are	 the	
parenting	factor	with	the	greatest	impact	on	hearing	loss	(Driscoll	et	al.	2015).		
Only,	 the	 higher	 degrees	 of	 hearing	 loss	 are	 more	 commonly	 associated	 with	
congenital	 deafness.	 For	 this	 reason	 it	 is	 important	 tracking	 all	 children	 with	 a	
family	 history	 of	 hearing	 loss	 and	 monitor	 their	 development	 during	 childhood	
(Driscoll	et	al.	2015).	







The	 highest	 rates	 of	 consanguineous	 marriage	 occur	 in	 north	 and	 sub-Saharan	
Africa,	 the	Middle	 East,	 and	west,	 central,	 and	 south	 Asia.	 In	 these	 regions	 even	
couples	 who	 regard	 themselves	 as	 unrelated	 may	 exhibit	 high	 levels	 of	
homozygosity,	 because	marriage	within	 clan,	 tribe,	 caste,	 or	 biraderi	 boundaries	
has	been	a	long-established	tradition	(Bittles	&	Black	2010).	
Consanguinity	 as	 common	 practice	 is	 found	 especially	 in	 underdeveloped	
countries,	requiring	your	discouragement,	according	to	Zakzouk	et	al.	in	which	the	
incidence	 of	 hereditary	 hearing	 loss	 is	 higher	 in	 these	 countries	 compared	 to	






diseases,	 among	 which	 the	 hearing	 loss.	 The	 effect	 of	 consanguinity	 in	 the	
















most	 affected	 and	 associated	 with	 an	 increased	 sensorineural	 hearing	 loss	 in	 a	
proportion	of	20-40:1000	newborns.		
The	 risk	 of	 hearing	 loss	 decreased	 with	 increasing	 birthweights,	 with	 adjusted	
odds	 ratios	 of	 4.4,	 3.8,	 1.7	 and	 1.4	 for	 the	 birthweights	 1500–1999,	 2000–2499,	
2500–2999	 and	 3000–3499	g	 respectively	 (Engdahl	 &	 Eskild	 2007).	 The	 risk	 of	
both	 mild	 to	 moderate	 and	 severe/profound	 hearing	 losses	 were	 influenced	 by	
birthweight	(Engdahl	&	Eskild	2007).	
The	 risk	 of	 hearing	 loss	 associated	 to	 low	 birth	 weight	 it	 is	 also	 associated	 to	
patients	that	are	commonly	exposed	to	other	risk	factors	for	hearing	loss	such	as	
ototoxic	 drugs,	 hypoxia	 and	 hyperbilirubinemia,	 which	 may	 lead	 to	 early	 or	
delayed-onset	 sensorineural	 hearing	 loss	 as	 well	 as	 progression	 of	 a	 mild	 pre-






At	 same	 time,	 prevalence	 of	 failed	hearing	 screening	 in	neonates	with	Very	Low	
Birth	Weight	 (VLBW)	 is	 significantly	 higher	 than	 in	 neonates	with	 normal	 birth	




Associated	 to	 metabolic	 changes	 described	 previously,	 the	 neonatal	 jaundice	 is	
undoubtedly	one	of	 the	situations	 that	often	arise.	 In	about	84%	of	 the	newborn	
(pre-term	and	term)	at	the	end	of	the	first	week	the	jaundice	appears.	This	should	





different	 pathological	 situations	 associated	 with	 neurological	 damage	 caused	 by	
hyperbilirubinemia,	 such	 as	 kernicterus,	 encephalopathy	 and	 neuronal	
dysfunction	 alone	 (Olds	 &	 Oghalai	 2015).	 The	 prevalence	 of	 BIND	 is	 not	 known	
because	it	is	difficult	to	know	the	incidence	of	CNS	dysfunction	that	can	be	subtle,	
transient	or	located.	Auditory	system	damage	can	occur	even	with	bilirubin	levels	
that	 might	 think	 they	 were	 soft,	 in	 the	 absence	 of	 other	 signs	 of	 kernicterus.	
Auditory	effects	goes	through	subtle	changes	in	hearing	and	speech	processing	to	
complete	deafness	(Olds	&	Oghalai	2015).	
The	pathophysiological	process	associated	with	 this	situation	 is	explained	by	 the	
fact	 that	 unconjugated	 bilirubin	 go	 through	 passive	 diffusion	 the	 blood-brain	





bodies	 of	 the	 spiral	 ganglia	 decrease,	 decreasing	 also	 the	 cell	 density	 and	






















by	 hyperbilirubinemia	 and	 which	 are	 basically	 the	 auditory	 dyssynchrony.	 The	
cochlea	is	spared,	however	the	injury	may	arise	in	the	auditory	nerve	(VIII	cranial	
nerve).	In	audiological	field	evaluation,	waves	III	and	V	of	the	auditory	brainstem	
potential	 have	 a	 diminished	 amplitude	 and	 interaural	 distance	 increased.	
Sometimes	 the	 substantial	 increase	 of	 the	 total	 bilirubin	 leads	 to	 loss	 of	wave	 I	
(Olds	&	Oghalai	2015).	
Cochlea	is	not	directly	affected	by	hyperbilirubinemia,	however	the	cochlear	injury	
can	arise	by	 the	auditory	nerve	or	 injury	of	 the	 cochlear	nuclei	of	 the	brainstem	
(Olds	 &	 Oghalai	 2015).	 It	 is	 estimated	 that	 the	 increase	 of	 both	 the	 conjugated	
bilirubin	or	not	conjugated,	 leads	to	neurotoxic	 injury.	Neonatal	 jaundice	 is	often	
associated	 with	 a	 mutation	 on	 the	 X	 chromosome	 named	 –	 G6PD	 deficiency	
(Kuzniewicz	 et	 al.	 2014;	 Nair	 &	 Al	 Khusaiby	 2003).	 Although	 it	 is	 not	
pathognomonic	 that	 G6PD	 deficiency	 develops	 jaundice	 or	 kernicterus,	 the	
prevalence	 of	 cases	 associated	 with	 this	 change	 of	 blood	 is	 significant.	 This	
mutation	leads	to	the	development	of	a	change	in	hemoglobin	framing	within	the	
framework	of	hemoglobinopathies	and	characteristically	confers	some	protection	
against	 infection	 by	 plasmodium,	 responsible	 for	 malaria.	 Is	 a	 very	 common	
hematological	 change	 in	 malaria	 endemic	 countries,	 and	 may	 represent	 an	
increase	in	cases	of	kernicterus	and	consequently	auditory	changes	(Peters	&	Van	
Noorden	2009;	Johnson	et	al.	2009).	
The	 ANSD	 (Auditory	 Neuropathy	 Spectrum	 Disorder)	 is	 the	 entity	 that	
encompasses	 these	 diseases	with	 abnormal	 neural	 auditory	 function	 (altered	 or	
missing	 ABR	waveforms)	 in	 the	 presence	 of	 normal	 cochlear	microphonics	 (the	
field	potential	emanating	from	the	receptor	potential	of	hair	cells)	and	otoacoustic	
emissions	 (OAEs,	 i.e.,	 sounds	 emanating	 from	 the	 ear	 due	 to	 non-linear	 force	
production	 by	 the	 outer	 hair	 cells)	 (Olds	 &	 Oghalai	 2015).	 This	 disorder	 is	
characterized	by	tonal	thresholds	with	moderate	to	profound	loss	that	can	vary	on	
different	 days,	 associated	 with	 a	 decrease	 in	 discrimination,	 which	 is	 not	
predictable	 considering	 the	 tonal	 threshold	 and	 associated	 with	 difficulties	 in	






&	Oghalai	 2015).	 A	 high	 total	 bilirubin	 and	 unconjugated	 bilirubin	 is	 associated	
with	a	 low	neurodevelopment	and	high	 incidence	of	hearing	 loss.	 In	 the	study	of	




for	 early	 and	 immediate	 action	 are	 important	 as	 well	 as	 the	 implementation	 of	
several	procedures	such	as	phototherapy,	transfusion	or	even	albumin	infusion.	It	










no	 clear	 threshold	 level	of	hypoxia	defining	 the	point	 at	which	hearing	 is	 at	 risk	
(Cristobal	&	Oghalai	2008).	Other	 study,	 found	 that	>50%	of	 survivors	of	 severe	
neonatal	respiratory	failure	had	sensorineural	hearing	loss	at	4	years	of	age.	Also,	
the	use	of	extracorporeal	membrane	oxygenation	has	been	 found	to	 increase	 the	
prevalence	of	sensorineural	hearing	loss	among	NICU	survivors.	In	these	patients,	




Exposure	 to	 the	 constant	 background	 noise	 generated	 by	 contemporary	 life-









Many	 studies	point	 out	 that	noise	 trauma	 can	 also	produce	damage	 to	 the	 inner	
hair	cells,	stria	vascularis,	spiral	ganglion	cells	and	supporting	cells.	The	initial	sign	




Environmental	 causes	 include	 infectious	 diseases	 and	 are	 of	 the	 utmost	







‘immunosuppressed’,	 the	 pregnant	woman	 actually	 undergoes	 an	 immunological	
transformation,	where	 the	 immune	 system	 is	 necessary	 to	 promote	 and	 support	
the	pregnancy	and	growing	 fetus.	When	 this	protection	 is	breached,	 as	 in	a	viral	
infection,	 this	security	 is	weakened	and	 infection	with	other	microorganisms	can	
then	propagate	and	lead	to	outcomes,	such	as	preterm	labor	(Vesikari	1971).	
Perinatal	 outcomes	 from	 viral	 infections	 during	 pregnancy	 can	 range	 from	 no	
effect	 to	 pregnancy,	 loss	 by	 spontaneous	 abortion	 due	 to	 fetal	 infection	 with	
resulting	congenital	viral	syndromes	(Vesikari	1971).	In	this	group	of	infections	we	
usually	 include	Toxoplasmosis,	Rubella,	 Cytomegalovirus,	Herpes	 and	other	 such	
as	syphilis	(TORCH).	These	diseases	can	present	hematogenous,	transplacental	or	
ascendant	 transmission.	 The	most	 frequent	 clinical	manifestation	 in	 the	 fetus	 is	
diverse	 and	 can	 range	 from	 embryonic	 resorption,	 abortion,	 placental	 infection	









Toxoplasmosis	 is	 a	 parasitic	 infection	 caused	 by	 Toxoplasma	 gondii,	 an	 obligate	
intracellular	protozoan	(Salviz	et	al.	2013).	Cats	are	hosts	of	T	gondii	(Salviz	et	al.	
2013).	 The	 infection	 is	 acquired	 when	 oocysts	 are	 ingested	 by	 consumption	 of	
contaminated	 food	 or	 water.	 Tachyzoites,	 a	 motile	 form	 of	 the	 parasite,	 enter	
nucleated	 cells	 and	 are	 disseminated	 through	 the	 blood	 stream.	 The	 tachzyoites	
elicit	 an	 inflammatory	 response	 (Salviz	 et	 al.	 2013).	 The	 tachyzoites	 can	 form	




as	 worldwide,	 despite	 the	 fact	 that	 it	 can	 be	 prevented	 (Montoya	 &	 Remington	
2008).	
According	 the	 CDC	 data,	 the	 seroprevalence	 in	 United	 States	 is	 22.5%	 and	
incidence	 is	 1-10	 per	 10000.	 If	 infection	 occurs	 around	 the	 time	 of	 pregnancy	
transplacental	 transmission	may	occur.	 If	 fetal	 infection	occurs	early	 in	gestation	
severe	 inflammation	 and	 necrosis	 can	 be	 observed	 particularly	 in	 the	 central	
nervous	system.	Untreated	patients	may	go	on	to	develop	chorioretinitis,	cognitive	
and	motor	dysfunction,	seizures	and	hearing	loss.	





patients	 that	 are	 identified	 early	 and	 are	 compliant	with	 treatment	 (Salviz	 et	 al.	
2013).	
Because	 of	 the	 high	 transmission	 rates	 observed	 after	 18	 weeks	 of	 gestation,	
treatment	 with	 pyrimethamine,	 sulfadiazine,	 and	 folinic	 acid	 is	 also	 used	 for	
patients	who	have	acquired	the	infection	after	18	weeks	of	gestation,	in	an	attempt	
to	 prevent	 fetal	 infection	 from	 occurring	 and,	 if	 transmission	 has	 occurred,	 to	












Congenital	 Syphilis	 is	 a	 condition	 caused	 by	 infection	 in	 utero	 with	 Treponema	
pallidum	 (CDC	 2015b).	 Effective	 prevention	 and	 detection	 of	 congenital	 syphilis	
depends	on	the	identification	of	syphilis	in	pregnant	women	and,	therefore,	on	the	
routine	serologic	screening	of	pregnant	women	during	the	first	prenatal	visit	(CDC	
2015a).	 Congenital	 syphilis	 (CS)	 is	 a	 disease	 that	 occurs	 when	 a	 mother	 with	
syphilis	transmit	/passes	the	infection	on	to	her	baby	during	pregnancy.	
CS	 can	 cause	 miscarriage,	 stillbirth	 or	 death	 shortly	 after	 birth.	 Up	 to	 40%	 of	
babies	born	from	women	with	untreated	syphilis	may	be	stillborn,	or	die	from	the	
infection	 as	 a	 newborn.	 Babies	 born	 with	 CS	 can	 have:	 deformed	 bones,	 severe	







virus	 is	 classified	 as	 a	 togavirus,	 genus	 Rubivirus.	 It	 is	 an	 enveloped	 RNA	 virus,	
with	a	single	antigenic	 type	 that	does	not	cross-react	with	other	members	of	 the	
togavirus	 group	 (Centers	 for	Disease	Control	 and	Prevention	2015).	Rubella	 is	 a	
contagious,	 generally	mild	 viral	 infection	 that	 occurs	most	 often	 in	 children	 and	
young	 adults	 (WHO	 Media	 centre	 2015b).	 Pregnancy	 outcomes	 as	 a	 result	 of	
maternal	rubella	infection	include	spontaneous	abortion,	fetal	infection,	stillbirths	














treatment	 for	 rubella	but	 the	disease	 is	preventable	by	vaccination	 (WHO	Media	
centre	2015b).	











of	 seropositive	 women.	 Vertical	 transmission	 occurs	 most	 commonly	 after	
maternal	primary	infection,	usually	by	the	following	mechanisms	(Vesikari	1971):	
transplacental	 after	 the	 virus	 infects	 the	 placenta,	 intrapartum	 via	 ingestion	 or	
aspiration	 of	 cervicovaginal	 secretions	 during	 delivery,	 postpartum	 via	
breastfeeding,	 and	 ascending	 from	 the	maternal	 genital	 tract	 antepartum	 (rare).	





sensorineural	 hearing	 loss.	 Early	 identification	 of	 children	 with	 CMV	 burden	 in	




















mucosal	 cells	 as	well	 as	 through	 skin	 interruptions	 and	migrate	 to	nerve	 tissues	




pregnancy,	 HSV	 infection	 has	 been	 associated	 with	 spontaneous	 abortion,	
intrauterine	growth	restriction,	preterm	labor,	and	congenital	and	neonatal	herpes	
infections.	 The	 clinical	 management	 revolves	 around	 decreasing	 vertical	
transmission	to	the	fetus,	thereby	decreasing	the	risk	of	neonatal	herpes	infection.	
Primary	or	 first	genital	HSV	 infection	 late	 in	pregnancy	carries	a	30–50%	risk	of	
neonatal	 infection,	 while	 early	 pregnancy	 infection	 carries	 a	 risk	 of	 <1%.		
Transplacental	or	ascending	transmembranal	transmission	of	HSV	from	mother	to	









This	 disease,	 caused	 by	 the	 bite	 of	 the	 anopheles	 mosquito	 transmits	 the	
Plasmodium	 spp	 protozoarium.	 There	 are	 5	 different	 kinds	 of	 Plasmodium:	
falciparum,	vivax,	berghei,	malariae	and	ovale	that	triggers	immune	processes	and	
relevant	 hemodynamic	 responses	 (OMIM	 2012).	 Among	 the	 relevant	
pathophysiological	phenomena,	sequestration	 in	cerebral	microcirculation,	which	




2011).	 The	 most	 severe	 course	 of	 the	 human	 disease	 is	 caused	 by	 Plasmodium	
falciparum,	leading	to	multi-organ	disease.	In	particular	cerebral	malaria	(CM)	is	a	
potentially	leading	cause	to	a	wide	range	of	neurocognitive	sequelae.	
Ototoxicity	 from	 antimalarial	 is	 a	 well-publicized	 cause	 of	 deafness	 and	 a	 great	
deal	 of	 time	 and	 resources	 are	 spent	 assessing	 it	 in	 relation	 to	 new	 drugs.	 The	
effect	 of	 the	 malaria	 parasite	 itself	 on	 hearing	 is,	 however,	 poorly	 documented	
(Zhao	&	Mackenzie	2011).	
Malaria	 induced	 by	Plasmodium	falciparum	 has	 been	 suspected	 to	 cause	 hearing	
loss	 (Schmutzhard	et	al.	2010).	Developmental,	 cognitive	and	 language	disorders	
have	been	observed	in	children,	surviving	to	cerebral	malaria.	Furthermore,	it	has	
been	 shown	 that	 severe	 falciparum	 malaria	 may	 lead	 to	 an	 acquired	 language	
disorder	 (Schmutzhard	 et	 al.	 2010).	 The	 study	 of	 Schmutzhard	 et	 al.	 show,	 that	
malaria	 leads	 to	 a	 significant	 hearing	 impairment	 in	mice.	When	 comparing	 the	
results	 of	 the	different	 subgroups	 an	 affection	 at	 all	measured	 frequencies	 could	
been	shown	in	the	CM	group,	but	only	at	the	lower	and	middle	frequencies	in	the	
non-CM	 group.	 Malaria	 retinopathy	 has	 been	 suggested	 to	 be	 the	 result	 of	
adherence	 and	 sequestration	 of	 P.	 falciparum	 -	 infected	 erythrocytes	 in	 the	
microvascular	 system	 leading	 to	 impaired	microcirculation.	 It	 seems	 conceivable	
that	impairment	of	cerebral	microcirculation	within	the	central	nervous	system	is	
very	 likely	 to	 include	both	organs	(Schmutzhard	et	al.	2010).	The	spiral	modular	
artery	enters	the	cochlea	at	the	basal	turn	and	ends	at	the	apical	turn.	Therefore,	





cochlea	 should	 effect	 the	 apical	 turns	 more	 than	 the	 basal	 (Schmutzhard	 et	 al.	
2010).	With	a	significant	hearing	loss	at	frequency	that	is	located	more	apically	in	
the	 cochlea	 -	 the	 hypothesis	 of	 microvascular	 affection	 in	 the	 CM	 group	 is	
supported.	 The	 non-CM	 group	 with	 a	 significant	 impairment	 of	 the	 lower	 and	
middle	 frequencies	 suggests	 an	 equivalent	 interpretation	 possibility.	 Other	
pathologic	alterations	are	known	to	affect	the	inner	ear	with	various	inflammatory	
mediators	(Schmutzhard	et	al.	2010).	In	2011,	Schmutzhard	et	al.	suggest	that	the	
severity	of	 the	disease	has	an	 impact	on	 the	development	of	hearing	 impairment	
(Schmutzhard	 et	 al.	 2011).	 ICAM	 1	 findings	 suggest	 that	 various	 systemic	




Meningitis	 is	 inflammation	 of	 the	 meninges	 (membranes)	 that	 surround	 and	
protect	 the	 brain	 and	 spinal	 cord.	 It	 is	 usually	 caused	 by	 a	 bacterial	 or	 viral	




In	meningitis,	 the	 infection	may	spread	 to	 the	 inner	ear	and	 irreversibly	damage	
the	hair	cells	of	the	cochlea	thus	causing	deafness	(Desai	et	al.	2015).	





















to	 disabilities,	 affecting	 a	 range	 of	 body	 structures	 and	 functions	 (Banks	 et	 al.	
2015).	 All	 three	 studies	 using	 a	 HIV-control	 group	 found	 a	 significantly	 higher	
prevalence	of	hearing	impairment	among	people	living	with	HIV	(PLHIV)(Banks	et	
al.	2015).	Although	more	research	 is	needed	 to	 fill	 the	gaps	 in	knowledge,	 in	 the	




The	 high	 occurrence	 of	 hearing	 loss	 requires	 the	 implementation	 of	 monitoring	
program	for	children	receiving	ototoxic	medication	(Ghafari	et	al.	2015).		
Aminoglycosides	 (AGs)	 are	 a	 well-known	 and	 successful	 class	 of	 antibiotics.	










cochleotoxicity	 include	 hearing	 loss	 and/or	 tinnitus,	 while	 those	 of	
vestibulotoxicity	 consist	 of	 disequilibrium	 and	 dizziness.	 AGs	 cochleotoxicity	
typically	 affects	 first	 the	 high	 frequency	 and	 then	 extends	 towards	 the	 lower	
frequency	and	 ranges	over	 time	 in	a	dose-dependent	manner	 (Huth	et	 al.	 2011).	
One	 main	 susceptibility	 factor	 (17%–33%	 of	 patients	 with	 reported	 ototoxic	
damage)	 is	 the	 genetic	 predisposition	 to	 AG	 ototoxicity.	 This	 increased	
susceptibility	 was	 inherited	 maternally	 suggesting	 mitochondrial	 involvement,	
since	 several	 mutations	 in	 mitochondrial	 DNA	 has	 been	 linked	 to	 increased	
susceptibility	to	AG	ototoxicity	(Huth	et	al.	2011).	The	mutation	A155G	in	mtDNA	
is	described	as	increasing	susceptibility	risk	to	AG	ototoxics	(Fan	et	al.	2017).	
Gentamicin	 is	 still	 widely	 used,	 and	 the	 neonatal	 population	 and	 young	 adult	
women	are	at	especially	high	risk	for	gentamicin-induced	ototoxicity	(Kushner	et	
al.	 2016).	 In	 countries	 like	 Tanzania,	 gentamicin	 is	 widely	 used	 and	 is	 a	 known	
ototoxic	agent	especially	in	less	well-controlled	medical	facility	(Freeland,	Jones	&	
N.	K.	Mohammed	2010)	
Others	 therapeutics	we	know	 that	 could	 lead	 to	ototoxicity	 are,	 for	 example,	 the	
antimalarials	as	quinine.	These	are	often	associated	to	hearing	loss	(Claessen	et	al.	





The	 use	 of	 artemisinin	 derivatives	 has	 increased	 exponentially	 with	 the	 use	 of	
artemisinin	 combination	 therapy	 (ACT)	 in	 all	 malaria’s	 areas	 (Carrara	 et	 al.	
2008a).	 They	 are	 highly	 effective	 and	 are	 considered	 safe,	 but	 in	 animal	 studies	
artemisinin	 derivatives	 produce	 neurotoxicity	 targeting	mainly	 the	 auditory	 and	
vestibular	pathways.	 In	 the	 study	of	 Carrara	 et	 al	 (2008)	neither	 audiometric	 or	









unsafe	 use	 of	 personal	 audio	 devices,	 including	 smartphones,	 and	 exposure	 to	
damaging	 levels	of	sound	at	noisy	entertainment	venues	such	as	nightclubs,	bars	
and	 sporting	 events,	 according	 to	 WHO	 data.	 Data	 from	 studies	 in	 middle-	 and	
high-income	 countries	 indicate	 that	 among	 individuals	 aged	 12-35	 years,	 nearly	
50%	are	exposed	to	unsafe	levels	of	sound	from	the	use	of	personal	audio	devices	
and	 around	 40%	 are	 exposed	 to	 potentially	 damaging	 levels	 of	 sound	 at	
entertainment	venues	(WHO	2013d).	Unsafe	levels	of	sounds	can	be,	for	example,	
exposure	 to	 in	 excess	 of	 85	 dB	 for	 eight	 hours	 or	 100dB	 for	 15	minutes	 (WHO	
Media	centre	2015a).	
Exposure	 to	 loud,	 prolonged	 sounds	 (acoustic	 trauma,	 AT)	 leads	 to	 the	 death	 of	
both	 inner	 and	 outer	 hair	 cells	 (IHCs	 and	 OHCs),	 death	 of	 neurons	 of	 the	 spiral	
ganglion	and	degeneration	of	the	auditory	nerve	(Baizer	et	al.	2015).	
Hearing	impairment	may	be	induced	by	a	single	impulsive	noise	or	after	repetitive	
exposure	 to	moderate	 or	 high	 intensity	 noise	 (Sanz	 et	 al.	 2015)	 The	 cumulative	
damaging	effects	on	the	inner	ear	depend	on	the	noise	characteristics	(frequency,	
level),	 chronicity	 and	 individual	 susceptibility	 to	 noise.	 	 Inner	 and	 particularly	






may	 increase	 susceptibility	 to	 noise-induced	 hearing	 loss	 and	 facilitate	 the	 cell	




Anemia	 is	 characterized	 by	 a	 decreased	 quantity	 of	 red	 blood	 cells,	 often	





morphology	 (Kassebaum	 et	 al.	 2014).	 Different	 biological,	 socioeconomic	 and	
environmental	 factors	 are	 reported	 to	 affect	 the	 dietary	 intake	 and	 nutrient	
absorption	 capacity	 of	 individuals	 (Degarege	 et	 al.	 2015).	 Hypoproliferative	
anemia’s	are	the	most	common	anemia,	and	in	the	clinic,	iron	deficiency	anemia	is	
the	most	 common	of	 these	 followed	by	 the	 anemia	of	 inflammation	or	 intestinal	
parasitosis.	In	anemia	there	is	a	reduced	O2	delivery	to	tissue	(Kasper	et	al.	2015).	
Anemia	 is	 pathophysiological	 diverse	 and	 often	 multifactorial.	 Symptoms	 result	
from	impaired	tissue	oxygen	delivery	and	may	include	weakness,	fatigue,	difficulty	
concentrating,	 or	poor	work	productivity.	 Children	may	have	 issues	with	mental	
and	motor	development	(Kassebaum	et	al.	2014).	
Global	 anemia	 prevalence	 in	 2010	was	 32.9%,	 (Kassebaum	 et	 al.	 2014)	 causing	
68.36	 million	 years	 lived	 with	 disability	 (8.8%	 of	 total	 for	 all	 conditions).	
Prevalence	dropped	 for	both	sexes	 from	1990	to	2010,	although	more	 for	males.	
Prevalence	in	females	was	higher	in	most	regions	and	age	groups.	South	Asia	and	
Central,	 West,	 and	 East	 sub-Saharan	 Africa	 had	 the	 highest	 burden,	 while	 East,	
Southeast,	and	South	Asia	saw	the	greatest	reductions	(Kassebaum	et	al.	2014).		
Iron-deficiency	 anemia	 was	 the	 top	 cause	 globally,	 although	 10	 different	









Figure	 1.3-20	 -	 Global	 and	 regional	 cause-specific	 anemia	 prevalence	 for	 1990	 and	
2010.(Kassebaum	et	al.	2014)	
	
Hemoglobinopathies	made	significant	 contributions	 in	most	populations,	 and	are	
especially	common	in	areas	in	which	malaria	is	endemic	(Kasper	et	al.	2015).	This	
clustering	 of	 hemoglobinopathies	 is	 assumed	 to	 reflect	 a	 selective	 survival	
advantage	 for	 the	 abnormal	 RBC,	 which	 presumably	 provides	 a	 less	 hospitable	
environment	during	the	obligate	RBC	stages	of	the	parasitic	life	cycle	(Kasper	et	al.	
2015).	
Sickle	 cells	 lose	 the	 pliability	 needed	 to	 pass	 through	 small	 capillaries.	 They	
possess	 altered	 "sticky"	 membranes	 	that	 are	 abnormally	 adherent	 to	 the	
endothelium	of	 small	 venules	 (Kasper	 et	 al.	 2015).	 These	 abnormalities	 provoke	
unpredictable	 episodes	 of	 microvascular	 	vasoocclusion	 and	 premature	 RBC	
destruction	(hemolytic	anemia).	Hemolysis	occurs	because	the	spleen	destroys	the	
abnormal	RBC.	The		rigid	adherent	cells	clog	small	capillaries	and	venules,	causing	
tissue	 	ischemia,	 acute	 pain,	 and	 gradual	 end-organ	 damage.	 This	 venoocclusive	
component	usually	dominates	the	clinical	course		(Kasper	et	al.	2015).	
A	 finite	 life	 span	 is	 a	 distinct	 characteristic	 of	 red	 cells.	 Hence,	 a	 logical,	 time-
honorand	classification	of	anemia	is	 in	three	groups:	(1)	decreased	production	of	
red	cells,	(2)	increased	destruction	of	red	cells,	and	(3)	acute	blood	loss.		
and malaria. Global prevalence decreased for most causes between
1990 and 2010. The largest gain for males was in reduction of
hookworm prevalence, while the largest percentage improvement
for females was in maternal hemorrhage. Malaria, schistosomiasis,
and CKDs were the only causes of anemia that increased
in prevalence, while ane ia as a result of all hemoglobinopathies
was relatively flat. The result, coupled with aging and population
growth, was a dramatic increase in the number of cases for these
conditions.
The lowest burden from iron deficiency was found in North
America, high income (2.9% of envelope), while sev ral regions had
a very high fraction of their burden caused by it, including Central Asia
(64.7%), South Asia (54.8%), and Andean Latin America (62.3%).
High-income regions tended to have a higher proportion of their
anemia burden attributable to hemoglobinopathies, CKDs, and
gastrointestinal hemorrhage. Malaria was a major cause of anemia in
many regions, but none more so than western sub-Saharan Africa,
where it accounted for 24.7% of the prevalence envelope for both
sexes combined.
Anemia burden by age group
Figure 4 shows global anemia burden by age group and sex. The
highest anemia prevalence was in the postneonatal period, followed
by age 1 to 4 years. These youngest age groups also had the least
favorable changes fro 1990 to 2010. Age group results by region
are shown in supplemental Figure 8, and specific causes are shown
in supplemental Figure 9. Age patterns of anemia were qualitatively
similar for all regions and most causes. Notable exceptions were
hookworm, CKDs, and anemia related to gastric and gynecologic
conditions. In males, there was a marked increase in prevalence of
anemia from hookworm at age 5 to 14 years, a rapid decline in
adulthood, and another increase in older age groups. Anemia from
CKD increased with age in an accelerating fashion for both sexes,
culminating as the most prevalent cause of anemia in the 801 years
age group. Maternal hemorrhage peaked at age 25 to 29 years.
Anemia from uterine fibro ds and other gynecologic conditions
peaked at young ages and decreased steadily with age. Gastritis and
peptic ulcer disease were estimated to account for an appreciable
portion of anemia burden in adults until age 50 to 54 years.
By age 15 years and continuing through adulthood, females
c nsistently had more anemia than m les. Me n DW for f males
was also higher throughout most of adulthood. The gender gap was
widest in the Caribbean and Central and South Asia, although in
percentage terms, it was greater in wealthy regions, especially
Australasia and Asia Pacific, high income. Gender differences were
most pronounced between ages 20 and 34 and worsen d between
1990 and 2010. Females had higher prevalence of all causes except
for other infectious disease, other neglected tropical diseases, other
hemoglobinopathies, and peptic ulcer disease. Complete anemia
burden figures by country, age group, year, and sex are illustrated in
Figure 5 (YLD) and tabulated in supplemental Table 7 (prevalence).
Figure 3. Global and regional cause-specific anemia prevalence for 1990 and 2010. Prevalence of anemia for both males and females decreased from 1990 to 2010. The
largest improvements for males were in anemia resulting from hookworm and iron deficiency, while the largest percentage gains for females were in iron deficiency and
maternal hemorrhage. Regional differences in proportion of cases resulting from specific causes varied widely. Malaria was a major cause of anemia in many regions, but
none more so than West sub-Saharan Africa, where it accounted for 24.7% of all prevalent anemia. South and East Asia, despite being among those regions with the greatest
reductions in anemia, had more than half the world’s anemia cases. Anemia prevalence in 2010 generally increased with decreasing regional mean age of death. Prevalence
was highest in East, Central, and West sub-Saharan Africa. These regions also saw the least improvement among all low- and middle-income regions between 1990 and
2010. AP, Asia Pacific; Cent, central; Eur, Europe; G6PD, glucose-6-phosphate dehydrogenase; hemog, hemoglobinemia; HI, high income; LA, Latin America; NA, North
America; NA/ME, North Africa/Middle East; NTD, neglected tropical diseases; South, Southern; SE, Southeast; SSA, sub-Saharan Africa.
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In	 Hemolytic	 anemia	 it	 should	 be	 classified	 as	 hereditary	 or	 acquired;	 in	 what	
hereditary	 intracorpuscular	 defects	 include	 hemoglobinopathies,	 enzymopathies	
or	 membrane	 cytoskeletal	 defects	 and	 extracorpuscular	 defects	 in	 Familial	
(atypical)	 hemolytic-uremic	 syndrome.	 Acquired	 hemolytic	 anemia	 include	
paroxysmal	 nocturnal	 hemoglobinuria	 (PNH)	 as	 intracorpuscular	 defect	 and	 as	
extracorpuscular:	 toxic	 agents,	 drugs,	 infections,	 autoimmune	 and	 mechanical	
(microangiopathic)	destruction	(Kasper	et	al.	2015).	




red	 blood	 cells	 in	 humans,	 affecting	 more	 than	 400	 million	 people	 worldwide	
(Glader	2016).	
With	 the	 most	 prevalent	 G6PD	 variants	 (G6PD	 A-	 and	 G6PD	 Mediterranean),	
hemolysis	 is	 induced	 in	 children	 and	 adults	 by	 the	 sudden	 destruction	 of	 older,	
more	deficient	erythrocytes	after	exposure	to	drugs	having	a	high	redox	potential	
(including	 the	 antimalarial	 drug	 primaquine	 and	 certain	 sulfa	 drugs)	 or	 to	 fava	
beans,	 selected	 infections,	 or	 metabolic	 abnormalities.	 However,	 in	 the	 neonate	
with	G6PD	deficiency,	decreased	bilirubin	elimination	may	play	an	important	role	
in	the	development	of	jaundice	(Glader	2016).	




such	 females	 can	 be	 susceptible	 to	 the	 same	 pathophysiological	 phenotype.	
Although	 heterozygous	 women,	 on	 average,	 have	 less	 severe	 clinical	
manifestations	 than	 G6PD-deficient	males,	 some	 develop	 severe	 acute	 hemolytic	
anemia	(Cappellini	&	Fiorelli	2008).	
The	worldwide	 distribution	 of	malaria	 is	 remarkably	 similar	 to	 that	 of	mutated	
G6PD	 alleles,	 making	 the	 malaria	 hypothesis	 of	 G6PD	 deficiency—that	 G6PD	





growth	 is	 slowest	 in	 G6PD-deficient	 cells.	 Luzzatto	 et	 al.	 data	 showed	 that	 red	
blood	cells	with	normal	G6PD	activity,	taken	from	G6PD	A–	heterozygous	females	
(who	 underwent	 random	 X-chromosome	 inactivation),	 had	 2–80	 times	 more	
parasitic	 growth	 than	 G6PD-deficient	 red-blood	 cells.	 G6PD-deficient	 red-blood	
cells	 infected	with	 parasites	 undergo	phagocytosis	 by	macrophages	 at	 an	 earlier	
stage	 of	 parasite	 maturation	 than	 do	 normal	 red-blood	 cells	 with	 parasitic	
infection,	which	could	be	a	further	protective	mechanism	against	malaria.	
Fortunately,	most	G6PD-deficient	 individuals	 are	 asymptomatic	 throughout	 their	
life,	and	unaware	of	their	status	(Cappellini	&	Fiorelli	2008).	The	illness	generally	
manifests	as	acute	hemolysis,	which	usually	arises	when	red	blood	cells	undergo	





The	 genetic	 influence	 in	 hearing	 loss	 is	 a	 known	 cause.	 Not	 only	 hearing	 loss	 is	






adolescence	 (Lafferty	 et	 al.	 2014).	 Approximately	 50%	 is	 explained	
genetically(Lafferty	 et	 al.	 2014).	 Among	 these,	 ≈70%	 hearing	 loss	 is	 the	 only	
clinical	sign	and	the	remaining	≈30%	can	be	syndromic	hearing	loss	(Lafferty	et	al.	
2014).	 The	 forms	 of	 nonsyndromic	 hearing	 loss,	 autosomal	 recessive	 are	
genetically	 heterogeneous	 and	 are	 the	most	 common	 form	of	 hereditary	hearing	
loss,	 accounting	 for	 about	 ≈77%	 of	 cases	 (Lafferty	 et	 al.	 2014).	 This	 number	 is	











The	most	 recent	 advances	 in	molecular	 genetics	 have	 allowed	 associate	 hearing	
loss	more	than	400	syndromes,	while	more	than	140	loci	related	to	non-syndromic	
hearing	loss	have	been	mapped	(Matos	et	al.	2013).	To	date,	179	deafness	loci	have	
been	reported	 in	 the	 literature:	67	DFNA	 loci,	106	DFNB	 loci,	and	6	X-linked	 loci	
(http://hereditaryhearingloss.org/).	
The	GJB2	(Gap	Junction	β-2)	forms	with	the	GJB6	gene	(Gap	Junction	β-6)	DFNB1	
locus	 located	on	 chromosome	13q11-q12,	 and	 encoding	 the	protein	 connexin-26	
(Cx26)	and	connexin-30	(Cx30),	respectively	(Nickel	&	Forge	2008).	The	connexin	
proteins	have	a	 transmembrane	 location	and	can	associate	 in	a	hexamer	forming	
connexons	 resulting	 from	 the	 dock	 of	 both	 hexamers	 on	 the	 surface	 of	 adjacent	
cells	 (Martínez	 et	 al.	 2009).	 The	 connexons	 are	 designated	 homomeric	 when	
consist	 of	 a	 single	 type	 of	 connexin	 or	 heteromeric,	 when	 they	 are	 formed	 by	
different	connexins	(Matos	et	al.	2013).	The	cells	connected	by	gap	 junctions	use	
























(Nickel	 &	 Forge	 2008).	 In	 the	 cochlea,	 Cx26	 and	 Cx30	 are	 co-located	 and	 co-
expressed,	 contributing	 to	 cochlear	 homeostasis,	 through	 the	 formation	 of	 gap	
junctions	heteromeric	(Nickel	&	Forge	2008).	The	maintenance	of	this	homeostasis	




have	 been	 identified	 in	 this	 gene	 and,	 depending	 on	 the	 population,	 account	 for	
about	10-40%	of	cases	of	hereditary	hearing	loss,	representing	the	most	common	
cause	of	non-syndromic	autosomal	recessive	hereditary	hearing	loss	(Matos	et	al.	
2011).	 The	most	 common	mutation	 in	 the	 Caucasian	 population	 is	 the	 c.35delG,	
which	 results	 in	 premature	 termination	of	 the	polypeptide	 chain	 of	 Cx26	 after	 a	
change	in	reading	frame	leading	to	a	premature	STOP	codon.	The	allelic	frequency	
for	this	mutation	was	estimated	at	2.5%	in	the	general	Caucasian	population,	in	a	
total	 of	 3.0%	 allele	 frequency	 for	 all	mutations	 in	GJB2	 (Matos	 et	 al.	 2011).	 The	
c.167delT	mutation,	in	turn,	has	a	high	frequency	in	Ashkenazi	Jewish	population	
(7.5%)	 and	 c.235delC	 mutation	 is	 the	 most	 common	 in	 Japanese	 and	 Korean	
populations,	 allele	 frequencies	 estimated	 at	 0.5	 and	1%,	 respectively.(Tang	 et	 al.	
2006;	Falah	et	al.	2011).		
The	GJB6	gene,	contrary	to	GJB2	gene,	has	 today	described	a	 few	mutations,	only	
six	 that	 have	 a	 pattern	 of	 recessive	 inheritance.	 These	 six	 mutations,	 four	 are	















missions	 from	 February	 2012	 to	 January	 2014,	 a	 total	 of	 2	 full	 years	 of	







Determination	 of	 the	 prevalence	 of	 HbS	 trait	 and	 G6PD	 deficiency	 will	 be	
important	as	they	may	be	associated	with	hearing	loss.	Both	factors	are	associated	
to	thromboembolic	events	triggered	by	the	deformation	of	the	erythrocytes	or	by	
their	 hemolysis.	 In	 presence	 of	 infection	 with	 Plasmodium	 falciparum,	 this	
erythrocyte's	deformation,	which	represents	a	protection	factor	to	severe	malaria,	
can	also	be	responsible	to	thromboembolic	events.	
The	 study	 of	 DFNB1	 locus	 will	 always	 be	 relevant	 by	 the	 fact	 that	 this	 locus	 is	
strongly	associated	to	HL	but	also	because	São	Tomé	and	Príncipe	is	a	country	that	
had	been	colonized	by	the	Portuguese	and	other	European	countries.	In	this	kind	
of	study,	we	are	 trying	 to	determine	the	 influence	of	other	people	on	the	genetic	
characterization	of	the	population.	São	Tomé	and	Príncipe	is	an	island,	and	as	such	




The	 evaluation	 of	 the	 immune	 status	 of	 rubella	 is	 important	 first	 to	 analyse	 the	











– Study	 the	 association	 of	 HbS	 traits	 and	 G6PD	 deficiency	 with	 cases	 of	
sensorineural	hearing	loss,		
– Determine	 the	 prevalence	 of	 hearing	 loss	 associated	 with	 HbS	 traits	 and	
G6PD	deficiency	in	the	sample,	
– Determine	 the	 prevalence	 of	 hearing	 loss	 caused	 by	 genetic	 factors	
associated	with	DFNB1	locus	in	the	sample,	


























that	will	 be	described	 in	 the	next	 chapters,	 as	 full	part	of	 each	published	papers	
presenting	the	results.	
	
The	 missions	 that	 took	 place	 between	 2011	 and	 2014,	 formed	 by	 the	 surgery	









loss?",	 we	 analyzed	 all	 the	 subjects	 that	 answered	 the	 question	 and	 have	 been	
evaluated	by	audiometric	exams.	
	
For	 the	 second	part	 of	 this	 study,	we	 selected	 a	 sample	of	 natural	 individuals	 of	
STP	that	was	based	on	data	collected	during	otolaryngology	missions	carried	out	
between	February	2012	and	 January	2014.	We	selected	 the	 individuals	who	met	
the	following	inclusion	criteria:	














This	 project	 is	 based	 on	 the	 work	 done	 during	 the	 Otolaryngology	 missions	 -	
Project	Health	 for	all	 specialties,	with	which	 the	ENT	department	of	 the	Hospital	
CUF	 Infante	 Santo	 has	 collaborated	 since	 2011.	 The	 sample	 consisted	 of	 data	
collected	during	the	years	2012-2014.	The	establishment	of	temporal	limitation	to	
February	 2012	was	 because	 it	was	 the	 point	 by	which	was	 possible	 to	 hold	 the	




electricity	 and	 otherwise	 offered	 less	 likely	 to	 run	 out	 of	 power	 during	 the	









years,	 these	age	classes	are	 less	exposed	to	risk	 factors	and	are	protected	from	a	








In	 São	 Tomé	 and	 Príncipe	 there	 is	 no	 way	 to	 assess	 auditory	 function,	 except	
during	missions.	The	individuals	in	this	project	are	those	who	voluntarily	from	the	
different	 geographical	 areas	 of	 São	 Tomé	 and	 Príncipe,	 resorted	 to	 ENT	
assessment	 and	 those	 who	 were	 selected	 during	 the	 missions	 for	 screening	





excluded	 as	 those	 presenting	 psychomotor	 developmental	 delays	 or	 probable	
cause	of	hearing	loss	identified.	
To	all	 individuals	was	done:	otoscopy,	medical	history	collection,	application	of	a	













The	 study	was	 submitted	 and	 approved	by	 the	Medical	 Ethics	 Committee	 of	 São	
Tomé	 and	 Príncipe	 and	 Ethics	 Research	 Committee	 NMS|FCM-UNL	
(nº02/2014/CEFCM).	 The	 Ethics	 Research	 Committee	 is	 aligned	 with	 the	





The	 methodology	 adopted	 was	 a	 case-control	 study	 based	 on	 subjects	 who	






The	organization	of	 subjects	 in	 the	 sample	 (n	=	316	 individuals)	was	performed	
according	to	the	audiological	data	being	integrated	in	a	control	or	case	group	being	
always	considered	the	respective	age	groups:	





and	 stored	 at	 room	 temperature.	 Later,	 it	 will	 be	 analyzed	 in	 the	 laboratory,	 in	
Portugal	(Figure	3.3-1).	Genomic	DNA	was	obtained	from	each	blood	sample	using	

















The	 GSI	 39	 Auto	 Tymp	 provides	 a	 flexible	 screening	 product	 for	
tympanometry	 and	 acoustic	 reflex	 measurements.	 It	 is	 a	 lightweight	 and	





The	 MIDIMATE	 622	 is	 the	 second	 member	 of	 the	 new	 generation	 of	
audiometers	 from	 GN	 Otometrics,	 which	 started	 with	 the	 Midimate	 602.	
This	 dual-channel	 clinical/diagnostic	 audiometer	 features	 a	 unique	
multilingual	menu-driven	display	 and	 five	user-programmable	 test	 setups	





Vivosonic	 Integrity	 V500	 is	 the	 #1	 Awake	 ABR	 system	 for	 clinics	
specializing	 in	 pediatric	 audiology,	 while	 providing	 equally	 valuable	
benefits	 for	clinics	serving	general	and	special	needs	adults,	as	well	as	the	
geriatric	population.	
Integrity™	 combines	 new	 signal	 processing	 technologies,	 improved	
amplifier	design	and	wireless	capabilities	to	produce	clear	recordings	with	
or	without	sedation.	With	this	innovative	technology,	Integrity™	minimizes	





reduces	 loss	 to	 follow-up	 issues	 for	newborn	hearing	screening	programs,	
and	 demonstrates	 reliable	 performance	 in	 less-than-ideal	 clinical	
environments	(Vivosonic	2017).	
	

































Figure	 3.4-2	 –	 Determination	 of	 electrophysiological	 threshold	 by	 Auditory	 Brainstem	 Response	
(ABR).	(Personal	photo)	
	
The	 determination	 of	 electrophysiological	 threshold	 with	 Auditory	 Brainstem	




































95	 °C	 for	 7	 min,	 cycling	 parameters	 were	 35	 cycles	 of	 95	 °C	 for	 30	 s,	 specific	
annealing	temperature	(60	°C)	for	30	s,	72	°C	for	30	s,	and	a	final	extension	at	72	°C	
for	 10	min.	 After	 amplification,	 10	ml	 of	 each	 PCR	 products	were	 digested	with	
appropriate	restriction	enzymes	(DdeI)	for	3	h	at	37	°C	followed	by	an	inactivation	
step	 at	 65	 °C	 for	 20	min	 and	 electrophoresed	 in	 2%	 agarose	 gel	 with	 ethidium	
bromide	 (0.5	mg/ml)	 for	 visualization	under	ultraviolet	 light	 (Figure	 3.5-1).	 The	
expected	products	for	each	genotype	of	the	tested	gene	are	shown	in	Table	3.5-1.	











We	 selected	 for	 this	 study	 two	 polymorphisms	 in	G6PD	 gene	 between	 the	most.	
prevalent	 SNPs	 described	 (rs1050828	 and	 rs1050829)	 in	 Sub-Saharan	 Africa	
(Howes	et	al.	2013;	Manco	et	al.	2007).	
The	 SNPs	 selected	 were	 genotyped	 using	 real-time	 PCR	 (RT-PCR	 7300	 Applied	
Biosystem),	 through	 TaqMan®	 SNP	 genotyping	 assays	 (Life	 Technology),	
according	 to	 manufacturer	 instructions	 (Figure	 3.6-1).	 Real-Time	 PCR	 genotype	











For	GJB2	 gene	 the	 DNA	 sample	was	 analyzed	 by	 sequencing	 regarding	 the	GJB2	
coding	region.	
PCR	 amplification	 and	 sequencing	 of	 the	 coding	 region	 of	 the	 GJB2	 gene	 was	
performed	 using	 previously	 described	 primers	 (Matos	 et	 al.	 2010).	 The	 GJB2	
fragment	that	was	amplified	comprises	the	coding	region	and	flanking	noncoding	
regions	including	the	acceptor	splice	site.	However,	the	extension	of	the	sequence	






NCBI’s	 Blast	 program	 (suite	 2-sequences)	 (Figure	 3.7-1).	 All	 the	 variants	 here	

























dilution	 solution	 to	¼	of	 the	DBS,	 corresponding	 to	32	mm2.	The	extraction	was	
carried	out	for	60	minutes	at	600	rpm	at	room	temperature	and	18	hours	at	4ºC.	










Figure	 3.9-1	 –	 Algorithm	 for	 interpretation	 of	 results	 of	 IgG	 rubella.	 	 Results	 are	 expressed	 in	
international	units	(U/I).	
	
The	procedure	of	 IgG	determination	 from	DBS	was	 first	validated	and	optimized,	
evaluating	 the	 correlation	 of	 IgG	 achieved	 by	 our	 extraction	 method	 versus	 the	
immune	status	(vaccinated	/	unvaccinated)	(work	done	by	Vera	Vicente	–	master	














































essential	 to	 the	 early	 implementation	 of	 social	 and	 educational	 measures	
necessary	to	promote	an	integrative	society.	
The	 aim	of	 this	 study	 is	 to	 compare	 the	 prevalence	 of	 self-reported	hearing	 loss	
with	the	prevalence	of	hearing	loss	obtained	from	audiometric	testing	in	a	sample	
with	different	age	groups	 from	the	population	of	 the	Democratic	Republic	of	São	
















compared	 to	 the	 full	 range	 of	 audiometric	 tests.	 The	 youngest	 group	 revealed	 a	
lower	 sensitivity	 (65.22%)	 and	 a	 higher	 specificity	 (73.58%)	when	 compared	 to	
the	oldest	group.	
Conclusions:	
The	 subjective	 perception	 of	 hearing	 loss	 continues	 to	 be	 a	 form	 of	 deafness	
identification	 and	 may	 be	 useful	 in	 epidemiological	 studies,	 especially	 in	 least	
developed	 countries	where	 hearing	 tests	 are	 not	 always	 available.	 In	 this	 study,	
based	 on	 the	 sensitivity,	more	 than	 30%	of	 children	with	 hearing	 loss	were	 not	
detected,	 meaning	 that	 the	 opportunity	 was	 lost	 for	 early	 intervention	 during	
critical	periods	of	language	acquisition,	which	could	be	problematic.	
	















- Hearing	 loss	 (HL)	 is	 an	 important	 problem	 in	 today’s	 society.	
Approximately	5%	of	 the	world’s	population	has	disabling	HL.	This	 loss	 is	
responsible	for	social	isolation,	depression,	low	education	and	thus	leads	to	
low	social	productivity	and	low	quality	of	life.	Auditory	evaluation	was	not	
available	 in	 São	 Tomé	 and	 Príncipe	 unless	 it	 was	 part	 of	 humanitarian	
missions	of	otolaryngology.	
- The	 application	 of	 questionnaires	was	 useful	 in	 least	 developed	 countries	
(LDC),	where	there	is	a	lack	of	equipment	to	facilitate	the	early	detection	of	
hearing	 impairment	 in	 children.	 In	 São	 Tomé	 and	 Príncipe,	 the	
questionnaire	was	applied	 to	patients	and	 tutors.	The	auditory	evaluation	
was	 performed	 only	 during	 missions,	 3	 to	 4	 weeks	 a	 year.	 The	 first	
limitation	was	the	location	of	the	exam,	which	was	in	a	quiet	room	without	
a	soundproof	booth	(none	are	available	on	the	island).	Attempts	were	made	
to	 limit	 the	 sound,	 which	 was	 tested	 by	 an	 iPhone	 app,	 The	 Auditory	
Brainstem	 Response	 (ABR)	 was	 used	 to	 assess	 all	 patients	 who	 did	 not	
cooperate	with	 the	 Pure	 Tone	Audiogram	 (PTA).	 To	 perform	 the	ABR	we	
chose	to	use	the	click	instead	of	tone	bursts	because	it	allowed	us	to	obtain	
more	information	in	a	short	time,	taking	into	account	the	limitations.	If	the	
ABR	 thresholds	 were	 normal	 for	 the	 click,	 we	 assumed	 that	 the	 low	
frequencies	were	normal.	
- For	younger	children,	the	questions	were	answered	by	the	caretakers,	and	
the	 self-report	 presented	 a	 high	 specificity	 despite	 the	 low	 sensitivity.	
Based	 on	 the	 sensitivity,	 more	 than	 30%	 of	 children	 with	 HL	 were	 not	
detected,	and	opportunities	for	early	intervention	during	critical	periods	of	










the	 world’s	 population	 has	 disabling	 HL,(WHO	 2013a)	 expecting	 that	 the	
prevalence	of	HL	is	higher	if	the	criteria	such	as	“worse	than	25	dB”	are	used.	
This	 loss	 is	 responsible	 for	 social	 isolation,	 depression,	 low	 education	 and	 thus	
leads	to	low	social	productivity	and	low	quality	of	life.	
The	 application	 of	 questionnaires	 is	 useful	 in	 least	 developed	 countries	 (LDC),	
where	 there	 is	 a	 lack	 of	 equipment	 to	 facilitate	 the	 early	 detection	 of	 hearing	
impairment	in	children.	




São	 Tomé	 and	 Príncipe	 in	 Sub-Saharan	 Africa	 belongs	 to	 the	 LDC.	 With	 scarce	
healthcare	 resources	 in	 these	 countries,	 there	 is	 no	 possibility	 to	 identify	HL	 by	
audiometric	exams.		
During	humanitarian	missions	of	 the	 Instituto	Marquês	de	Valle	Flor	 (IMVF)	and	
the	 Instituto	 Camões	 for	 the	 project	 “Health	 for	 all	 specialties”,	 a	 group	 of	
otolaryngologists	and	audiologists	came	to	this	equatorial	island	and	evaluated	the	
audiologic	status	of	the	population.	
While	 standardized	 audiometric	 assessment	 of	 HL	 could	 be	 considered	 the	 gold	
standard	 for	 estimating	 its	 prevalence,	 large	 studies	 are	 often	 constrained	 by	
limited	 budget,	 expertise	 and	 the	 logistic	 difficulty	 of	 performing	 audiometric	
screening	on	a	large	scale(Sindhusake	et	al.	2001).	Moreover,	some	countries,	such	











the	 following:	 Social	 Hearing	 Handicap	 Index	 (SHHI),	 Hearing	 Performance	
Inventory	 (HPI),	 Hearing	 Handicap	 Inventory	 for	 the	 Elderly:	 Screening	 Version	
(HHIE-S)	 and	 National	 Health	 and	 Nutrition	 Examination	 Survey	 (NHANES).	 In	
these	tests,	we	can	find	questions	on	hearing	such	as	“Do	you	have	a	problem	with	
your	hearing?”	or	“Do	you	feel	you	have	a	hearing	problem?”.	
The	validation	of	 the	question,	 confirmed	 through	 the	 results	 of	 the	 audiometric	
testing,	 is	 important	 and	 necessary	 to	 assess	 the	 HL	 status,	 and	 although	 it	 is	 a	
“subjective”	exam,	it	is	considered	a	gold	standard	assessment	when	characterizing	
hearing.	
According	 to	 Peter	 Torre	 III	 et	 al.,	 there	 have	 been	 epidemiological	 studies	 in	
which	different	questions	about	audiology	assessment	are	rated	on	adult	patients	
over	forty	years	of	age	(Torre	et	al.	2006).	
The	 study	 of	Marini	et	 al.	 investigated	 the	 value	 of	 the	 hearing	 and	 non-hearing	
complaints	reported	on	the	clinical	history	and	compared	them	with	the	results	of	
the	 audiometric	 exams	 using	 the	 Pure	 Tone	 Audiogram	 (PTA).	 A	 sensitivity	 of	
80.9%	 and	 a	 specificity	 of	 69.7%	was	 reported	 for	 the	 HL	 complaints	 in	 all	 age	
groups	(Marini	et	al.	2005).	
Newton	 et	 al.	 evaluated	 the	 use	 of	 a	 questionnaire	 to	 detect	 HL	 in	 Kenyan	 pre-
school	children	and	demonstrated	that	it	could	be	usefully	applied	at	the	primary	
health	care	level	(Newton	et	al.	2001).	
The	 necessity	 of	 knowledge	 concerning	 the	 HL	 status	 in	 the	 population	 of	 São	
Tomé	 and	 Príncipe,	 who	 do	 not	 have	 access	 to	 audiometric	 examination,	 is	














observed	at	 the	audiology	appointment	during	 the	humanitarian	missions	 in	São	
Tomé	 and	 Príncipe	 (Hospital	 Ayres	 de	Menezes,	 schools	 and	 a	 local	 hotel).	 Only	
individuals	 or	 caretakers	 (if	 children	 or	 older	 individuals	 could	 not	 answer	 the	
question)	 answered	 a	 self-reported	 question	 “Do	 you	 feel	 you	 have	 a	 hearing	
loss?”.	 If	 the	 answer	 was	 “yes”,	 follow-up	 questions	 “Which	 ear?	 One	 or	 both?”,	
were	asked.	The	audiometric	or	electrophysiological	threshold	was	recorded	for	all	
individuals	who	answered	both	questions.	
We	 included	 in	 this	 study	 all	 individuals	 who	 were	 accepted	 to	 participate,	
answered	 the	 clinical	 oral	 inquiry	 about	previous	history	 (familial	history	of	HL;	
personal	 history	 of	 ear	 infections	 and	 infectious	 diseases	 such	 as	 malaria	 and	
meningitis;	 head	 trauma;	 medications;	 and	 for	 young	 children,	 questions	 were	
asked	 about	 the	 history	 of	 infections	 and	 medications	 in	 the	 mother	 during	






Madsen	 Midimate	 622	 (audiometer).	 The	 audiometric	 exams	 were	 performed	
without	an	audiometric	cabin,	with	earphones-TDH39,	in	a	closed	room,	and	with	a	
level	 of	 noise	measured	 by	 iPhone	SchabelDoesIT	GbR,	Munich,	Germany	(version	
1.0.0).	The	noise	did	not	exceed	30	dBSPL,	based	on	ANSI	S3.1-1999	(R2013).	The	
audiometric	 equipment	 was	 calibrated	 according	 to	 the	 calibration	 ISO389	
1975/Oslo	recommendation.			
The	procedure	used	 to	determine	 the	audiometric	 thresholds	was	 the	bottom-up	






conduction	 in	 the	 non-test	 ear.	 The	 stimulus	 used	 was	 a	 narrow	 band	 noise	
centred	around	the	test	frequency.	
The	 electrophysiological	 estimation	 of	 the	 thresholds	 was	 performed	 when	 the	
PTA	 threshold	 results	 were	 not	 available	 or	 when	 subjects	 did	 not	 cooperate	
during	the	PTA	exams	(younger	or	deaf	individuals).		
Electrophysiological	 thresholds	 were	 translated	 into	 the	 audiometric	 thresholds	
for	the	frequencies	of	2000	Hz	and	4000	Hz.	No	correction	factor	was	applied	as	is	
advocated	 in	 studies	 conducted	 by	 Jerger	 and	 Mauldin,	 1978;(Jerger	 &	 Mauldin	
1978)	Gorga	et	al.,	1985;(Gorga	et	al.	1985)	van	der	Drift	et	al.,	1987;(van	der	Drift	
et	al.	1987)	and	Gorga	et	al.,	2006,(Gorga	et	al.	2006)	in	which	a	strong	correlation	
was	established	between	 the	electrophysiological	 thresholds	with	 the	 "click"	and	
the	 audiometric	 thresholds	 at	 2000	 and	4000	Hz.	Moreover,	 a	 simple	 correction	
applied	 to	 the	 electrophysiological	 thresholds	 did	 not	 increase	 the	 prediction	 of	
audiometric	thresholds.		
The	 Vivosonic	 IntegrityTM	V500	 audiometer	 system	was	 used	 to	 collect	 the	 ABR	
and	 determine	 the	 electrophysiological	 thresholds.	 This	 modular	 equipment	 is	
comprised	of	 four	main	 components	 as	 follows:	 the	 computer,	 the	VivoLink	 (SN:	
VL0026),	 the	 Amplitrode	 (SN:	 AJ0270)	 and	 the	 earphones.	 The	 earphones	 used	
were	 the	 ER-3A	 (ER-3A	 Left	 SN:63762	 and,	 ER-3A	 Right	 SN:	 63763),	 calibrated	
according	 to	 ANSI	 S3.6-1996.	 The	 click	 stimulus	 was	 used	 to	 evoke	 the	 ABR,	
calibrated	 in	 decibel	 peak-equivalent	 to	 the	 sound	 pressure	 level	 (dBpeSPL)	
according	 to	 the	 procedure	 IEC	 60645-3	 to	 the	 calibration	 of	 short	 duration	
stimuli.	
Electrophysiological	 thresholds	 were	 determined	 according	 to	 the	 protocol	
established	 by	 the	American	Academy	 of	 Audiology	 in	 the	Audiologic	 Guidelines	
for	the	Assessment	of	Hearing	in	Infants	and	Young	Children	(Dworsack-dodge	et	










If	 this	 information	was	not	provided,	 conventionally	 the	 right	 ear	was	 chosen	 to	
initiate	the	exam.		
According	to	the	hearing	exams,	we	adopted	two	classifications	of	HL.	
Both	 classifications	 are	based	on	 the	mean	value	of	PTA	at	500,	1000,	2000	and	
4000	 Hz	 air	 conduction	 thresholds.	 One	 classification	 is	 the	WHO	 classification,	
which	defines	HL	as	a	hearing	 threshold	 (mean	value	PTA)	higher	 than	25	dB	 in	
the	“better	ear”,	or	the	electrophysiological	threshold	of	the	“better	ear”	correlated	







In	 this	study,	we	adopted	 the	self-reports	of	HL	 in	one	or	both	ears	and	adopted	
self-reports	 of	 HL	 in	 both	 ears,	 the	 latter	 of	 which	 is	 more	 likely	 a	 WHO	
classification.	
	




The	 study	 of	 HL	 in	 São	 Tomé	 and	 Príncipe	was	 submitted	 and	 approved	 by	 the	
ethics	 committee	 of	 São	 Tomé	 e	 Príncipe	 and	 the	 Ethics	 Research	 Committee	 of	









A	 total	of	567	 individuals	were	analyzed,	 aged	1	 to	83	years	with	a	mean	age	of	
20.74±16.148	years.		
Otoscopy	was	performed	on	 all	 subjects,	 and	 a	normal	 tympanic	membrane	was	
the	most	prevalent	observation,	except	in	cases	of	chronic	otitis	media.	
The	 sample	was	 divided	 into	 three	 age	 groups	 as	 follows:	 17.5%	of	 the	 subjects	
were	younger	than	7	years	of	age	(99\567);	38.1%	of	subjects	ranged	from	7	to	19	
years	 of	 age	 (216\567);	 and	 44.4%	 of	 subjects	were	 older	 than	 20	 years	 of	 age	
(252\567).		
The	younger	group	had	an	age	distribution	that	was	higher	at	6	years	(39\99)	than	




The	 audiometric	 tests	 used	 to	 validate	 the	 question	 were	 the	 PTA	 in	 81.3%	
(461\567)	of	the	cases	and	the	ABR	in	18.7%	(106\567)	of	the	subjects.	The	use	of	





There	 was	 a	 high	 statistical	 difference	 between	 the	 age	 groups	 and	 the	 applied	
audiometric	 exams	 (PTA	 and	 ABR),	 showing	 that	 the	 ABR	was	 preferred	 in	 the	
youngest	 group,	 and	 the	 PTA	 was	 the	 preferred	 method	 of	 testing	 in	 the	 older	
group	(p=0.0001).	
Using	 the	 criteria	of	 the	mean	value	of	PTA	at	500,	1000,	2000	and	4000	Hz	air	
conduction	 thresholds	 higher	 than	 25	 dB,	 audiometry	 revealed	HL	 in	 46.56%	of	
subjects	 in	 the	 right	 ear	 (264\567)	 and	 in	 44.44%	 of	 subjects	 in	 the	 left	 ear	















	 	 	 Hearing	Loss	(HL)	 Sensitivity	 Specificity	
	 	 n	 Yes	 No	 	 	
Total	Sample	
Right	Ear	Complaint		 567	 264	 303	 74.62%	 76.9%	
Yes	 267	 197	 70	 	 	
No	 300	 67	 233	 	 	
	 	 	 	 	 	
Left	Ear	Complaint		 567	 252	 315	 79.76%	 73.02%	
Yes	 286	 201	 85	 	 	
No	 281	 51	 230	 	 	
<7	Years	
Right	Ear	Complaint		 99	 37	 62	 58.97%	 81.67%	
Yes	 41	 23	 11	 	 	
No	 58	 16	 49	 	 	
	 	 	 	 	 	
Left	Ear	Complaint		 99	 37	 62	 70.27%	 75.81%	
Yes	 41	 26	 15	 	 	
No	 58	 11	 47	 	 	
≥7	<20	Years	
Right	Ear	Complaint		 216	 103	 113	 79.61%	 69.03%	
Yes	 117	 82	 35	 	 	
No	 99	 21	 78	 	 	
	 	 	 	 	 	
Left	Ear	Complaint		 567	 252	 315	 88.24%	 64.04%	
Yes	 286	 201	 85	 	 	






Right	Ear	Complaint		 252	 122	 130	 75.41%	 81.54%	
Yes	 116	 92	 24	 	 	
No	 136	 30	 106	 	 	
	 	 	 	 	 	
Left	Ear	Complaint		 252	 113	 139	 75.22%	 79.14%	
Yes	 114	 85	 29	 	 	





HL.	 Of	 these	 subjects,	 HL	 was	 confirmed	 by	 audiologic	 testing	 (268\360)	 in	
74.44%	of	subjects	(Table	4.1-2).		
	








	 	 n	 Yes	 No	 	 	
Age	Group		 	 567	 360	 207	 87.01%	 60.29%	
<7Y	 	 99	 44	 55	 65.22%	 73.58%	
HL	 Yes	 44	 (30)	 (14)	 	 	
	 No	 55	 (16)	 (39)	 	 	
	 	 	 	 	 	 	
≥7	<20	Years	 	 216	 159	 57	 90%	 46.88%	
HL	 Yes	 159	 (108)	 (51)	 	 	
	 No	 57	 (12)	 (45)	 	 	
	 	 	 	 	 	 	
≥20	Years	 	 252	 157	 95	 91.55%	 75.45%	
HL	 Yes	 157	 (130)	 (27)	 	 	
	 No	 95	 (12)	 (83)	 	 	





Gender		 	 567	 360	 207	 74.44%	 80.68%	
Male	 	 271	 107	 164	 75.61%	 82.24%	
HL	 Yes	 143	 (124)	 (19)	 	 	
	 No	 128	 (40)	 (88)	 	 	
	 	 	 	 	 	 	
Female	 	 296	 196	 100	 73.47%	 79%	
HL	 Yes	 165	 (144)	 (21)	 	 	
	 No	 131	 (52)	 (79)	 	 	
	 	 	 	 	 	 	
Oral	Language	 	 520	 330	 190	 67.90%	 77.74%	
Yes	 	 438	 268	 170	 67.16%	 85.29%	
HL	 Yes	 205	 (180)	 (25)	 	 	
	 No	 233	 (88)	 (145)	 	 	
	 	 	 	 	 	 	
No	 	 82	 62	 20	 98.39%	 55%	
HL	 Yes	 70	 (61)	 (9)	 	 	
	 No	 12	 (1)	 (11)	 	 	
	
It	was	observed	that	 the	probability	of	 the	question	diagnosing	HL	 in	 individuals	
who	had	HL	 confirmed	by	 audiologic	 testing	was	87.01%	 (sensitivity),	while	 the	
probability	 of	 the	 answer	 to	 the	 question	 being	 negative	 and	 the	 individual	 not	
presenting	with	any	HL	was	64.48%	(specificity)	(Table	4.1-2).	
According	 to	 age	 range,	 it	was	observed	 that	 the	 sensitivity	 increases	 as	 the	 age	
increases,	 reaching	 its	 highest	 in	 individuals	 over	 the	 age	 of	 20	 with	 a	 91.55%	
sensitivity.	The	specificity	was	lower	in	the	7	to	19	years	of	age	group	(Table	4.1-
2).	
In	 analysing	 the	 gender	 groups,	 a	 higher	 sensitivity	 (75.61%)	 and	 specificity	
(82.24%)	 was	 observed	 in	 males	 compared	 to	 females	 (73.47%	 and	 79%,	
respectively)	(Table	4.1-2).		
Of	 all	 individuals,	 some	 of	 them	 did	 not	 have	 oral	 language	 because	 they	 were	









found	 that	 the	 complaint	 of	 HL	 had	 decreased,	 being	 present	 in	 34.6%	 of	












	 	 n	 Yes	 No	 	 	
Age	Group		 	 567	 196	 371	 71.43%	 80.05%	
<7Y	 	 99	 31		 68	 67.74%	 88.76%	
HL	 Yes	 30	 (21)	 (9)	 	 	
	 No	 69	 (10)	 (59)	 	 	
	 	 	 	 	 	 	
≥7	<20	Years	 	 216	 89		 127	 74.16%	 83.46%	
HL	 Yes	 87	 (66)	 (21)	 	 	
	 No	 129	 (23)	 (106)	 	 	
	 	 	 	 	 	 	
≥20	Years	 	 252	 76	 176	 69.74%	 75%	
HL	 Yes	 97	 (53)	 (44)	 	 	
	 No	 155	 (23)	 (132)	 	 	
	 	 	 	 	 	 	
Gender		 	 567	 196	 371	 71.43%	 80.58%	
Male	 	 271	 90	 181	 68.89%	 79.01%	
HL	 Yes	 100	 (62)	 (38)	 	 	
	 No	 171	 (28)	 (143)	 	 	
	 	 	 	 	 	 	





HL	 Yes	 114	 (78)	 (36)	 	 	
	 No	 182	 (28)	 (154)	 	 	
	 	 	 	 	 	 	
Oral	Language	 	 520	 169	 351	 67.82%	 80.34%	
Yes	 	 438	 107	 331	 56.07%	 80%	
HL	 Yes	 124	 (60)	 (64)	 	 	
	 No	 314	 (47)	 (267)	 	 	
	 	 	 	 	 	 	
No	 	 82	 62	 20	 93.55%	 75%	
HL	 Yes	 63	 (58)	 (5)	 	 	















Epidemiological	 studies	 often	 report	 the	 prevalence	 of	 HL	worldwide.	 However,	
few	studies	validate	the	subjective	complaint	with	gold	standard	audiometric	tests.	
This	type	of	validation	is	useful	in	cases	where	the	subjective	complaint	is	the	only	







older	 age	 groups,	 usually	 older	 than	 40	 years	 of	 age.	 In	 our	 study,	 different	 age	
groups	 are	 included,	 with	 subjects	 younger	 than	 20	 years	 of	 age	 being	 more	
prevalent.	 Only	Marini	 et	 al.	 also	 evaluated	 self-reported	HL	 in	 individuals	 from	
different	age	groups.	
In	 the	 literature,	 the	 definition	 of	 HL	 varies	 according	 to	which	 ear	 (“better”	 or	
“worse”)	 is	 used	 to	 classify	 the	 individual	 as	 well	 as	 to	 which	 frequencies	 are	
included	in	the	calculation	of	the	hearing	thresholds	(Valete-Rosalino	&	Rozenfeld	
2005).	
Classifying	HL	by	 the	“worse	ear”	(at	 least	one	or	both	ears	with	HL)	 leads	 to	an	
increase	 in	 the	 prevalence	 of	 HL	 (Valete-Rosalino	 &	 Rozenfeld	 2005).	 In	 these	
cases,	the	group	of	individuals	with	HL	included	UHL,	thus	a	high	prevalence	of	HL	
was	reported.		
The	diagnosis	of	UHL	 is	 important	 for	oral	development	 in	children.	Detection	of	
UHL	before	 school	 entrance	means	 that	 the	 school	 teacher	 can	provide	 the	 child	
with	a	favourable	class	position	and	reduce	the	possibility	of	a	handicap	(Newton	
et	 al.	 2001).	 Children	with	UHL	have	been	 found	 to	have	 lower	 language	 scores,	
higher	grade	failures	and	needs	for	individualized	education	plans	(IEPs)	(Lieu	et	
al.	2012).	
In	 our	 study,	 we	 found	 a	 prevalence	 of	 HL	 of	 63.49%	 in	 the	 total	 sample	when	
considering	 the	 “worse	 ear“	 (at	 least	 one	 or	 both	 ears	 with	 HL)	 compared	 to	
37.74%	when	considering	the	“better	ear”	(both	ears	with	HL).			




When	 considering	 HL	 by	 the	 “better	 ear”,	 the	 specificity	 was	 high	 at	 84.14%,	
showing	 that	 the	 question	 was	 capable	 of	 identifying	 the	 normal	 hearing	
population.	Sensitivity,	although	presenting	lower	values,	was	above	60%.	At	this	






In	 children	 with	 HL	 in	 both	 ears,	 the	 answer	 to	 the	 question	 about	 HL	 was	
sometimes	difficult,	resulting	in	a	lower	sensitivity	(67.74%)	and	a	high	specificity	
of	 88.76%.	 In	 this	 younger	 group,	 considering	 HL	 in	 both	 or	 one/both	 ears,	 the	
complaint	was	always	minor	compared	to	the	diagnostic	determination	of	HL.	The	
question	 was	 posed	 mostly	 to	 the	 parents	 or	 tutors	 of	 the	 children,	 and	 it	 was	
difficult	 for	 them	 to	 identify	 the	 affected	 ear.	 As	 cited	 in	 Newton	 et	 al.	 (2001)	
“parents	may	also	be	in	denial”.	In	Robertson	et	al.	(1995),	58%	of	parents	noted	
abnormal	 behaviour	 in	 their	 children,	 whereas	 some	 parents	 went	 through	 a	
process	of	denial	(Newton	et	al.	2001;	Robertson	et	al.	1995).		
To	 achieve	 early	 identification	 of	 HL,	 it	 is	 essential	 to	 become	 educated	 about	









the	 middle	 age	 group,	 and	 the	 specificity	 decreased.	 The	 prevalence	 of	 HL	 was	















higher	 sensitivity	 to	 the	 hearing	 complaint	 (80%)	 and	 a	 specificity	 of	 83.3%.	 In	
contrast,	 in	 a	 study	 by	 Marini	 et	 al	 (Marini	 et	 al.	 2005),	 in	 which	 different	 age	
groups	were	 included,	 both	 the	 sensitivity	 and	 the	 specificity	were	higher	 in	 the	
male	 group	 (82.6%	 and	 69.7%,	 respectively),	 and	 the	 female	 group	 revealed	 a	
higher	sensitivity	 (68.72%)	and	specificity	 (84.62%).	The	results	 from	this	 study	
were	similar	to	a	study	considering	the	“better	ear”(Marini	et	al.	2005).	









Although	 audiometric	 testing	 still	 remains	 the	 gold	 standard,	 the	 subjective	
perception	of	HL	continues	to	be	an	important	method	of	identifying	HL,	especially	
in	 epidemiologic	 studies	 and	where	 the	 audiometric	 exams	 are	 nonexistent.	 The	
question	 “Do	 you	 feel	 you	 have	 hearing	 loss?”	 has	 been	 demonstrated	 to	 be	
efficient	in	identifying	HL	in	older	individuals	and	has	become	a	useful	question	on	
audiological	screening	in	this	population.	
In	younger	children,	where	mostly	 the	caretakers	answer	 the	questions,	 the	self-
report	presents	a	high	specificity	despite	a	low	sensitivity.	Based	on	the	sensitivity,	
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Abstract
Background: Hearing loss is a problem with higher incidence in South Asia, Asia Pacific and sub-Saharan
Africa. In these countries there is also associated history of anemia and malaria.
Objective: This study aims to identify a putative role of Beta globin mutation - sickle cell trait and HL in São Tomé
and Príncipe population.
Methods: A retrospective case-control study of a convenience sample was collected during Otolaryngologist
Humanitarian Missions in São Tomé and Príncipe. Control group includes individuals with normal hearing in both
ears, and the case group has participants presenting bilateral or unilateral HL. It was evaluated the potential risk
factors and sickle cell trait with HL, as well self-report of malaria infection, consanguinity, familial history of HL. The
HbS gene point mutation (Glu6Val) was determined by PCR-RFLP.
Results: Our results showed a statistical significance between HL - oral language and self-report of HL. Taken
altogether, our data did not reveal association between sickle cell trait and HL. However, a statistical association
between HL and self-report of malaria was found.
Conclusion: No association between sickle cell trait and the high prevalence of HL was found. Self-report of
Malaria was found as a risk factor for the development of HL in São Tomé and Príncipe population. The multifactorial
profile of HL shall not exclude the relevance of other etiologic factors than Malaria to justify the high prevalence of
HL in São Tomé and Príncipe and further investigation must be applied.
Keywords Hearing loss; Sensorineural hearing loss; São tomé and
príncipe; Sickle cell trait; Sickle cell disease; Malaria;
Hemoglobinopathies
Introduction
More than 360 million people in the World have disabling hearing
loss (HL). According to new World Health Organization (WHO)
Global Estimates on prevalence of the HL [1,2], there is a higher
incidence in South Asia, Asia Pacific and sub-Saharan Africa [1-3].
Sub-Saharan Africa holds 10% of the world’s population and two thirds
of the world’s least developed nations.
More than 1.2 million of the children living in sub-Saharan Africa
aged 5 to 14 years old have moderate to severe bilateral HL [3]. The
consequences of hearing problems are well known. HL in children can
result in developmental delays and lead to significant inability to
engage in oral/aural communication.
Anemia has been proposed as an etiologic factor in sensorineural
deafness for many years, but there is little supporting evidence [4]. In
these African countries there is a high prevalence of anemia and this
could be associated with infections, hemoglobinopathies or stunting
[5].
Several gene mutations and polymorphisms in the human hosts
confer survival advantage and have increased in frequency through
natural selection over generations. These include hemoglobinopathies
like Sickle Cell Disease (SCD), thalassemias and glucose-6-phosphate
dehydrogenase (G6PD) deficiency. Sickle Cell Disease (SCD) refers to
a group of symptomatic disorders associated with a specific mutation
on the Beta globin (HBB) gene [6]. Sickle hemoglobin (HbS), a
structural variant of normal adult hemoglobin, results in the
substitution of glutamic acid with valine in the sixth position of β-
chain of the hemoglobin (β6Glu-Val) [7]. HbS is the most common
pathological hemoglobin variant worldwide [7].
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Several studies have suggested that HbS has an effect of protection
against Plasmodium falciparum, the etiologic agent of malaria [6],
showing that heterozygous people carrying the sickle-cell trait (HbAS)
are protected against severe malaria (prevalence of HbAS, in some
populations, is above 90%) [6,8].
This mechanism act as natural selection and is co-responsible for
the high prevalence of HbS in malaria endemic regions as a result of
natural selection over generations [9].
The red cells of individuals with the mutant homozygous gene
(HbSS) become sickle shaped in low oxygen tension pressure with
reduced oxygen-carrying capacity. The basal turn of the cochlea is
particularly sensitive to anoxia, due to the high oxygen consumption
rate of the stria vascularis and poor capacity for anaerobic metabolism.
In this cases, SNHL start with the loss on the higher frequencies, then
the lower frequencies, resulting from the damage at the apical region
(low frequencies) and finally loss of the function throughout the entire
cochlea [8].
SNHL is one of the several complications of this disease and has
been found to occur in 8% of SCD children in Nigeria, 12% in USA,
22% in Jamaica, 36.5% in Kenya and 60% in Ghana [3,8].
In some studies, HbAS in malaria exposure could be also a cause of
SNHL [10].
São Tomé and Príncipe it’s an archipelago in western equatorial
Africa, near Gabon, Equatorial Guinea, Camaroon and Nigeria, with
Portuguese as official language [11]. São Tomé and Príncipe was
discovered by Portuguese explorers in 1470. The resident population is
about 187,000 inhabitants who have a low average age distribution
(17-18 years) with low socioeconomic conditions and poor sanitary
conditions, as well as a public health infection problem–malaria [12–
14].
Since 2011 an otolaryngologist group formed by 2 doctors, 2 nurses
and 1 audiologist began humanitarian missions in São Tomé and
Príncipe (Project “Health for all”–Instituto Marquês de Valle Flor
(IMVF)). Apparently according their clinical registries, this was the
first hearing evaluation performed in these islands. Upon the first
mission, a high prevalence of SNHL in the population was identified
and it was observed upon subsequent missions.
As far as we know this is the first study developed in São Tomé and
Príncipe population to evaluate the causes inherent to the high
incidence of HL in this population. Such way, this study proposes to
answer the question: will it be possible to establish an association
between the sickle cell trait (HbAS) and the high incidence of SNHL in
São Tomé and Príncipe?
Materials and Methods
Subjects
We present a case-control study, with a convenience sample where
the control group include individuals with normal hearing in both
ears, and patients with unilateral or bilateral HL compose the case
group. The project was submitted and approved by the Medical Ethics
Committee of São Tomé and Príncipe and Ethics Research Committee
NMS|FCM-UNL.
A total of 316 individuals (136 HL patients and 180 controls with
bilateral normal hearing), ranging from 2 to 35 years old, agreed to
participate in this study. The limitation to 35 years was chosen to avoid
action of other risk factors of HL, like acoustic trauma, age and the
effect of other diseases. We organized into two age groups based on
WHO: 1) below 14 years old (2–14 years) as children group and 2)
above 15 years old (15–35 years) as adults group. The patients were
recruited during consultation provided by the humanitarian missions
in São Tomé and Príncipe over a period from February 2012 to May
2014. The controls (normal hearing bilateral) were recruited at
consultation at health services, primary schools from São Tomé and
local hotel.
All patients signed an informed consent and answered a clinical
questionnaire recording risk factors and clinical history. An
otolaryngologist observed all. The risk factors included were family
history of HL, consanguinity, self-report of malaria infection, pre-natal
and perinatal history and history of infections.
All 316 individuals were evaluated regarding their hearing status
with Pure Tone Audiogram (PTA) or Auditory Brainstem Response
(ABR) depending on collaboration to participate on the audiometric
exams.
Audiometric exams were carried out by an audiologist without an
audiometric cabin, with earphones-TDH39, in a closed room, with a
level of noise measured by iPhone using SchabelDoesIT GbR, Munich,
Germany (version 1.0.0), considered acceptable (ANSI S3.1-1999)
(R2013). The equipment used was the Madsen Midimate 622 and
Vivosonic Integrity V500 audiometer (auditory brainstem response),
calibrated according to calibration ISO389 1975/Oslo
Recommendation. The IntegrityTM V500 system used to collect
auditory brainstem is a modular equipment comprised by 4 main
components: the computer, the VivoLink (SN: VL0026), the
Amplitrode (SN: AJ0270) and the earphones. The earphones used were
the ER-3A (ER-3A Left SN:63762 e ER-3A Right SN: 63763) and were
calibrated according to ANSI S3.6-1996 and the stimulus used was the
CLICK, calibrated in dB equivalent to the sound pressure level
(dBpeSPL) according to the procedure IEC 60645-3 for the calibration
of short duration stimulus.
Electrophysiological thresholds were translated into the audiometric
thresholds for frequencies 2000 Hz and 4000 Hz. No correction factor
was applied as is advocated in studies conducted by Jerger and
Mauldin [15]; Gorga et al. [16]; van der Drift et al. [17]; Gorga et al.
[18] in which establish a strong correlation between the
electrophysiological thresholds with the "click" and the audiometric
thresholds at 2000 and 4000 Hz.
The hearing loss of each patient was determined based on the better
ear and following the WHO classification [19].
Patients with less than 2 years and more than 35 years of age,
conductive hearing loss, syndromic hearing loss, obvious
environmental causes such as meningitis, cerebral malaria, intra-
uterine or neonatal complications, ototoxicity, severe head trauma or
developmental delay were excluded.
DNA extraction
Blood samples of all patients and controls were collected into
Guthrie cards. Genomic DNA was obtained from each sample using a
commercially available kit (QIAamp® DNA micro kit, Qiagen)
according to the manufacturer’s instructions. All DNA samples were
stored at –20°C.
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The HbS gene point mutation (Glu6Val) was determined by PCR-
RFLP. The primers and PCR conditions for the mutation site of this
gene is shown in Table 1. For all of them the nucleotide mutated
resulted in either gain or loss of restriction site, which therefore
allowed the wild-type (HbAA) and variant alleles to be discriminated
by RFLP after appropriate restriction enzyme digestion.
PCR was carried out with 50 ng of DNA in 50 ml reaction volume,
containing 1.3x ImmoBuffer, 1.5 mM MgCl2, 0.6 mM dNTP, 1.0 mM
of each primer, and 0.75 U of Immolase (Bioline). The amplification
started with an initial denaturation step at 95°C for 7 min, cycling
parameters were 35 cycles of 95°C for 30 s, specific annealing
temperature (60°C) for 30 s, 72°C for 30 s and a final extension at 72°C
for 10 min. After amplification, 10 ml of each PCR products were
digested with appropriate restriction enzymes (DdeI) for 3 h at 37°C
followed by an inactivation step at 65°C for 20 min and
electrophoresed in 2% agarose gel with ethidium bromide (0.5 mg/ml)
for visualization under ultraviolet light. The expected products for each
genotype of the tested gene are shown in Table 1. All the genotype
determinations were carried out twice in independent experiments and
inconclusive samples were reanalyzed.
Gene Primers PCR fragment
Patterns after restriction enzyme
digestion
HbAS codon 6 (rs334) Rv 5’- AGG GTG GGA AAA TAG ACC AA -3’ 395 bp HbAA: 202, 180, 13 bp
 FW 5’- CGG CTG TCA TCA CTT AGA CCT -3’  HbAS: 382, 202,180,13 bp
   HbSS: 382, 13 bp
Table 1: PCR-RFLP conditions for identification of HbAS (rs334) polymorphism.
Statistical Analysis
The Hardy-Weinberg equilibrium of HbS was assessed by Qui-
square test, calculated by HW calculator™ - Michael H Court
(2005-2008).
Description of the sample was made with descriptive statistics,
considering frequency analysis, means and standard deviation (SD).
To study the association between HL and each of the following
parameters as district origin, oral language, perception of HL, sex and
history of malaria infection, have been used the Qui-squared test.
The association between HbS genotype and the degree of HL of each
ear and was analysed with Qui-square test by Monte Carlo Simulation.
To identify risk factors of HL we adopted a Binary Logistic
Regression, where HL is a response variable and independent variables
were HbS, age groups and self-report of Malaria infection.
All analyses were performed using the IBM, SPSS 20 version.
Results
We evaluated 316 subjects (Table 2) of whom 146 (45.6%) were men
and 172 (54.4%) were women, with an age mean of 17.4 ± 9.74 years













































































































Yes: 3 (1,7%) 4 (2.9%) 1 (2.3%) 3 (3.3%)  
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Missing 5 (2.8%) 4 (3%)  4 (4.3%)  

































































































HbSS: 3 (1.7%) 2 (1.5%) 0 2 (2.2%)  
SD – Standard Deviation; HbAA - Wild Type; HbAS - Trait; HbSS - Homozygotic
Table 2: General characteristics for convenience sample of São Tomé
and Príncipe population.
Both groups (case-control) are homogeneous to gender (p=0.256)
and age groups (p=0.361).
According to our results, HL is not associated with the district of
origin (p=0.058) of each individual.
Figure 1: Case/control group distribution by HL grade.
Among the 316 subjects, we found 180 (57.0%) individuals with
bilateral normal hearing, 44 (13.9%) unilateral HL (UHL) and 92
(29.1%) with bilateral HL (Figure 1). The individuals with UHL and
bilateral HL were included in the case group.
Figure 2: The Hardy-Weinberg Principle for HbS genotype was
confirmed (p>0.05).
The Hardy-Weinberg Principle for HbS genotype was confirmed
based on the distribution of HbS genotype in control and case group
(Figure 2).
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When we calculate the media of the tone threshold, we found the
left ear (40.02 dB) slight the same than the right (39.85 dB). The
audiometric curve in the global sample has a horizontal shape, around
mild HL.
The self-reported HL was confirmed by the audiometric evaluation,
showing a positive association (p<0.0001) between both parameters.
The tendency for self-reported HL was confirmed by the exams
(ϕ=0.553; p<0.0001).
Considering oral language for communication, this was absent in 33
(24.3%) of the individuals from case group and in 4 (2.2%) of the
control groups these showing a negative association (ϕ=-0.379;
p<0.0001) between oral language and HL (p<0.0001). There was a
tendency to have oral language in the control group.
A familial history of HL was found to be more prevalent in the
control group than in the case group, respectively with 34 controls
(18.9%) and 20 patients (14.7%). In the case group, 16 (80%) had
bilateral HL and 4 (20%) unilateral HL.
From our sample 3 individuals (1.7%) in the control group and 4
patients (2.9%) in case group confirmed the existence of consanguinity
in their families. Thus, no association between HL and consanguinity
was performed.
In São Tomé and Principe we did not found any registry about
history of malaria infection. At same time, we found that malaria
infection is a public health problem and all individuals enrolled
recognize malaria infection and can answer about their clinical history
regarding this endemic infection. Self-report of malaria infection was
more prevalent in the case group with 91 patients reporting a history of
malaria (66.9%), being reported by 103 individuals (57.2%) of the
control group.
The genotype distribution in our population was shown in Table 2.
Concerning our results the HbAS showed no significant predisposition
to HL (Table 3).
 Cases n (%) Controls n (%) P-value Crude OR (95% CI) P-value Adjusted OR (95% CI)
Age group   0.362  0.07  
[2-14] 69 (45.7%) 82 (54.3%)  Reference  Reference
[15-35] 98 (59.4%) 98 (59.4%)  0.812 [0.520-1.269]  0.633 [0.386-1.038]
Malaria infection   0.071  0.021  
No: 41 (30.1%) 72 (40%)  Reference  Reference
Yes: 91 (66.9%) 103 (57.2%)  1.552 [0.964-2.497]  1.840 [1.097-3.085]
HbS   0.744  0.839  
(HbAA) 112 (82.3%) 142 (78.9%)  Reference  Reference
(HbAS) 22 (16.2%) 35 (19.4%) 0.449 0.797 [0.443-1.435] 0.573 0.842 [0.463-1.530]
(HbSS) 2 (1.5%) 3 (1.7%) 0.855 0.845 [0.139-5.145] 0.832 0.821 [0.133-5.063]
Table 3: Binary logistic regression between HbS and HL without and with risk factors (age group and history of malaria infection), HL: Normal
hearing–0–Reference Category is a response variable; independent variables: HbS (0–HbAA wild type, 1- HbAS trait, 2–HbSS homozygotic), age
groups (0–[2-14] years, 1–[15-35] years) and history of Malaria infection (0–no, 1–yes).
By applying the model of binary logistic regression the self-report of
malaria was identified as a risk factor for HL (Table 3). The history of
malaria infection almost doubled the risk of HL (OR=1.840; CI 95%
[1.097-3.085]). We also found that, even not statistically significant, the
oldest age group presented a decreased risk of HL in 36.7%.
For sickle cell trait we did not verify a significant predisposition to
develop HL (OR=0.842; CI95% [0.463-1.530]) as sickle cell disease
(OR=0.821; CI95% [0.133-5.063]).
Discussion
The results of this study revealed a prevalence of bilateral SNHL in
92 (29.1%) individuals and unilateral SNHL in 44 (13.9%) of subjects
from our convenience sample. The unilateral and bilateral SNHL,
accounting for 43% of the total sample, were included in the case study
group since the unilateral SNHL also contribute to worse language
acquisition and decreased school performance [20].
The horizontal audiologic curve in tonal audiogram was not specific
or characteristic to a specific risk factor, meaning that inumerous
causes may be responsible for SNHL in São Tomé and Príncipe and not
one in particular.
Analysing the risk factors, the history family of HL and
consanguinity were excluded from the analysis because they have a
small number of cases. They haven’t significant association in contrast
to what we are expecting, since has been reported the relevance of
these factors in HL [21, 22].
The individuals included in this study rarely reported to have
consanguineous parents, even knowing that São Tomé and Príncipe are
small islands, with high probability of consanguinity.
São Tomé and Príncipe is a population of Sub-Saharan Africa in
which several haemoglobinopathies have been identified, including
HbSS as the most prevalent [7,23]. It would be expected to obtain an
increased prevalence of HbS homozygous (HbSS) and increased HbAS
[4,8,10,24] in the São Tomé and Príncipe population. However in our
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results, HbSS genotype were found only in 16% and 18% for HbAS of
the sample.
The HbAS has been reported in many studies as a factor of
protection from malaria, reducing its severity [6]. The mechanism that
contribute for this protection is the accelerated sickling of parasite-
infected HbAS erythrocytes, low growth rates and parasite invasion in
HbAS erythrocytes (in low oxygen conditions) and increased
phagocytosis of infected HbAS erythrocytes [6]. Recently, had been
show that intra-erythrocytic parasite growth is greatly inhibited by
HbS polymerization when oxygen levels drop below 5% and, higher
parasite-infected sickle erythrocyte phagocytosis by host immune cells
has been observed when compared to infected normal erythrocytes
[6]. Moreover, HbS erythrocytes infected by P. falciparum lower the
surface expression of PfEMP-1, which results in a reduction of
cytoadherence and thus protection against severe malaria [6]. This
haemoglobin alteration otherwise may lead to thromboembolic events
which sought being the source of SNHL [10].
The study model adopted did not confirm this assumption that the
HbAS can promote SNHL. In our study we found a significant
association between SNHL and a self-report of malaria. Although the
patient provides the clinical malaria episode information, we
considered their report valid. We must also consider that in the São
Tomé Príncipe population exists a strong public awareness of Malaria
infection as public health problem and standard procedures and
guidelines for infection evaluation are followed, including the
collection of thick blood film Plasmodium sp. in the presence of fever
and illness.
Our results are supported by others, suggesting also that mild
clinical malaria may also be associated with SNHL [25,26].
The malaria infection may trigger the onset of SNHL by
pathophysiological processes, thromboembolism and release of
inflammatory mediators [26,27]. On the other hand, malaria treatment
adopted may be ototoxic. Some studies report reversibility of
ototoxicity of some antimalarial [28–32]. In the specific case of
children it does not apply [33] especially when is not performed a drug
weight adjustment, and children ingest high doses of antimalarial
therapy which may induce irreversible ototoxicity [32,33]. Eventually
the higher association of the youngest patients of the case group with
HL could be supported by the report of children malaria infection in
this country during last 14 years [34,35].
The epidemiological profile of Malaria in São Tomé and Príncipe
reveals a significant decrease of malaria admissions and deaths over
2006-2007 [34]. Since then, the children were most affected,
representing a high proportion relatively to all patients. In 2003 they
started some measures to control the disease witch include indoor
residual spraying (IRS). In 2004 initiated the intermittent preventive
treatment (IPT) with and sulfadoxine and pyrimethamine and changed
the antimalarial policy with association of artesunate (AS) and
amodiaquine (AQ), as first line treatment, in 2005 implemented the
use of insecticide-treated nets (ITN) [34].
Our results support the hypothesis that the sickle cell trait (HbAS)
acts as a protective role against malaria and SNHL in São Tomé and
Príncipe.
Moreover, although São Tomé and Príncipe region is also affected by
other HBB mutations, their prevalence is not relevant [23], justifying
no screening for them in our study. There are others haemoglobin
diseases, like deficiency of glucose-6-phosphate dehydrogenase, which
ototoxicity is well known when combined with primaquine
antimalarial therapy [36,37].
Conclusion
No association between sickle cell trait (HbAS) and the high
prevalence of HL was found. However, our study suggests that in this
sample, HbAS is preventing HL because is protecting against malaria.
Malaria was found as a risk factor for the development of HL in São
Tomé and Príncipe population. The multifactorial profile of HL and
the horizontal audiologic curve, highly suggests the relevance of other
etiologic factors than Malaria to justify the high prevalence of HL in
São Tomé and Príncipe and further investigation must be applied.
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Sub-Saharan	 Africa,	 in	 which	 was	 detected	 a	 high	 prevalence	 of	 sensorineural	
Hearing	 Loss	 (SNHL).	 HL	 is	 a	 common	 condition	 with	 both	 genetic	 and	
environmental	causes,	and	it	greatly	impacts	on	global	health.	STP	population	has	
leading	 with	 additional	 health	 problems	 over	 the	 years,	 such	 as	 anemia	 and	
malaria	infection.		








The	 same	 effect	 of	 increased	 risk	was	 found	 after	 stratification	 for	male	 gender	
(OR	3.721	CI	95%	[1.631	–	8.489]).			
Conclusions:	 Our	 results	 did	 not	 allowed	 us	 to	 correlate	 any	 specific	 variant	 of	















Africa,	 which	 has	 been	 receiving	 humanitarian	 help	 from	 Portugal	 through	 a	
program	 called	 “Health	 for	 all	 –	 specialties”.	 In	 this	 program,	 a	 team	 of	
otolaryngologists,	nurses,	audiologists	and	speech	therapist	collaborate	in	STP.	
During	the	humanitarian	action,	the	clinical	team	was	faced	with	a	high	prevalence	
of	HL,	mainly	sensorineural	hearing	 loss	 (SNHL)	 in	STP	population	(Caroça	et	al.	
2013;	 Caroça,	 Campelo,	 et	 al.	 2016).	 Anemia	 and	 malaria	 infection	 were	 two	
additional	 health	 problems	 detected	 in	 this	 population(Instituto	 Nacional	 de	
Estatística	et	al.	2010).		
Anemia	 can	 be	 caused	 by	 several	 factors	 as	 such	 hemoglobinopathies	 or	






genetic	 enzymopathy	 in	 humans.	 This	 pathology	 is	 an	 X-linked	 disorder	 with	
recessive	genetic	trait.		
G6PD	 is	 a	 cytoplasmic	 enzyme	 that	 catalyzes	 the	 first	 step	 in	 the	 hexose	
monophosphate	 pathway	 leading	 to	 synthesis	 of	 pentose	 phosphate.	 It	 also	
catalyzes	 conversion	 of	 nicotinamide	 adenine	 dinucleotide	 phosphate	 (NADP)	 to	
its	 reduced	 form	 (NADPH),	 thus	 protecting	 erythrocytes	 from	 oxidative	 damage.	






chronic	hemolytic	 anemia,	 neonatal	 jaundice	 or	hyperbilirubinemia,	 but	 also	 can	
remain	asymptomatic	and	is	rarely	mortal	(Cappellini	&	Fiorelli	2008).	
The	 reduced	 capacity	 of	 cell	 defense	 against	 oxidative	 damage	 induced	 by	 the	
G6PD	deficiency,	has	been	correlated	to	a	high	resistance	against	malaria	infection	






generated	 by	G6PD	 (Asn126Asp)	 polymorphism	 and	 characterized	 by	 c.376A>G;	
and	 202A	 (G6PD	 type	 A-,	 severely	 deficient	 phenotype)	 generated	 by	 G6PD	
(Val68Met)	and	characterized	by	c.202G>A	(Cappellini	&	Fiorelli	2008;	Nguetse	et	
al.	2016;	Petit	et	al.	2016).	However,	the	type	A-	is	heterogeneous	since	it	can	result	
from	 a	 combination	 of	 the	 Asn126Asp	 replacement	with	 any	 of	 three	 additional	
mutations,	 the	 most	 common	 of	 which	 is	 Val68Met	 (Luzzatto	 &	 Seneca	 2014;	
Manco	et	al.	2007).		










clinical	 history	 and	 clinical	 observation.	 The	 risk	 factors	 included	 were:	 family	





perinatal	history,	and	history	of	 infections.	 In	Table	4.3-1	can	be	 find	the	general	
characteristics	of	the	global	population	under	study.	
	
Table	 4.3-1	 –	 Global	 distribution	 and	 characterization	 of	 the	 individuals	 enrolled	 in	 this	 study	
(n=316).		




















































































































The	 audiometric	 exams	were	 carried	out	 by	 an	 audiologist.	 The	 equipment	used	
was	the	Madsen	Midimate	622	and	Vivosonic	Integrity	V500	audiometer	(auditory	
brainstem	 response).	 The	 audiometric	 exams	 were	 carried	 out	 without	 an	
audiometric	cabin,	with	earphones-TDH39,	in	a	closed	room,	with	a	level	of	noise	
measured	 by	 iPhone	 de	 SchabelDoesIT	 GbR,	 Munich,	 Germany	 (version	 1.0.0),	
considered	 acceptable,	 based	 on	 ANSI	 S3.1-1999	 (R2013).	 The	 audiometric	
equipment	 was	 calibrated	 according	 to	 calibration	 ISO389	 1975/Oslo	
Recommendation.	The	IntegrityTM	V500	system	used	to	collect	auditory	brainstem	
is	 a	 modular	 equipment	 comprised	 by	 4	 main	 components:	 the	 computer,	 the	





Hearing	 loss	 is	 classified	 in	 mild	 (26-40dB),	 moderate	 (41-60dB),	 severe	 (61-




35	 years	 of	 age,	 conductive	 hearing	 loss,	 and	 history	 of	 cranial	 trauma,	 intra-
uterine,	neonatal	complications	and	obvious	mental	retardation.	
This	 is	a	case-control	study,	where	control	group	include	patients	with	both	ears	




aligned	with	 the	Declaration	of	Helsinki	 for	 the	Protection	of	Human	Subjects.	A	








A	drop	of	peripheral	blood	 samples	of	 all	 enrolled	population	was	 collected	 into	
Guthrie	paper	by	qualified	assistants.	Genomic	DNA	was	obtained	from	each	blood	





We	 selected	 for	 this	 study	 two	 polymorphisms	 in	G6PD	gene	 between	 the	most	
prevalent	 Single	 Nucleotide	 Polymorphisms	 (SNPs)	 described	 in	 this	 gene	
(rs1050828	and	rs1050829)	 in	Sub-Saharan	Africa	(Manco	et	al.	2007;	Howes	et	
al.	2013).		
The	 SNPs	 selected	 were	 genotyped	 using	 Real-Time	 Polymerase	 Chain	 Reaction	
(RT-PCR	7300	Applied	Biosystem),	through	TaqMan®	SNP	genotyping	assays	(Life	
Technology),	 according	 to	 manufacturer	 instructions.	 Real-Time	 PCR	 genotype	













































c.376A>G		 B	(376A)	 63.9	 63.7	
c.376A>G		 A+	(376G)	 36.1	 36.3	









This	 study	 comprised	 316	 individual,	 from	which	 136	were	 included	 in	HL	 case	
group	while	 the	other	180	represent	 the	 control	group.	The	most	 representative	
G6PD	 gene	 variants	 from	 Sub-Saharan	 Africa	 were	 studied,	 carrying-out	 their	
genotyping	to	evaluate	a	possible	association	between	them	and	the	high	incidence	
of	hearing	loss	in	this	country.	Table	4.3-1	describe	the	main	characteristics	of	the	
populations	 under	 study.	 No	 significant	 differences	 were	 found	 between	 both	
groups,	exception	for	oral	language	stratification	(P<0.0001).		
	




X-chromossome).	 However,	 the	 allelic	 frequency	 determined	 for	 each	 allele	 was	
very	similar	between	both	genders,	except	for	c.202	G>A	variant	(Table	4.3-3).	
Our	 data	was	 analyzed	 according	 the	most	 common	 sub-Saharan	G6PD	 variants,	
which	could	be	correlated	accordingly	their	phenotypic	relevance	(B	–	normal;	A+	-	
intermediate;	A-	 -	deficient).	Table	4.3-4	presents	 the	G6PD	variants	distribution.	
The	 normal	 phenotype	 described	 by	 B	 variant	 group	 corresponds	 to	 the	 most	
frequent	 one	 (51.1%	 in	 control	 group	 and	 50.7%	 in	 case	 group),	 while	 the	
intermediate	 phenotype	 correspond	 to	 around	 12%	 in	 both	 populations.	 Full	































































































































































































G6PD	 variant	 group,	 as	 well	 as	 the	 distribution	 of	 the	 potential	 risk	 factors	
inherent	to	this	study:	gender,	age	and	malaria	infection.		
The	genotypic	analysis	was	also	performed	between	each	population,	however	the	









0.019).	However,	 and	after	 stratification	by	gender,	 in	male	population	 the	 same	




The	 enrolled	 population	 was	 recruited	 during	 humanitarian	 missions	 occurred	
during	2012	–	2014.		The	high	prevalence	of	hearing	impairment	in	STP	open	the	
door	to	study	the	possible	risk	factors	inherent	to	HL	disorder	in	this	country.	To	
answer	 questions	 about	 the	 most	 relevant	 risk	 factors	 were	 considered	 to	 be	
studied	 in	 this	 population:	 1)	 their	 genetic	 background	 (Caroça,	 de	Matos,	 et	 al.	
2016)	through	the	study	of	the	role	of	the	DFNB1	locus	(GJB2	and	GJB6	genes);	2)	
the	 putative	 role	 of	 Beta	 globin	mutation	 -	 sickle	 cell	 trait	 and	HL	 (Caroca	&	 de	
Lima	 2016);	 and	 3)	 to	 estimate	 the	 rate	 of	 infected	 people	 with	 rubella	 and	 its	
correlation	 with	 HL	 (Caroça	 et	 al.	 2017).	 These	 previous	 studies	 helped	 us	 to	
characterize	 STP	 population,	 and	 especially	 for	 rubella	 infection,	 allowed	 to	
implement	the	rubella	vaccination	in	this	country	(Caroca	&	de	Lima	2016;	Caroça	
et	al.	2017;	Caroça,	de	Matos,	et	al.	2016).	
The	high	 frequency	of	 polymorphic	 variants	 has	 arisen	because	G6PD	deficiency	
gives	a	relative	protection	against	severe	malaria	hypothesizing	about	its	selective	
advantageous	 in	 malaria	 endemic	 areas	 consequence	 of	 evolutionary	 pressure	
(Cappellini	&	Fiorelli	2008;	Ruwende	et	al.	1995;	Petit	et	al.	2016).	Many	variants	
have	been	describe,	however	the	main	focus	of	this	work	was	on	G6PD	type	B,	type	
A+	 and	 type	 A-	 described	 as	 the	 most	 prevalent	 in	 Africa	 by	 several	 studies	
(Luzzatto	 &	 Seneca	 2014;	 Nguetse	 et	 al.	 2016;	 Ruwende	 et	 al.	 1995;	 Petit	 et	 al.	
2016;	Manco	et	al.	2007;	Beutler	et	al.	1989).		
The	 distribution	 and	 prevalence	 of	 G6PD	 variants	 have	 shown	 a	 distinct	
geographical	pattern,	reflecting	correlations	with	epidemiology	of	malaria,	such	as	
malaria-endemic	 and	 malaria	 eliminating	 countries	 (Luzzatto	 &	 Seneca	 2014;	
















CI	 [1.107	–	3.148]).	We	also	 found	an	association	between	malaria	 infection	and	
HbS	in	STP	population	(Caroca	&	de	Lima	2016).		
The	 epidemiological	 profile	 of	 Malaria	 in	 São	 Tomé	 and	 Príncipe	 reveals	 a	
significant	 decrease	 of	 malaria	 admissions	 and	 deaths	 over	 2006-2007	 (WHO	
2015).	 Since	 then,	 the	 high	 proportion	 of	 all	 patients	 pointed	 to	 children	 as	 the	
most	affected.	Some	preventive	actions	to	control	the	disease	have	started	in	2003,	
including	 indoor	 residual	 spraying	 (IRS)	 to	 intermittent	 preventive	 treatment	
(IPT)	and	also	through	change	the	antimalarial	policy	(WHO	2015).		
The	G6PD	deficiency	is	an	X-linked	trait,	and	is	often	stated	as	being	more	common	
in	males,	 however,	 this	 is	 not	 correct.	 As	 a	 result	 of	 X-chromosome	 inactivation,	
heterozygous	 females	 are	 genetic	 mosaics.	 However,	 could	 not	 be	 state	 the	
mathematical	 average	 of	 alleles’	 distribution,	 50%	G6PD	 normal	 and	 50%	G6PD	
deficient,	 in	 females.	 The	 random	 distribution	 of	 heterozygous	 genotype	 define	
females	in	which	the	enzyme	activity	phenotype	overlaps	with	normal,	whereas	in	
others	 it	 overlaps	with	 the	G6PD	deficiency	 prevalent	 in	 homozygous.	Of	 course	
this	mosaicism	interferes	in	clinical	implications	(Luzzatto	&	Seneca	2014).		
G6PD	deficiency	is	normally	associated	to	hemolytic	anemia,	which	could	manifest	








this	 can	probably	 increase	 the	 risk	of	having	HL	when	associated	 to	malaria	and	
G6PD,	 as	 we	 have	 when	 analysing	 the	 male	 gender.	 In	 our	 sample,	 male	 group	
presents	a	high	risk	to	develop	HL	(OR:	3.721	95%	CI	[1.631	–	8.489]).	This	could	
be	 explained	 by	 the	 fact	 that,	 male	 gender	 is	 usually	 more	 exposed	 to	 malaria	
infection	 as	 described	 by	 Cardoso	 et	 al.	 and	 Prettz	 et	 al.	 inherent	 to	 their	 job	
activity	being	more	exposed	to	P.	falciparum	infection,	leading	to	hemolytic	anemia	





G6PD	 variants	 and	 because	 of	 it,	 we	 expected	 a	 high	 incidence	 in	
hyperbilirubinemia	neonatal	and	HL	consequently.		
Prevention	 should	 be	 emphasized,	 screening	 newborns	 in	 regions	 with	 a	 high	
frequency	of	G6PD	deficiency,	educating	the	population	to	avoid	the	drugs	and	fava	
beans	that	precipitate	attacks	of	hemolytic	anemia.	At	the	same	time,	it’s	essential	
being	 alert	 to	 kernicterus	 in	 newborns,	 preventing	 sequel	 in	 future,	 as	 HL	 and	
mental	retardation	(Mason	et	al.	2007).		
The	effect	of	 the	G6PD	deficiency	 in	 the	ear	 is	not	known	unless	during	neonatal	
period	(Nair	&	Al	Khusaiby	2003;	Olds	&	Oghalai	2015).	It	is	well	known	that	G6PD	
deficiency	 is	 associated	 with	 hyperbilirubinemia	 and	 Kernicterus,	 which	 is	 a	
Bilirrubin	 Induced	 Neurologic	 Disfunction	 (BIND),	 associated	 with	 Auditory	
Neuropathy	Spectrum	Disorder	(ANSD),	acute	and	chronic	hemolytic	anemia	(Nair	
&	Al	Khusaiby	2003;	Johnson	&	Bhutani	2011;	Kuzniewicz	et	al.	2014).		
Hyperbilirubinemia	 occurs	 commonly	 in	 neonates	 and	 is	 usually	 mild	 and	
transient,	 with	 no	 long-lasting	 sequel.	 However,	 bilirubin-induced	 neurologic	
damage	 may	 occur	 in	 some	 children	 (Kuzniewicz	 et	 al.	 2014).	 The	 auditory	
pathway	 is	 the	 most	 sensitive	 part	 of	 the	 central	 nervous	 system	 to	 bilirubin-
induced	toxicity,	and	permanent	sequel	may	result	from	only	moderately	elevated	











an	 increase	 in	virulence	of	P.	falciparum	 in	sub-Saharan	Africa.	 In	the	sample,	we	
found	 that	 malaria	 infection	 has	 significant	 implication	 in	 developing	 HL	
increasing	 the	 risk	 in	 general	 population,	 being	 more	 representative	 in	 male	
gender.	 Our	 results	 did	 not	 allowed	 us	 to	 correlate	 any	 specific	 variant	 of	G6PD	
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Abstract
Hearing loss (HL) is a common condition with both genetic and environmental causes, and it greatly impacts
global health. The prevalence of HL is reportedly higher in developing countries such as the Sub-Saharan
African island of São Tomé and Prı́ncipe, where the deaf community is estimated to be less than 1% of the
population. We investigated the role of the DFNB1 locus (GJB2 and GJB6 genes) in the etiology of non-
syndromic sensorineural hearing loss (NSSHL) in São Tomé and Prı́ncipe. A sample of 316 individuals,
comprising 136 NSSHL patients (92 bilateral, 44 unilateral) and 180 controls, underwent a clinical and au-
diological examination. Sequencing of the GJB2 coding region and testing for the (GJB6-D13S1830) and
del(GJB6-D13S1854) GJB6 deletions were performed. A total of 311 out of 316 individuals were successfully
analyzed regarding the GJB2 and GJB6 genetic variations, respectively. The frequency of the GJB2 coding
mutations in patients and controls was low. Some of those coding mutations are the most commonly found in
Eurasian and Mediterranean populations and have also been identified in Portugal. None of the GJB6 deletions
was present. The presence of certain coding variants in São Tomé and Prı́ncipe suggests a non–Sub-Saharan
genetic influx and supports the previously reported genetic influx from European (mainly Portuguese) ancestors.
In summary, DFNB1 locus does not appear to be a major contributor to NSSHL in São Tomé and Prı́ncipe.
However, the presence of both pathogenic and likely pathogenic mutations in GJB2 suggests that GJB2-related
NSSHL might still occur in this population, warranting further research on GJB2 testing in NSSHL cases.
Introduction
Hearing loss (HL) is a condition that is an outcomeof both environmental and genetic factors. The preva-
lence of HL is higher in certain developing countries such as
many African countries. In São Tomé and Prı́ncipe, the deaf
community is estimated to comprise less than 1% of the
population based on the National Institute of Statistic of São
Tomé and Prı́ncipe (INE, 2014). Mutations in the GJB2 gene
(encoding connexin 26) are responsible for a significant
proportion of nonsyndromic hearing loss (NSHL) cases in
several populations. Two large deletions, del(GJB6-D13S1830)
and del(GJB6-D13S1854), truncating the GJB6 gene (en-
coding connexin 30), are also responsible for NSHL in some
populations, being mostly found in trans with GJB2 muta-
tions (del Castillo et al., 2003, 2005). These genes map to
13q11-q12, and both of them are located within the DFNB1
locus, with the first locus defined for nonsyndromic autoso-
mal recessive HL. Loci for nonsyndromic autosomal reces-
sive HL are designated by DFNB followed by a suffix integer
(Smith and Van Camp, 1998). Mutations in GJB2 reportedly
do not play a significant role in the etiology of HL in Sub-
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de Lisboa, Lisboa, Portugal.
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Saharan African populations or their descendant populations
(Bosch et al., 2014b; Javidnia et al., 2014; Lasisi et al., 2014;
Shan et al., 2010). The role of del(GJB6-D13S1830) GJB6
large deletion in NSHL in these populations is so far null
(Bosch et al., 2014a; Kabahuma et al., 2011; Samanich et al.,
2007; Shan et al., 2010). Regarding the del(GJB6-D13S1854)
GJB6 deletion, its presence has been investigated in Nigerian
HL patients (Lasisi et al., 2014) and in HL patients of a pre-
dominantly Caribbean Hispanic and African descent (Shan
et al., 2010), without positive results.
São Tomé and Prı́ncipe, a former Portuguese colony, was
formerly settled first by people from different regions of Sub-
Saharan Africa, mostly slaves from the Gulf of Guinea, Congo,
and Angola, brought to work in local plantations, and, to a minor
extent, Portuguese who were involved in the slave trade be-
tween Africa and the Americas. In the first centuries after the
discovery of São Tomé and Prı́ncipe, besides the Portuguese,
other Europeans were involved in the slave trade along the coast
of Africa, namely the French, Spanish, Dutch, and English
(Neves, 1989). In fact, São Tomé and Prı́ncipe’s population has
been shown to present 10.7% – 0.9% of European (mainly
Portuguese) admixture (Tomás et al., 2002). Therefore, a pu-
tative role of GJB2, or even of the del(GJB6-D13S1830) and
del(GJB6-D13S1854) large GJB6 deletions, in the HL observed
in São Tomé and Prı́ncipe might potentially be anticipated.
The aim of the present study was to examine the genetic
basis of HL in this understudied Sub-Saharan African island
population, and so as to obtain a broader insight on the role of




A total of 316 individuals (136 HL patients and 180 controls),
all of whom were born in São Tomé and Prı́ncipe, ranging from
2 to 35 years old, participated in this study. The subjects were
recruited during consultation provided by the humanitarian
missions in São Tomé and Prı́ncipe, at hospitals, schools, and a
hotel, over a period from February 2012 to May 2014, consti-
tuting a convenience sample. All patients and controls answered
a clinical questionnaire identifying risk factors (family history
of HL, consanguinity, malaria infection, prenatal and perinatal
history, and history of other infections), clinical history, and
otolaryngology observation.
The patients presented with mild to profound nonsyndro-
mic sensorineural hearing loss (NSSHL), which was bilateral
HL in 92 individuals and unilateral HL in 44 individuals. All
the control individuals had normal hearing in both ears. The
patients and control samples did not display a significant
difference in gender ( p = 0.233) and age ( p = 0.271).
The classification of HL was adopted from the World
Health Organization (WHO, 2013). It considers the mean
value of hearing threshold (considering the 0.5, 1, 2, and
4 kHz frequencies) in the better ear. The individual has HL
when the best ear presents a hearing threshold higher than 25
dB and is graded after that with mild (26–40 dB), moderate
(41–60 dB), severe (61–80 dB), and profound (81 dB or
greater) (WHO, 2013).
The project was reviewed and approved by the Medical
Ethics Committee of São Tomé and Prı́ncipe and the Ethics
Research Committee NMSjUNL (n!02/2014/CEFCM).
Audiological examination
All 316 individuals were evaluated regarding their hearing
status with a pure tone audiogram—Madsen Midimate 622 or
auditory brainstem response—Vivosonic Integrity V500 au-
diometer depending on collaboration. The audiometric exams
were carried out without an audiometric cabin, with earphones
TDH39, in a closed room, with a level of noise measured
by iPhone de SchabelDoesIT GbR, Munich, Germany (version
1.0.0), considered acceptable, based on ANSI S3.1-1999
(R2013). Electrophysiological thresholds were translated into
the audiometric thresholds for frequencies 2 and 4 kHz, without
applying any correction factor (Gorga et al., 1985, 2006; Jerger
and Mauldin, 1978; van de Drift et al., 1987).
DFNB1 molecular analysis
Peripheral blood samples were collected in Guthrie paper
cards after informed consent had been signed. Approval of
the Medical Ethics Committee was also obtained. Genomic
DNA was extracted from each blood sample by using a
commercially available kit (QIAamp" DNA micro kit; Qia-
gen) according to the manufacturer’s instructions. All DNA
samples were stored at -20!C until analysis.
Of the 316 subjects, 311 were successfully analyzed by se-
quencing regarding the GJB2 coding region, and by multiplex
polymerase chain reaction (PCR) (del Castillo et al., 2005)
regarding the presence of the two GJB6 large deletions,
del(GJB6-D13S1830) and del(GJB6-D13S1854). These 311
individuals comprise 134 patients (90 bilateral and 44 unilat-
eral) and 177 controls, matched by sex and age. PCR amplifi-
cation and sequencing of the coding region of the GJB2 gene
was performed using previously described primers (Matos
et al., 2010). The GJB2 fragment that was amplified comprises
the coding region and flanking noncoding regions, including
the acceptor splice site. However, the extension of the sequence
obtained beyond the coding region was variable, not allowing
results from the acceptor splice site for all the subjects.
All electrophoretograms were visually inspected; the low-
quality extremities were trimmed off; and heterozygosities
were marked, using the Chromas Lite software (v.2.01). The
resulting analyzed and edited sequences were copied from
Chromas Lite in Fasta format and blasted against the refer-
ence sequence NG_008358.1 using NCBI’s Blast program
(suite 2-sequences). All the variants described here were
named according to the recommendations of the Human
Genome Variation Society.
Statistical analyses
A chi-square test was performed, and p-values were calcu-
lated using the SPSS v.20 software. When chi-square was not
possible, we adopted Fisher’s exact test. Hardy–Weinberg
equilibrium test was performed using Court Lab’s HW calcu-
lator. This test was only performed for c.*84T>C, c.*104A>T,
and c.*111C>T, since these were the only variants whose re-
spective genotypes were all observed in five or more individuals.
Results
Insofar as the GJB2 sequencing is concerned, all the ana-
lyzed subjects were sequenced between c.-2 and c.*6 positions,
although most sequences extended, with quality, several nu-
cleotides before c.-2 and after c.*6. The sequencing results







allowed for the identification of eight coding variants (Table 1)
and 10 noncoding variants (Table 2) in patients and/or controls.
Coding variants of GJB2
Eight different coding variants, all in heterozygosity, have
been identified in this study, in patients and/or control indi-
viduals (Table 1). None of these patients harbored any mu-
tation in the acceptor splice site.
Noncoding variants of GJB2
We have identified 10 noncoding variants in the subjects of
this study, being the genotyping results presented in Table 2.
The most commonly identified variant in bilateral and uni-
lateral HL patients and controls was c.*84T>C, presenting in
the latter group an allelic frequency of 51.36%. This variant
as well as c.*104A>T and c.*111C>T are in Hardy–
Weinberg equilibrium in the control group.
Table 1. GJB2 Coding Variants Identified in Patients and Controls (All in Heterozygosity)
and Respective Carrier Frequencies
GJB2 coding variants Bilateral HL Unilateral HL Controls
c.35delG (p.Gly12Valfs) 0/90 0/44 1/177 (0.28%)
c.101T>C (p.Met34Thr) 1/90 (0.56%) 0/44 0/177
c.109G>A (p.Val37Ile) 0/90 0/44 1/177 (0.28%)
c.186C>T (p.Asn62 = ) 0/90 0/44 1/177 (0.28%)
c.225G>T (p.Arg75 = ) 1/90 (0.56%) 0/44 5/177 (1.41%)
c.380G>A (p.Arg127His) 1/90 (0.56%) 0/44 1/177 (0.28%)
c.457G>A (p.Val153Ile) 0/90 0/44 1/177 (0.28%)
c.499G>A (p.Val167Met) 1/90 (0.56%) 1/44 (1.14%) 1/177 (0.28%)
Frequency of mutated alleles 4/180 (2.22%) 1/88 (1.13%) 11/354 (3.11%)
HL, hearing loss.
Boldface = carrier frequencies > 0.
Table 2. GJB2 Noncoding Variants Identified in the Subjects and Respective Genotypic Frequencies
GJB2 noncoding
variants Genotypes Bilateral HL Unilateral HL Controls
c.-22-12C>T CC 59.4% (19/32) 60% (6/10) 66.7% (26/39)
CT 31.3% (10/32) 40% (4/10) 30.8% (12/39)
TT 9.4% (3/32) 0% (0/10) 2.6% (1/39)
c.-15C>T CC 82.7% (67/81) 85.7 (36/42) 88% (146/166)
CT 16% (13/81) 14.3% (6/42) 11.4% (19/166)
TT 1.2% (1/81) 0% (0/42) 0.6% (1/166)
c.-14G>A GG 98.8% (80/81) 100% (43/43) 99.4% (165/166)
GA 1.2% (1/81) 0% (0/43) 0.6% (1/166)
AA 0% (0/81) 0% (0/43) 0% (0/166)
c.-7G>A GG 100% (88/88) 100% (44/44) 99.4% (175/176)
GA 0% (0/88) 0% (0/44) 0.6% (1/176)
AA 0% (0/88) 0% (0/44) 0% (0/176)
c.-6T>A TT 100% (89/89) 100% (44/44) 97.7% (172/176)
TA 0% (0/89) 0% (0/44) 2.3% (4/176)
AA 0% (0/89) 0% (0/44) 0% (0/176)
c.*78A>T AA 97.6% (80/82) 100% (40/40) 100% (152/152)
AT 2.4% (2/82) 0% (0/40) 0% (0/152)
TT 0% (0/82) 0% (0/40) 0% (0/152)
c.*84T>C TT 21.3% (17/80) 30% (12/40) 24.5% (36/147)
TC 36.3% (29/80) 47.5% (19/40) 48.3% (71/147)
CC 42.5% (34/80) 22.5% (9/40) 27.2% (40/147)
c.*96A>G AA 100% (54/54) 100% (29/29) 99.2% (122/123)
AG 0% (0/54) 0% (0/29) 0.81% (1/123)
GG 0% (0/54) 0% (0/29) 0% (0/123)
c.*104A>T AA 57.7% (30/52) 79.3% (23/29) 68.1% (79/116)
AT 40.4% (21/52) 17.2% (5/29) 29.3% (34/116)
TT 1.9% (1/52) 3.4% (1/29) 2.6% (3/116)
c.*111C>T CC 57.1% (28/49) 79.3% (23/29) 67% (75/112)
CT 42.9% (21/49) 17.2% (5/29) 30.4% (34/112)
TT 0% (0/49) 3.4% (1/29) 2.7% (3/112)






We have observed a statistically significant difference in the
distribution of genotypes regarding c.*84T>C between bilat-
eral HL patients and controls when considering only the cases
with severe and profound deafness (Table 3; p = 0.005). When
also including the moderate bilateral HL patients, the differ-
ence in genotypic distribution did not remain statistically
significant for the c.*84T>C variant ( p = 0.101).
GJB6 deletions
The del(GJB6-D13S1830) and del(GJB6-D13S1854)
GJB6 deletions have not been identified in the 134 patients
(90 bilateral +44 unilateral) or 177 controls analyzed.
Table 3. Genotypic Distribution Regarding
the c.*84T>C Variant in Controls and Patients
with Bilateral, Severe, or Profound Hearing
Loss (Chi-Square Test; p = 0.005)
c.*84T>C
TT TC CC Total
Controls 36 71 40 147
Expected count 38.4 61.3 47.3
Patients 16 12 24 52
Expected count 13.6 21.7 16.7
Total 52 83 64 199
Table 4. All GJB2 Variants Identified in This Study and the Populations, Per the 1000 Genomes
Project (Phase 3), in Which the Attendant Variants Have Been Observed






c.-22-12C>T rs9578260 Intron Polymorphismb ACB, ASW, CLM, ESN, ITU, LWK, MSL,
MXL, PEL, PUR, YRI
c.-15C>T rs72561725 5¢UTR Polymorphismb ACB, ASW, CEU, CLM, ESN, GWD, LWK,
MSL, MXL, PUR, YRI
c.-14G>A rs367567291 5¢UTR Unknown n.a.
c.-7G>A rs398123813 5¢UTR Unknown n.a.
c.-6T>A rs148136545 5¢UTR Unknown ASW, CLM, ESN, LWK, MSL, PUR
c.35delG rs80338939 p.Gly12Valfs Pathogenicc BEB, CEU, CLM, FIN, GBR, IBS, MXL, TSI
c.101T>C rs35887622 p.Met34Thr Pathogenicd ASW, CEU, CLM, FIN, GBR, IBS, MXL,
PUR, TSI
c.109G>A rs72474224 p.Val37Ile Pathogenicc CDX, CHB, CHS, CLM, JPT, KHV,
LWK, MXL
c.186C>T rs397516869 p.Asn62 = Unknown n.a.
c.225G>T rs149137695 p.Arg75 = Unknown n.a.
c.380G>A rs111033196 p.Arg127His Controversial BEB, GBR, GIH, ITU, KHV, PJL, STU, TSI
c.457G>A rs111033186 p.Val153Ile Controversial BEB, CLM, GIH, ITU, PJL, STU, TSI
c.499G>A rs111033360 p.Val167Met Likely
pathogenice
LWK
c.*78A>T rs576671031 3¢UTR Unknown ACB
c.*84T>C rs3751385 3¢UTR Polymorphismf All populations
c.*96A>G rs188027627 3¢UTR Unknown ESN, LWK
c.*104A>T rs7337074 3¢UTR Polymorphismb ACB, ASW, CLM, ESN, GWD, IBS, LWK,
MSL, MXL, PEL, PUR, YRI
c.*111C>T rs7329857 3¢UTR Polymorphismb ACB, ASW, CLM, ESN, GIH, GWD, IBS,
LWK, MSL, MXL, PEL, PUR, YRI
Unknown—The authors consider that there are still insufficient data in the literature, including this study, for inferring benignity or
pathogenicity of the variant.
Controversial—In view of the conflicting data in the literature regarding the pathogenicity of the variant, the authors are unable to
classify it as either benign (polymorphism) or pathogenic.
aOne thousand Genome Project’s Populations: ACB, African Caribbeans in Barbados; ASW, Americans of African Ancestry in SW USA;
BEB, Bengali from Bangladesh; CDX, Chinese Dai in Xishuangbanna, China; CEU, Utah Residents (CEPH) with Northern and Western
European Ancestry; CHB, Han Chinese in Bejing, China; CHS, Southern Han Chinese; CLM, Colombians from Medelin, Colombia; ESN,
Esan in Nigera; FIN, Finnish in Finland; GBR, British in England and Scotland; GIH, Gujarati Indian from Houston, Texas; GWD, Gambian
in Western Divisions in The Gambia; IBS, Iberian population in Spain; ITU, Indian Telugu from the UK; JPT, Japanese in Tokyo, Japan;
KHV, Kinh in Ho Chi Minh City, Vietnam; LWK, Luhya in Webuye, Kenya; MSL, Mende in Sierra Leone; MXL, Mexican Ancestry from
Los Angeles USA; PEL, Peruvians from Lima, Peru; PJL, Punjabi from Lahore, Pakistan; PUR, Puerto Ricans from Puerto Rico; STU, Sri
Lankan Tamil from the UK; TSI, Toscani in Italy; YRI, Yoruba in Ibadan, Nigera.
bSignificant allelic frequencies in some 1000 Genome Project’s populations and homozygous genotypes have been observed in normal-
hearing controls.
cThe pathogenicity of the variant is well established in the literature.
dIn spite of OMIM considering this variant as one of unknown significance (www.omim.org/entry/121011), we considered it as path-
ogenic based on several reports from the literature.
eBased on in silico analytic tools as assessed at the Deafness Variation Database (http://deafnessvariationdatabase.org/).
fThis variant is clearly a polymorphism based on the genotypic frequencies available for several populations (dbSNP at NCBI).
n.a., not available.








HL remains an important global health burden. We high-
light and contextualize the salient findings and conclusions
from the present study.
Coding variants of GJB2
Pathogenic and controversial variants. In this study, with
regard to São Tomé and Prı́ncipe’s population, we have iden-
tified the pathogenic c.35delG, p.Met34Thr and p.Val37Ile
mutations, and the controversial p.Arg127His and p.Val153Ile
variants (Table 4). These five sequence changes are the most
commonly found in patients from Eurasian and Mediterranean
populations, and all have been previously found in Portuguese
HL patients (Matos et al., 2013). Thus, a non–Sub-Saharan
genetic influence in São Tomé and Prı́ncipe’s population is
suggested, and the European genetic influx reported by Tomás
et al. (2002), most likely due to admixture with the Portuguese,
is supported by our results.
p.Val167Met: a likely recessive pathogenic variant. As
regards the p.Val167Met variant, it has been previously found,
in heterozygosity, in four Kenyans with prelingual, non-
syndromic HL (Gasmelseed et al., 2004) and in one Camer-
oonian HL patient (Bosch et al., 2014b). This variant has also
been observed in the Luhya (Webuye, Kenya) population
(Table 4), from the 1000 genomes project (www.1000genomes
.org/), in heterozygosity and with an allelic frequency of
0.51%. The p.Val167Met variant, carried by one control in-
dividual from our sample, was also present in 1 out of 188
African-American control chromosomes (Samanich et al.,
2007). The p.Val167Met variant has also been identified, in
heterozygosity, in two studies, including African-American
subjects, but the ethnicities of the carriers were not disclosed
(Putcha et al., 2007; Ross et al., 2007). In silico analytic tools,
as accessed at the Deafness Variation Database (http://
deafnessvariationdatabase.org/), suggest the pathogenicity of
p.Val167Met. Taking all together, p.Val167Met seems to be a
recessive pathogenic variant of Sub-Saharan African origin.
Synonymous variants. We have identified two synony-
mous variants as well. The p.Arg75 = variant was identified in
one bilateral HL patient and in five controls (5/177 al-
leles = 1.41%), and the p.Asn62 = variant was found in one
control individual (1/354 alleles = 0.28%). Noteworthy, these
two synonymous GJB2 coding variants, of as yet unknown
significance (Table 4), are present in Sub-Saharan African
and Eastern Asian populations (Bosch et al., 2014b; Chen
et al., 2014; Gasmelseed et al., 2004; Han et al., 2008; Ming-
kun et al., 2007; Trotta et al., 2011).
Noncoding variants of GJB2
As expected, the São Tomé and Prı́ncipe’s population
harbors some GJB2 noncoding variants that are shared mainly
with Sub-Saharan African populations and populations of a
Sub-Saharan African ancestry. A statistically significant dif-
ference in genotypic distribution regarding the c.*84T>C
variant was observed between controls and patients with
severe or profound bilateral HL ( p = 0.005).
The most common of the 10 noncoding variants genotyped
in the subjects of our sample, c.*84T>C, is also found in the
project’s populations of all the 1000 genomes (Table 4) and
was observed in the control sample with an allelic frequency
close to those of the Sub-Saharan populations as well as the
Americans of African ancestry, Han Chinese and Japanese
populations.
The c.*84T>C variant (rs3751385) has been previously
found to be significantly associated with HL (Dickson et al.,
2010), in the context of demonstrating the creation of synthetic
genome-wide associations by rare variants. In our sample, both
allele T and C at the c.*84 are common but a synthetic asso-
ciation between one or both c.*84 alleles and HL cannot be
excluded. A larger sample would be necessary to further in-
vestigate a putative association of variants at position c.*84
with HL in São Tomé and Prı́ncipe’s population.
As regards the noncoding variants c.-22-12C>T and
c.-15C>T, they were identified in controls with allelic fre-
quencies of 17.95% and 6.33%, respectively. These poly-
morphisms are the most frequent in Sub-Saharan African
populations and in populations of a Sub-Saharan African
ancestry (www.1000genomes.org/; Table 4).
The c.-6T>A variant, observed in controls with an allelic
frequency of 1.14%, is also the most frequent in Sub-Saharan
African populations and in populations of a Sub-Saharan
African ancestry (www.1000genomes.org/). To the extent of
our knowledge, this variant, of an unknown effect (Table 4),
has only been described in the heterozygous state (Al-
Qahtani et al., 2010; Shan et al., 2010; Tang et al., 2006;
www.1000genomes.org/).
Some other noncoding variants, of an unknown effect
(Table 4), were rarely observed in this study. The c.-7G>A,
c.-14G>A, c.*78A>T, and c.*96A>G variants were each ob-
served in our sample only once or twice, in heterozygosity.
The c.*96A>G variant was observed only in the Luhya (We-
buye, Kenya) and Essan (Nigeria) populations, in the hetero-
zygous form. The c.*78A>T variant has been observed only in
the African Caribbean (Barbados) population (Table 4), also in
the heterozygous form. No populational data are available for
the c.-7G>A and c.-14G>A variants (Table 4).
GJB6 deletions
None of the two large GJB6 deletions has been identified in
São Tomé and Prı́ncipe. These results are similar to those
obtained in previous studies on HL patients from Sub-
Saharan African populations and Sub-Saharan African
ancestry populations.
The del(GJB6-D13S1854) is not particularly frequent in
Portuguese NSSHL patients (0.4% of the patients’ alleles),
and the del(GJB6-D13S1830) seems to be fairly rare in these
patients (Chora et al., 2010; Matos et al., 2013). Given the
relatively low degree of European (mainly Portuguese) ad-
mixture of São Tomé and Prı́ncipe’s population (Tomás et al.,
2002), it is likely that none of the GJB6 deletions plays a
relevant role in NSSHL in São Tomé and Prı́ncipe’s popu-
lation, as suggested by our data.
Conclusions
The role of GJB2 coding mutations in NSSHL in São Tomé
and Prı́ncipe seems to be of little significance. Our study,
however, suggests the existence of pathogenic, and likely
pathogenic, coding variants in São Tomé and Prı́ncipe’s pop-
ulation. Thus, although no biallelic HL patients have been







identified in our sample, the eventual occurrence of GJB2-
related HL in this population should not be disregarded. The
role of the GJB6 large deletions in NSSHL in São Tomé and
Prı́ncipe, if any, is predicted by this study to be small.
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Abstract
Background: Rubella infection can affect several organs and cause birth defects that are responsible for congenital
rubella syndrome (CRS). Congenital hearing loss is the most common symptom of this syndrome, occurring in
approximately 60% of CRS cases. Worldwide, over 100 000 babies are born with CRS every year. There is no specific
treatment for rubella, but the disease is preventable by vaccination. Since 1969, the rubella vaccine has been
implemented in many countries, but in Africa, only a few countries routinely immunize against rubella. The aim of
this study was to estimate the rate of infection from the wild-type rubella virus in São Tomé and Príncipe by
determining rubella seroprevalence with a DBS method. The goal of this study was to reinforce the need for
implementation of the rubella vaccine in this country. As secondary objectives, the validation of a DBS method was
first attempted and an association between seroprevalence and hearing loss was assessed.
Methods: We collected samples from individuals observed during humanitarian missions in São Tomé and Príncipe.
All individuals underwent an audiometric evaluation, and a drop of blood was collected for the dried blood spot (DBS).
We define two groups: the case group (individuals with unilateral or bilateral hearing loss (HL)) and the control group
(individuals with two normal ears). Patients were excluded if they suffered from conductive HL, if they showed
evidence of possible causes of HL, if they had developmental delay or if they refused to participate in the study.
Results: Among the 315 subjects, we found 64.1% individuals with IgG for the rubella virus, 32.1% without immunity
for the rubella virus and 3.8% who were borderline.
In the control group, 62.6% were positive for the rubella IgG, whereas in the case group, 72% were positive. Analyzing
both groups, with ages ranging from 2 to 14 years of age and from 15 to 35 years of age, we found a seroprevalence
of 50.3% to rubella in the younger group and 82.1% in the older group, with a significant difference between cases
and control group noted within the younger patients (p = 0.025).
Conclusions: Rubella is a disease that can be prevented. Rubella infections are still very common in São Tomé and
Príncipe, and women of child-bearing age are still at risk for rubella infection during pregnancy, justifying the urgency
of vaccination against rubella.
A statistically significant association between the group of children under 14 years of age with HL and immunity for
rubella was observed in this country, although this study did not allow us to establish a cause-effect relationship
between rubella infection and SNHL.
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Primary rubella infection during pregnancy, particularly
during the first trimester, can affect several organs and
cause birth defects that are responsible for congenital
rubella syndrome (CRS) [1]. The most common defects
of CRS are hearing impairment (unilateral or bilateral
sensorineural), eye defects (e.g., cataracts, congenital
glaucoma, or pigmentary retinopathy), and cardiac de-
fects (e.g., patent ductus arteriosus or peripheral pul-
monic stenosis). Congenital hearing loss is the most
common sequela, occurring in approximately 60% of
cases, especially when infection occurs in the 4th month
of pregnancy [2]. In a Brazilian study, congenital rubella
was thought to be the cause of hearing loss in 32% of
patients with deafness [3], and in studies conducted in
sub-Saharan Africa, rubella was considered to be one of
the causes of HL [4].
The Global Measles and Rubella Strategic Plan (2012–
2020) included goals to eliminate rubella and CRS in at
least two WHO regions by 2015 as well as in at least five
WHO regions by 2020. However, in this plan, the
African region does not have a specific target. The num-
ber of rubella cases reported from 2000 to 2014 in-
creased in the African region (from 865 cases in seven
countries to 7402 cases in 44 countries). Although the
rubella vaccine has been implemented in many countries
since 1969, worldwide coverage is still a distant goal,
particularly in Africa, where only a few countries rou-
tinely immunize against rubella [5, 6].
The efficacy of the vaccine is approximately 95%, with-
out significant side effects [7]. In 2015, the Americas re-
gion was the world’s first region to eliminate rubella and
CRS. In Europe, all 53 Member States of the WHO
European Region committed in 2010 to the goal of inter-
rupting the endemic transmission of measles and rubella
by 2015, which was not yet achieved in all regions. How-
ever, many states, including Portugal, have already inter-
rupted the endemic transmission of rubella [8].
The São Tomé and Príncipe islands are within the At-
lantic in sub-Saharan Africa, located at the level of the
Equator. It is an underdeveloped country with few eco-
nomic resources that survives through external support,
including humanitarian service. As part of a humanitar-
ian project on the islands of São Tomé and Príncipe, the
“Health for All” system of Institute Marquês Valle Flor
(IMVF) has been implemented to improve the primary
and secondary health care of the population. This pro-
ject includes doctors of several specialties, including
otolaryngology.
During these tasks, an increased prevalence of sensori-
neural hearing loss (SNHL) cases was initially noted,
particularly in the younger age group [9]. CRS cannot be
excluded as a possible etiology of SNHL and is one of
several possible causes.
The epidemiology of rubella is not known in this
country, and there is no vaccine implementation [10]
nor is there the possibility of diagnosis through labora-
tory tests.
The aim of this study is to estimate the rate of infected
people with wild-type rubella virus in São Tomé and
Príncipe by determining rubella seroprevalence through
the DBS method to reinforce the need for vaccine imple-
mentation in this country. As secondary objectives, the
validation of a DBS method was first attempted and an




The samples studied were collected between January and
May of 2014 from individuals who presented for an
audiology consultations at the Hospital Ayres de
Menezes on São Tomé Island and the Hospital Dr Man-
uel Quaresma Dias da Graça on Principe Island during
humanitarian missions. Samples were also collected
from students and workers from a hotel. All participants
in the study were natives and residents of the islands. In
total, we analyzed 315 samples collected from individ-
uals 2 to 35 years old. Of these, 171 individuals were fe-
male and 144 were male. All individuals underwent
audiometric evaluation (tonal audiogram or auditory
brainstem response measurements) according to the de-
gree of collaboration, having adapted the results of the
auditory brainstem response (ABR) to audiometric
thresholds according to standards [11].
We defined two groups based on the WHO classifica-
tion [12]. The case group was composed of individuals
with hearing loss, in which we included individuals with
unilateral HL or both ears with HL. The control group
included individuals with two normal ears.
All patients answered a questionnaire about self-
reported HL and clinical history. There are no clinical
registries about these patients in any hospital from São
Tomé or Príncipe.
Patients were excluded if they suffered from conduct-
ive deafness, showed evidence of possible causes of HL,
had developmental delay, or did not give consent to par-
ticipate in the study.
In addition to the audiometric evaluation, a drop of
blood was collected via venous or capillary puncture and
blotted onto filter paper. After collection, the blood
spots were dried at room temperature for 24 h (Dried
blood spot—DBS). The IgG measurement was carried
out in Portugal after 9 months (during which the sam-
ples were stored at room temperature).
The project was submitted to and approved by the
Medical Ethics Committee of STP and Ethics Research
Committee NMS|FCM-UNL (n°02/2014/CEFCM). The






Ethics Research Committee is aligned with the Declar-
ation of Helsinki for the Protection of Human Subjects.
A full consent process was applied for all participants.
Consent to use the survey data was also obtained.
Technical validation of the rubella IgG determination
The procedure of IgG determination from DBS was vali-
dated and optimized by two approaches: 1) First, sam-
ples were collected from 20 pregnant women at the
Hospital da Luz, Portugal. We simultaneously collected
blood samples for DBS and for serum. The specificity
and sensitivity of the IgG determination from DBS were
evaluated compared to the standard method (IgG deter-
mination from serum). 2) Second, 15 DBS samples were
collected in 10 children between 1 and 10 years of age
(who were vaccinated against rubella) and 5 children be-
tween 9 and 12 months of age (who were not vaccinated
against rubella). In this group, IgG determination from
DBS was correlated with the immune status (vaccinated
/ unvaccinated).
The extraction protocol for IgG in DBS was tested
with three different volumes of diluent (200 μL, 400 μL,
and 800 μL) in this validation step, while the protocol
for the determination of the serum IgG was recom-
mended by the SERION ELISA classic rubella virus IgG
kit. Both the extraction and IgG ELISA protocols are de-
scribed below.
Rubella IgG determination from the São Tomé and
Príncipe population
Rubella IgG extraction: For the IgG extraction, we added
400 μL of SERION ELISA kit dilution solution to ¼ of
the DBS, corresponding to 32 mm2. The extraction was
carried out for 60 min at 600 rpm at room temperature
and 18 h at 4 °C.
Rubella IgG determination: The SERION ELISA classic
rubella virus IgG kit was used for this determination.
We performed the protocol recommended by SERION.
Briefly, 100 μL of the control, standard and extracted
samples were pipetted into a 96 well microplate (only
one sample per patient was tested). The microplate was
then incubated at 37 °C for 60 min in a humid chamber
and washed 3 times with wash solution (300 μl). Then,
the IgG conjugate (100 μl) was added and the microplate
was incubated under the same conditions, after which
the washing process was repeated. Subsequently, the
substrate (100 μl) was added and the incubation process
was repeated. Finally, we added a stop solution (100 μl),
and the optical density was read at 415 nm against
630 nm. The optical densities were converted into UI
through the Serion Activity V11 program, with the fol-
lowing interpretation: negative: <10UI; borderline; 10–
15UI;positive >15UI.
The results were interpreted according to the algo-
rithm shown in Fig. 1.
Statistical processing of the data
Sample descriptions were made using descriptive statis-
tics, considering the frequency analysis, means and
standard deviations (SDs).
To study the association between IgG rubella in the
case/ control group and each of the following parame-
ters, age group, district origin, oral language, gender and
HL, the chi-square test was used by Monte Carlo
Simulation.
To identify the risk factors of HL, we adopted a Binary
Logistic Regression, where HL is a response variable.
The independent variables were the IgG rubella and age
groups.
All analyses were performed using the Statistical Pack-
age for the Social Sciences for Mac version 20.0 (SPSS).
Results
Technical validation of the rubella IgG determination
The sensitivity and specificity for each of the different
volumes of diluent tested, when compared with the
standard method were, 100 and 50% (200 μL), 89 and
100% (400 μL) and 72 and 100% (800 μL). According to
these results, a volume diluent of 400 μL was chosen for
the determination of Rubella IgG in the São Tomé and
Príncipe populations.
The DBS method also showed a good correlation
(100%) with the immune status (vaccinated/unvaccin-
ated). The ten vaccinated children were positive for the
IgG while the five unvaccinated children were negative
for IgG.
Rubella IgG determination from São Tomé and Príncipe
population
We evaluated 315 subjects (Table 1), from 2 to 35 years
of age, of whom 144 (45.7%) were men and 171 (54.3%)
were women, with a mean age of 17.36 ± 9.734 years.
Among the 315 subjects, we found 202 (64.1%) indi-
viduals with IgG for the rubella virus. Of these, 101
(32.1%) did not have immunity to rubella and 12 (3.8%)
were borderline. Borderline cases were excluded from
the study.
In the sample, we did not find any statistical signifi-
cance for gender (p = 0.391), resident district (p = 0.061,
or chi-squared test by Monte Carlo simulation), family
history of HL (p = 0.207), or consanguinity (p = 0.461).
We established two groups concerning hearing status:
a control group with patients with normal hearing in
both ears and a case group with at least one ear with
sensorineural hearing loss (SNHL).
In the control group, we found 62.6% of positive im-
munity to rubella, whereas in the case group, positive






immunity was 72%. There was not a significant differ-
ence between the case and control groups (p = 0.085).
Analyzing both the 2-to-14 years of age group and the
15-to-35 years of age group, we found a seroprevalence
of 50.3% to rubella in the younger group and 82.1% in
the older group, with a significant difference between
the case and control groups within the younger group
(p = 0.025) but not within the older group (p = 0.528)
(Table 2).
By applying the binary logistic regression model, posi-
tive immunity to rubella was identified as a risk factor
for HL (Table 3). Positive immunity to rubella almost
doubled the risk of HL (OR = 1.776; CI 95% [1.050–
3.004]) when analyzed with the age groups, but without
any statistical significance in these age groups. There-
fore, immunity to rubella was associated with HL.
A higher prevalence of “no oral language” was found
in the case group compared to the control group (p =
0.0001).
Discussion
Since their first diagnostic application almost five de-
cades ago, DBSs have been employed in many research
areas and in clinical applications for several viruses, in-
cluding Human immunodeficiency virus, Hepatitis C
virus, Hepatitis B virus, Hepatitis A virus, Hepatitis E
virus, Human cytomegalovirus, Epstein-Barr virus, Her-
pes simplex viruses, and measles-, dengue- and rubella-
viruses. Although it is not expected that current wet
sampling techniques will be replaced by the use of DBSs,
this method allows sampling in individuals and settings
with difficult access and/or a lack suitable storage facil-
ities [13]. Indeed, the DBS method is a minimally inva-
sive and more economic sampling method that is readily
available and that facilitates sample collection and stor-
age. It involves the collection of capillary blood from a
fingerstick onto a protein-saver card, which is then air-
dried and stored until processing. DBS samples can be
stored and transported for testing at a later date, which
may also provide enhanced surveillance in resource-
limited settings [14].
In the current study, the accuracy of the IgG deter-
mination from DBS samples was assessed before the de-
termination of rubella seroprevalence. The main
limitations of this evaluation were the number of sam-
ples tested, which were lower than initially planned, and
the fact that immunity by vaccination may not be similar
to immunity by natural infection. In fact, children from
São Tomé and Príncipe had higher average IgG results
than Portuguese children (respectively 89.35 and 50.9; p
= 0.034, data not presented). Despite these limitations,
the results suggest that the determination of IgG for the
rubella virus in DBS had a good correlation with the
standard method. These results are in accordance with a
previous publication that showed no significant differ-
ences in the antibody concentrations in paired serum-
Fig. 1 Algorithm for the interpretation of the results. The results are expressed in international units (U/I)






DBS samples, [15] although in our study, only the quali-
tative correlation is presented. Actually, quantitative
DBS samples were also previously tested for the diagno-
sis of rubella during an outbreak, with an excellent cor-
relation with the determination in serum, provided that
the DBS indeterminate results were positive [16]. In
addition, this methodology was used for the diagnosis of
congenital rubella syndrome in another study, by detect-
ing rubella IgM and IgG (the last in ≥ 6 months old in-
fants) in DBS, although in this study, the comparison
was not performed with the reference sample, serum,
but with oral fluid samples [17]. Therefore, using DBS
for serology determinations seems to be an appropriate
and useful approach, particularly in countries where rou-
tine immunization is not performed, to estimate the rate
of infection with the wild-type rubella virus.
The prevalence of IgG in the population from São
Tomé and Príncipe of 303 individuals from 2 to 35 years
of age was 66.7%, confirming that rubella infections are
still very common in this country. In the group of chil-
dren under 14 years of age, the prevalence of immunity
to rubella was 50.3% (74/147 subjects), while in the age
group between 15 and 35 years of age, the prevalence in-
creased by up to 82.1% (128/156 subjects. This increase









































































































Abbreviations: SD standard deviation
*Chi-square Test by Monte Carlo Simulation; Bold: Total sample; Italic: p-Value; Italic bold: statistic significant p-Value
Table 2 Sample description of the case/control group and
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suggests that women of child-bearing age are still suffer-
ing from rubella primary infections, and 18% of these
women are at risk for rubella infection during pregnancy
and subsequent CRS/birth defects in their children.
Interestingly, an association between seroprevalence
and SNHL was observed in the younger group (children
<14 years, p = 0.025), but in the older group (>14 years,
p = 0.528). While congenital rubella infection is a known
cause of deafness, the relationship between postnatal ac-
quired infection and hearing loss is not proven, although
a few reports suggest that it may occasionally occur [18,
19]. In this study, it was not possible to conclude how
many cases of HL are attributable to rubella infection
because the time of infection cannot be determined.
Therefore, the rate of positive IgG infection resulting from
congenital infections is not known, although the probabil-
ity of infection during the gestational period is higher in
the youngest group. The detection of rubella IgM in DBS
from newborns will help to clarify this key question. This
will be part of a future project of our team.
The development of oral language is dependent of the
hearing status. Therefore, we found an expected higher
prevalence of “no oral language” in the case group than
in the control group.
According to the CDC, the rubella vaccine may be ad-
ministered in combination with the mumps vaccine or
the measles and mumps vaccine [20]. These should be
administered at 12 to 15 months of age, with a second
dose given at 4 to 6 years of age. However, given the
need to control the transmission of rubella during preg-
nancy, vaccination of female children between 10–12
years of age and women of childbearing age is also rec-
ommended. The rubella vaccine has been shown to be
effective without significant side effects and should thus
be quickly implemented in the population of São Tomé
and Príncipe as well as other African countries in which
the rubella vaccine is not currently implemented and
where there is an increase of SNHL [4].
The combined vaccine with the measles and mumps
vaccine would be advantageous because these two
pathologies can also unleash SNHL in the course of the
disease [20].
Conclusion
Rubella is a preventable disease. Currently, most of the
African countries do not use this vaccine.
Rubella infections are still very common in São Tomé
and Príncipe, and women of child-bearing age are still at
risk of rubella infection during pregnancy and subse-
quent CRS/birth defects of their children, justifying the
urgency of vaccination against rubella.
According to the results obtained, a statistically signifi-
cant association between the group of children under
14 years of age with SNHL and immunity for rubella
was observed in this country. However, this study did
not permit us to establish a cause-effect relationship be-
tween rubella infection and SNHL. Therefore, another
study aiming to screen newborns for congenital rubella
infection and to follow them for audiometric assessment
is critical to determine the real impact of this infection
in this African country.
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Negative 37 (28%) 64 (37.4%) Reference Reference
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Abbreviations: HL normal hearing – 0 – Reference Category is a response variable, independent variables Rubella IgG (0 –Negative, 1- Positive), age groups (0 – [2–14]
years, 1 – [15–35] years); Italic: p-Value; Italic bold: statistic significant p-Value












Jose de Mello Saúde PhD Grant—to data collection and analysis.
Availability of data and materials
Data supporting findings can be found in: http://comum.rcaap.pt/handle/
10400.26/5369 after publication.
Authors’ contributions
CC, PP, MJC, and JP designed the study. CC, VV and PC analysed the data
and wrote the manuscript. PC, HC, SNS, MJC, PP and JP gave essential
feedback on all versions of the manuscript. All authors have read and
approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
“Not applicable”.
Ethics approval and consent to participate
The project was submitted and approved by the Medical Ethics Committee
of STP and Ethics Research Committee NMS|FCM-UNL (n°02/2014/CEFCM).
The Ethics Research Committee is aligned with the Declaration of Helsinki for
the Protection of Human Subjects. A full written consent process was applied
for all participants. Consent to use the survey data was also obtained.
Author details
1Otolaryngology Department, NOVA Medical School/Faculty of Medical
Sciences, Universidade Nova de Lisboa, Campo dos Mártires da Pátria, 130,
1169-056 Lisboa, Portugal. 2Hospital CUF Infante Santo, Avenida Infante
Santo, 34, 6°, 1350-079 Lisboa, Portugal. 3Centre for Toxicogenomics and
Human Health (ToxOmics), NOVA Medical School / Faculty of Medical
Sciences, Universidade Nova de Lisboa, Campo dos Mártires da Pátria, 130,
1169-056 Lisboa, Portugal. 4CEDOC, NOVA Medical School/ Faculty of
Medical Sciences, Universidade Nova de Lisboa, Lisboa, Portugal. 5Escola
Superior de Tecnologia da Saúde de Lisboa, Avenida D. João II, Lote 4.69.01,
1990-096 Lisboa, Portugal. 6BioISI-Biosystems and Integrative Sciences
Institute, Faculty of Science of the University of Lisbon, Lisbon, Portugal.
7ESS/IPS, School of Health, Polytechnic Institute of Setúbal, Setúbal, Portugal.
8Clinical Pathology Laboratory—Labco, Hospital da Luz, Avenida Lusíada,
100, 1500-650 Lisboa, Portugal.
Received: 25 March 2016 Accepted: 27 January 2017
References
1. Centers for Disease Control and Prevention. Rubella Virus. Epidemiol. Prev.
Vaccine-Preventable Dis. 13th Ed. [Internet]. 2015; April:325–40. Available
from: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/rubella.pdf.
2. Best JM, Reef S. The Immunological Basis for Immunization Series. Immunol.
Basis Immun. Ser. - Modul. 11 Rubella. 2008;1–24. Available from: http://
apps.who.int/iris/bitstream/10665/43922/1/9789241596848_eng.pdf.
3. da Silva LPA, Queiros F, Lima I. Etiology of hearing impairment in children
and adolescents of a reference center APADA in the city of Salvador, state
of Bahia. Braz J Otorhinolaryngol. 2006;72:33–6. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/16917550.
4. Lasisi OA, Ayodele JK, Ijaduola GTA. Challenges in management of
childhood sensorineural hearing loss in sub-Saharan Africa, Nigeria. Int J
Pediatr Otorhinolaryngol. 2006;70:625–9.
5. WHO. Immunization, Vaccines and Biologicals - Rubella and Congenital
Rubella Syndrome (CRS) [Internet]. World Heal. Organ. 2015 [cited 2015 Oct
9]. p. 1–2. Available from: http://www.who.int/immunization/monitoring_
surveillance/burden/vpd/surveillance_type/passive/rubella/en/.
6. Grant GB. Global Progress Toward Rubella and Congenital Rubella
Syndrome Control and Elimination—2000–2014No Title [Internet]. Ctr Dis
Control Prev 2015 [cited 2016 Nov 21]. Available from: http://www.cdc.gov/
mmwr/preview/mmwrhtml/mm6437a5.htm.
7. WHO Media centre. Media centre - Rubella [Internet]. World Heal. Organ.
2015 [cited 2015 Oct 24]. p. 1–3. Available from: http://www.who.int/
mediacentre/factsheets/fs367/en/.
8. Control EC for DP and. Measles and rubella monitoring October 2015.
Reporting on surveillance data October 2014 to September 2015 and epidemic
intelligence data to the end of October 2015. Stockholm: ECDC; 2015.
9. Caroça C, Campelo P, Ribeiro D, Lourenço V, Martins T, Caria H, et al.
Hearing loss in Sao Tome and Principe - 2 Years of Humanitarian Missions.
Rev Port Otorrinolaringol e Cir Cérvico-Facial. 2016;54:5–11.
10. WHO. Immunization Profile - Sao Tome and Principe [Internet]. 2013 [cited
2013 Apr 27]. p. 1–12. Available from:http://apps.who.int/immunization_
monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%
5B%5D=STP&commit=OK.
11. Gorga MP, Johnson TA, Kaminski JK, Beauchaine KL, Cassie A, Neely ST.
Using a combination of click- and toneburst-evoked auditory brainstem
response measurements to estimate pure-tone thresholds. Ear Hear. 2006;
27:60–74.
12. WHO. Prevention of blindness and deafness - Grades of hearing impairment
[Internet]. WHO. 2013 [cited 2013 Apr 28]. Available from: http://www.who.
int/pbd/deafness/hearing_impairment_grades/en/.
13. Snijdewind IJM, van Kampen JJA, Fraaij PLA, van der Ende ME, Osterhaus
ADME, Gruters RA. Current and future applications of dried blood spots in
viral disease management. Antiviral Res. 2012;93:309–21. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S016635421100547X.
14. Dokubo EK, Evans J, Winkelman V, Cyrus S, Tobler LH, Asher A, et al.
Comparison of Hepatitis C Virus RNA and antibody detection in dried blood
spots and plasma specimens. J Clin Virol. 2014;59:223–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/24529844.
15. Hardelid P, Williams D, Dezateux C, Cubitt WD, Peckham CS, Tookey PA,
et al. Agreement of rubella IgG antibody measured in serum and dried
blood spots using two commercial enzyme-linked immunosorbent assays.
J Med Virol. 2008;80:360–4. Available from: http://doi.wiley.com/10.1002/jmv.
21077.
16. Helfand RF, Cabezas C, Abernathy E, Castillo-Solorzano C, Ortiz AC, Sun H,
et al. Dried Blood Spots versus Sera for Detection of Rubella Virus-Specific
Immunoglobulin M (IgM) and IgG in Samples Collected during a Rubella
Outbreak in Peru. Clin Vaccine Immunol. 2007;14:1522–5. Available from:
http://cvi.asm.org/cgi/doi/10.1128/CVI.00144-07.
17. Adam O, Ali AK, Hübschen JM, Muller CP. Identification of congenital rubella
syndrome in Sudan. BMC Infect Dis. 2014;14:305. Available from: http://
bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-14-305.
18. Hulbert TV, Larsen RA, Davis CL, Holtom PD. Bilateral hearing loss after
measles and rubella vaccination in an adult. N Engl J Med. 1991;325:134.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2052052.
19. Kobayashi H, Suzuki A, Nomura Y. Unilateral hearing loss following rubella
infection in an adult. Acta Otolaryngol Suppl. 1994;514:49–51. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/8073885.
20. Centers for Disease Control and Prevention. Prevention of measles, rubella,
congenital rubella syndrome, and mumps, 2013: summary
recommendations of the Advisory Committee on Immunization Practices
(ACIP). MMWR. 2013;62:1–34.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:










More	 than	 360	 million	 people	 in	 the	 World	 have	 disabling	 hearing	 loss	 with	 a	
higher	 incidence	 in	 South	Asia,	 Asia	 Pacific	 and	 sub-Saharan	Africa(WHO	2013c;	
Tucci	 et	 al.	 2010,Olusanya	 et	 al.	 2014).	 According	 to	 new	 Global	 Estimates	 on	
prevalence	of	the	HL	there	is	a	higher	incidence	in	South	Asia,	Asia	Pacific	and	sub-
Saharan	Africa	(WHO	2013c;	Tucci	et	al.	2010;	Olusanya	et	al.	2014).	Sub-Saharan	
Africa	 holds	 10%	 of	 the	 world’s	 population	 and	 two	 thirds	 of	 the	 world’s	 least	
developed	nations.			
More	 than	 1.2	million	 of	 the	 children	 living	 in	 sub-Saharan	 Africa	 aged	 5	 to	 14	
years	old	have	moderate	to	severe	bilateral	HL	(Tucci	et	al.	2010).	Infections	of	the	
ear	are	the	leading	cause	of	the	hearing	impairment,	especially	in	low	and	middle-
income	 countries	 (Li	 et	 al.	 2015),	 but	 others	 infectious	 diseases	 such	 as	 rubella,	
meningitis,	 measles	 and	 mumps	 can	 also	 lead	 to	 HL.	 Most	 of	 these	 infectious	
diseases	can	be	prevented	through	vaccination	in	the	countries	where	they	exist.	
The	 consequences	 of	 hearing	 problems	 are	well	 known.	Mild	 to	moderate	HL	 in	
children	 can	 result	 in	 developmental	 delays	 and	 profound	 HL	 can	 lead	 to	
significant	inability	to	engage	in	oral/aural	communication.	
During	 the	 humanitarian	 missions	 in	 São	 Tomé	 and	 Principe	 with	 the	 Project	
“Health	 for	 all”	 –	 Instituto	 Marquês	 de	 Valle	 Flôr	 (IMVF)	 a	 group	 of	
otolaryngologists	and	audiologists	started	the	audiometric	evaluation	and	verify	a	










São	Tomé	and	Principe	 is	a	small	 country	 in	Africa	Sub-Saharan	 in	 the	middle	of	
the	 Atlantic	 sea,	 near	 Gabon,	 Equatorial	 Guinea,	 Camaroon	 and	 Nigeria.	 The	
population	 is	 young,	 with	 about	 187000	 inhabitants,	 poor	 socioeconomics	 and	
sanitary	 conditions	 with	 a	 public	 health	 infectious	 problem	 –	 malaria	 (Instituto	
Nacional	de	Estatística	2013;	Instituto	Nacional	de	Estatística	et	al.	2010).		
Also	 associated	 to	malaria	 infections	 they	have	 a	high	prevalence	of	 anemia,	 not	
only	associated	to	malaria	but	also	to	hemoglobinopathies	and	deficiency	anemia,	
more	 frequent	 in	woman	and	 child	 (Instituto	Nacional	 de	Estatística	 et	 al.	 2010;	
STP	&	Unicef	2015).	












generated	 by	G6PD	 (Asn126Asp)	 polymorphism	 and	 characterized	 by	 c.376A>G;	
and	 202A	 (G6PD	 type	 A-,	 severely	 deficient	 phenotype)	 generated	 by	 G6PD	
(Val68Met)	and	characterized	by	c.202G>A	(Cappellini	&	Fiorelli	2008;	Nguetse	et	
al.	2016;	Petit	et	al.	2016).	However,	the	type	A-	is	heterogeneous	since	it	can	result	
from	 a	 combination	 of	 the	 Asn126Asp	 replacement	with	 any	 of	 three	 additional	
mutations,	 the	 most	 common	 of	 which	 is	 Val68Met	 (Luzzatto	 &	 Seneca	 2014;	
Manco	et	al.	2007).	
Glucose-6-phosphate	dehydrogenase	(G6PD)	deficiency	is	one	of	the	most	common	








a	heterozygous	 female	 can	be	as	deficient	 for	G6PD	as	 those	of	 a	G6PD-deficient	
male:	 therefore,	 such	 females	 can	 be	 susceptible	 to	 the	 same	 pathophysiological	
phenotype	(Cappellini	&	Fiorelli	2008).	
Considering	 that	 São	 Tomé	 and	 Príncipe	 are	 islands,	 colonized	 by	 several	
European	 and	 African	 countries,	 especially	 the	 Portuguese	 and	 Jews,	 the	
consanguinity	 associated	with	 a	 genetic	 cause	 caused	 by	mutations	 of	 GJB2	 and	
GJB6	could	be	significant.	
	

























































































































































































































































































































































































The	 groups	were	 homogeneous,	with	 no	 statistically	 significant	 difference	when	
assessed	for	gender	(p=0.346)	or	for	age	groups	(p=0.275).	
All	administrative	districts	of	São	Tomé	and	Príncipe	were	covered	by	audiology	
consultation,	 and	 the	 Água	 Grande	 district	 presented	 the	 highest	 percentage	 of	
individuals	 (58.1%),	 with	 no	 statistically	 significant	 difference	 between	 case-
control	groups	(p=0.051),	verifying	a	higher	prevalence	(65.2%)	of	HL	in	Mé-Zóchi	
district.	
The	 hearing	 threshold	 was	 determined	 in	 84.6%	 of	 subjects	 by	 pure	 tone	
audiogram	(PTA)	and	the	remaining	18.6%	by	auditory	brainstem	response	(ABR).	
It	was	evaluated	 the	 self-report	of	hearing	 loss	by	 the	question	 "do	you	 feel	 you	
have	 a	 hearing	 loss?"	 and	 there	 has	 been	 confirmed	 by	 the	 audiometric	 tests	
(p=0.0001).	The	prevalence	of	persons	with	hearing	complaints	was	58%	and	that	
effectively	presented	hearing	loss	was	42.7%.	
We	 evaluated	 hearing	 loss	 by	 degrees	 according	 to	 the	 WHO	 classification,	 the	
global	 sample	 presents	 with	 70.1%	 of	 subjects	 normal	 hearing,	 followed	 in	
descending	 order:	 profound	 hearing	 loss	 (13.1%),	moderate	 (6.4%),	 severe	 (5.4	
%)	and	finally	mild	(5%).	
The	development	of	oral	language	in	the	total	sample	revealed	that	13.1%	did	not	



















By	 questioning	 about	 the	 history	 of	 clinical	 malaria	 infection,	 about	 63.7%	
answered	 affirmatively	 that	 at	 some	 point	 in	 life	 suffered	 infection	 by	 malaria,	



















case-control	 groups.	 Analyzing	 the	 G6PD	 variants	 based	 on	 this	 mutations	 we	
organized	 the	 sample	 in	 variant	 B	 and	 non-variant	 B.	 G6PD	B	was	 found	 in	 152	








Evaluating	 the	 impact	 of	 DFNB1	 in	 sensorineural	 hearing	 loss	 on	 an	 island,	
whereas	 the	 information	 collected	 during	 the	 investigation	 about	 consanguinity	
does	 not	 have	 revealed	 significant	 and	 recalling	 the	 historical	 facts	 about	 the	
colonization	of	 the	 island,	 this	did	not	prove	 significant.	 For	GJB2	gene	 (Cx26)	 it	
was	 found	 5%	 with	 heterozygous	 mutations,	 most	 of	 mutations	 in	 the	 control	




The	 immunity	 to	 rubella,	 is	 a	 known	 risk	 factor	 for	 gestational	 age,	 and	 is	 not	
known	 in	 this	 community.	 There	 is	 no	 availability	 to	 make	 the	 diagnosis	 by	
laboratory	 tests	 on	 the	 island,	 being	 an	 often-overlooked	 disease.	 The	 results	
showed	that	in	this	sample	it	is	confirmed	that	the	population	is	in	contact	with	the	
virus,	showing	positive	IgG	results	in	67.1%,	with	a	higher	prevalence	in	the	case	
group.	Although	not	presenting	a	 statistically	 significant	 relevance	 (p=0.110),	we	






It	 was	 performed	 multiple	 binary	 logistic	 regression	 (Table	 4.6-2)	 where	 the	
dependent	 variable	 is	 HL	 (case-control)	 and	 the	 independent	 variables	 are	 age	
groups,	 gender,	 clinical	 malaria	 history,	 Hemoglobin	 S,	 G6PD	 variants	 and	
immunity	 to	 rubella.	 They	 are	 still	 considered	 as	 independent	 variables	
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significant,	 increase	 two	 and	 half	 times	 the	 possibility	 of	 having	 hearing	 loss	





The	 remaining	 analysis	 of	 the	 model,	 although	 no	 statistical	 significance	 in	 this	
sample	the	older	age	group	is	at	higher	risk	for	hearing	loss	(p=0.130;	OR=2.047;	
95%	[0.809-5.181])	and	sickle	cell	disease	(HbSS)	is	associated	with	an	increased	





variant	 in	 association	with	 the	male	has	a	higher	 risk	of	developing	hearing	 loss	
(p=0.258;	 OR=1.804;	 95%	 [0.649-5.014]),	 instead	 interaction	 of	 G6PD	 non-B	
variant	 with	 malaria	 infection	 is	 associated	 to	 a	 lower	 risk	 of	 hearing	 loss	
(p=0.459;	OR=0.669;	95%	[0.230-1.942]).	To	 interaction	of	G6PD	non-B	and	HbS	





















The	oral	 language	 reflects	 the	effect	of	hearing	 loss	on	 the	acquisition	of	 correct	
oral	 language,	 therefore	 it	 is	 important	 to	 identify	cases	 that	do	not	have	oral	or	
have	poorly.	As	expected	before	the	prevalence	of	increased	SNHL,	the	existence	of	
oral	 language	 is	 also	 reduced,	 in	 this	 sample,	 showing	 a	 statistically	 significant	
association	(p=0.0001).	
Although	 we	 think	 that	 the	 consanguinity	 in	 an	 island	 is	 a	 reality,	 which	 is	 not	
confirmed	 analyzing	 the	 sample	 for	 genetic	 deafness	 recessive	 non-syndromic.	
(DFNB1).	 Identifying	 mutations	 of	 GJB2	 (Cx26)	 and	 GJB6	 (Cx30)	 genes	 in	 the	
sample,	 it	 tried	 to	 also	 check	 the	 influence	 of	 the	 island's	 colonization	 and	 the	




Family	 history	 did	 not	 prove	 significance,	 and	 also	 there	 was	 no	 association	
between	family	history	and	GJB2	and	GJB6	mutations.	 In	any	case,	 it	stresses	the	
importance	of	 family	history	 in	 the	 clinical	history,	 especially	 for	direct	 relatives	
(parents	 and	 siblings)	 knowing	 that	 only	 15%	 of	 those	 with	 a	 positive	 family	
history,	have	genetic	HL,	and	should	 therefore	 target	of	audiometric	 surveillance	
(Driscoll	et	al.	2015).	
In	 São	 Tomé	 and	 Príncipe,	 health	 care	 is	 limited,	 with	 no	 additional	 tests	 of	
laboratory	 diagnosis	 available.	 For	 this	 reason	 the	 infectious	 causes	 in	 the	






of	 infectious	 diseases	 that	 may	 be	 involved	 in	 the	 diagnosis	 of	 hearing	 loss,	
especially	 diseases	 that	 are	 part	 of	 TORCH	 (toxoplasmosis,	 rubella,	
cytomegalovirus	and	herpes)	(Shet	2011).	
Rubella	 has	 been	 decreasing	 its	 etiologic	 role	 in	 most	 of	 worldwide	 due	 to	 the	
implementation	of	the	vaccine(WHO	2015b;	da	Silva	et	al.	2006),	but	in	the	case	of	
São	 Tomé	 and	 Príncipe,	 this	 may	 be	 an	 important	 cause,	 because	 it	 is	 not	
implemented	 this	 vaccine	 (WHO	 2013b)	 this	 study	 revealed	 the	 existance	 of	
disease	 in	 STP	 population,	 with	 high	 prevalence	 and	 statistical	 significance	
stratified	by	age	group,	doubling	the	risk	of	SNHL	(as	described	in	Section/Chapter	
4.5)	 This	 may	 be	 another	 important	 cause	 of	 congenital	 HL,	 preventable	 and	
therefore	 should	 be	 implemented	 vaccination	 as	 soon	 as	 possible	 (Hulbert	 et	 al.	
1991).	There	are	also	particular	cases	of	heart	and	eye	disease	on	the	island	that	
can	be	framed	in	cases	of	gestational	rubella.	
The	 infectious	 framework	 of	 meningitis	 is	 under	 diagnosed	 due	 to	 the	 high	
prevalence	of	malaria	and	sometimes	diagnosed	as	cerebral	malaria,	and	there	 is	
therefore	history	of	HL	associated	with	the	diagnosis	of	meningitis.	
There	 are	 also	 several	 factors	 related	 to	 the	 environment	 and	 the	 individual	
himself	that	may	be	associated	with	the	development	of	HL,	of	which	stand	out:	the	






a	 high	 rate	 of	mortality	 and	morbidity.	 Recently,	 the	 incidence	 of	 severe	 clinical	
malaria	has	decreased	as	the	mortality	due	to	this	pathology.	There	are	no	medical	
records	 in	hospital	 about	 the	diagnosis	 of	 this	 disease,	 so	 the	questionnaire	was	
based	 only	 on	 the	 subjects	 or	 tutors	 response.	 The	 established	 antimalarial	





Mohammed	 2010),	 but	 in	 this	 study,	 there	 were	 small	 number	 of	 subjects	 that	
knew	the	treatment	they	had	done	and	so	no	relation	was	possible	to	achieve.	
In	 STP,	 for	 several	 years,	 it	 is	 implemented	 prophylactic	 antimalarial	 therapy	




increases	when	 associated	with	 younger	 age	 groups	 and	males.	 The	 justification	
for	this	may	be	because	this	is	the	gender	that	is	more	susceptible	to	infection	by	








normally	 associated	with	malaria	 endemic	 areas	 and	 occasionally	 are	 associated	
with	HL	in	homozygous	form	(Burch-Sims	&	Matlock	2005;	Mgbor	&	Emodi	2004).	
In	 this	sample	 this	was	demonstrated	that	sickle	cell	disease	(HbSS)	have	almost	
two	 and	half	 of	 risk	 to	 develop	HL	 and	 sickle	 cell	 trait,	 is	 protecting	 to	HL.	 This	
protection	of	 the	 sickle	 cell	 trait	 to	HL	may	 result	 from	 the	 fact	 that	 this	 variant	
confers	protection	against	malaria,	reducing	the	risk	of	HL.	
The	 variants	 non-wild	 type	 (non-B)	 of	 Glucose-6-phosphate	 dehydrogenase	
(G6PD)	 deficiency	 in	 part	 is	 associated	 with	 the	 increase	 of	 severe	 neonatal	
jaundice	 cases	 and	 acute	 hemolytic	 anemia	 and	 consequent	 SNHL	 neonatal	
(Kuzniewicz	et	al.	2014;	Worley	et	al.	1996).	
When	evaluating	the	G6PD	non-B	variant	in	association	with	gender,	it	was	found	
that	 these	 were	 not	 statistically	 significant,	 but	 almost	 duplicating	 the	 risk	 to	









significant,	 we	 found	 a	 low	 risk	 of	 develop	 HL,	 probably	 is	 associated	 to	 more	




an	 inverse	 relationship	 between	 both,	 presented	 a	 low	 risk	 to	 have	 HL.	 Instead	
that,	 sickle	 cell	 disorders	with	malaria	 infection	 increased	 the	 risk	 of	 HL	 in	 this	
sample,	 probably	 because	 of	 the	 association	 of	 pathologic	 effect	 of	 malaria	
infection	and	vascular	disease	in	sickle	cell	disorders.				
Common	to	sickle	cell	disorders,	malaria	infection	and	G6PD	deficiency	we	have	a	
common	 diagnostic	 –	 anemia.	 Anemia	 is	 a	 frequent	 diagnostic	 in	 São	 Tomé	 and	
Príncipe,	 being	more	 prevalent	 in	 child	 and	 women	 (ICF	Macro	 Inc.	 2015),	 and	
women	 could	 be	 associated	 to	 iron	 deficiency	 (ICF	 Macro	 Inc.	 2015;	 Instituto	
Nacional	 de	 Estatística	 et	 al.	 2010).	 This	 anemia	 prevalence	 in	woman	 could	 be	




Analyzing	the	main	effects	of	 the	risk	 factors	evaluated,	 it	was	found	that	rubella	
have	an	increased	risk	for	hearing	loss,	whereas	males	are	protected.	Malaria	was	
almost	 a	 risk	 factor	 with	 around	 three	 times	 more	 prone	 to	 HL.	 For	 the	
interactions	observed,	malarial	infection	and	male	are	at	increased	risk	for	hearing	
loss,	while	the	presence	of	malaria	in	older	age	group	presents	a	reduced	risk	for	
hearing	 loss.	 Malaria	 infection	 has	 a	 great	 impact	 in	 younger	 age	 and	 should	
carried	out	more	control	of	this	disease.	Younger	group	are	immunologically	more	
fragile	 and	 susceptible	 to	 ototoxicity.	 The	 hemoglobinopathies	 that	 confer	
protection	to	malaria	infection	(HbS	and	G6PD)	revealed	that	HgS	is	not	prevalent	






for	 the	variants	B,	A+	and	A-	 revealed	an	 increased	prevalence	of	non-B	variants,	
being	 in	 Hardy	Weinberg	 disequilibrium,	which	means	 that	 this	 population	 it	 is	
being	under	selective	pressure.	G6PD	deficiency	is	often	associated	with	neonatal	
jaundice	and	acute	or	chronic	hemolytic	anemia,	 in	some	cases	triggered	by	drug	
therapies	 that	 have	 the	 potential	 to	 induce	 oxidative	 stress,	 and	 may	 be	
responsible	 to	 hearing	 loss.	 Eventually	 the	 inclusion	 and	 exclusion	 criteria	 have	
undergone	 some	 influence	 on	 the	 results	 of	 G6PD	 deficiency,	 and	 therefore	 not	
significant.	 In	 this	 country	 preventive	 measure	 should	 be	 taken,	 particularly	
perinatal	 screening,	 greater	 control	 of	 neonatal	 jaundice	 and	 therapies	 used	 to	
prevent	hemolysis	and	peripartum	complications.		





This	 is	 an	 original	 work	 done	 during	 humanitarian	 missions,	 trying	 to	 identify	
some	possible	 causes	of	HL,	 it	 is	 important	 to	 recognize	 that	 cannot	be	 involved	
only	one	single	cause,	but	a	set	of	 factors	that	synergistically	 lead	to	the	onset	of	
















the	 first	 mission	 (February	 2011),	 there	 was	 not	 the	 possibility	 to	 carrying	 out	
hearing	 assessment	 in	 the	 population	 of	 STP.	 This	 project	 allowed	 not	 only	 the	
identification,	 as	 well	 as	 the	 guidance	 of	 deaf	 individuals	 to	 a	 better	 social	
integration	and	identification	of	possible	risk	factors	for	the	onset	of	deafness.	





During	 these	 6	 years	 of	 humanitarian	 missions,	 even	 without	 knowing	 what	 is	




According	 the	 results,	 we	 can	 answer	 the	 questions	 purposed	 on	 objectives	
chapter:	
• Did	the	population	of	STP	recognize	the	existence	of	hearing	loss?	








































and	 inflammatory	 mediators	 that	 can	 induce	 HL.	 Also	 antimalarial	
therapeutics’	can	lead	to	HL	
ü HbS	 is	 a	 hemoglobinophathy	 that	 usually	 is	 associated	 to	 malaria	






ü G6PD	 Def	 is	 another	 genetic	 disease	 from	 hemoglobin	 that	 confers	
protection	 for	 malaria	 infection.	 In	 this	 sample	 we	 didn’t	 state	 an	
increased	risk	impact.	
ü G6PD	 def	 is	more	 prevalent	 as	 disease	manifestation	 in	male	 because	
they	 are	 hemizygotic,	 having	 more	 exuberant	 hemolytic	 anemia,	 with	
higher	risk	to	HL	
ü G6PD	def	 has	 a	 protector	 effect	 to	develop	 severe	malaria	 infection	 in	
this	sample	G6PD	variant	non-B	is	acting	as	protector	to	HL	because	is	
protecting	to	malaria	
ü G6PD	 def	 and	 HbS	 have	 a	 protector	 effect	 to	 develop	 severe	 malaria	









































At	 the	 same	 time	we	 started	 the	 adaptation	of	 hearing	 aids,	 those	 children	with	








Figure	 6.1-3	 –	 Speech	 therapy	 during	 humanitarian	 mission,	 trying	 to	 increment	 oral	 language.	
(Personal	photo)	
	





The	 need	 of	 communication	 with	 deaf	 was	 imperative,	 so	 it	 was	 created	 the	
conditions	to	promote	the	emergence	of	their	own	sign	language.	
Since	 February	 2013	 integration	 in	 an	 element	 to	 guide	 the	 emergence	 of	 sign	
language	 of	 São	 Tomé	 and	 Príncipe	 and	 in	 July	 2014,	 publication	 of	 the	 first	
dictionary	 of	 Sign	 Language	 in	 São	 Tomé	 and	 Príncipe.	 (“Emerging	 Linguistic	









































6.2.1 Early	 identification	of	hearing	 loss,	 follow-up	and	 identification	of	other	risk	
factors	
With	implementation	of	Neonatal	Hearing	Screening	(Acustic	Otoemissions),	early	
identification	 of	 hearing	 loss	 could	 be	 possible.	 In	 these	 situations,	 and	 with	
Computerized	Tomography	 in	 São	Tomé	and	Principe,	we	 are	 creating	 favorable	
conditions	 to	 adapt	 cochlear	 implant.	 Nowadays	 they	 need	 at	 least	 an	 operating	
room	 with	 good	 conditions,	 a	 speech	 therapist,	 an	 audiologist	 and	 a	
psychotherapist	composing	a	small	team	to	adapt	a	cochlear	implant.	
At	the	same	time,	there	is	the	needing	of	follow-up	hearing	loss	cases	in	order	to	
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Decisão final sobre o projeto "O que poderá estar associado à surdez 
neurosensorial em São Tomé e Príncipe?" 
 
A Comissão de Ética da NMS|FCM-UNL (CEFCM) decidiu, por unanimidade, 
aprovar o projeto de investigação intitulado " O que poderá estar associado à surdez 
neurosensorial em São Tomé e Príncipe?" (nº02/2014/CEFCM), submetido pela 
Dra. Cristina Caroça.  
 
Lisboa, 21 de Outubro de 2015 
 











TO WHOM IT MAY CONCERN  
 
 
The Ethics Research Committee NMS|FCM-UNL (CEFCM) has unanimously 
approved the Project entitled "O que poderá estar associado à surdez 
neurosensorial em São Tomé e Príncipe?" (nr.02/2014/CEFCM), submitted by Dr. 
Cristina Caroça. 
 
Lisbon, October 21th, 2015 
 

















Termo de consentimento livre e informado 
 
 
O que poder  estar associado   surdez neurosensorial na Popula	o de So Tom
  e 
Prncipe? 
O estudo tem por objectivo a elabora	o de uma tese para obten	o do grau de Doutor em 
Otorrinolaringologia, a decorrer na Universidade Nova de Lisboa, sob a orienta	o do Prof. Doutor 
Joo Pa	o do Centro Clnico e Universitrio de Otorrinolaringologia do Hospital CUF Infante Santo 
 FCML (co-orientadoras: Dra Susana Nunes Silva; Prof. Helena Caria).  
Pesquisa: Estabelecer uma rela	o entre tra	os de hemoglobinopatias e surdez neurosensorial em 
So Tom
 e Prncipe. 
Investigadora: Cristina Paiva Chaves Caro	a, Otorrinolaringologista do Centro Clnico e 
Universitrio de Otorrinolaringologia do Hospital CUF Infante Santo - FCML 
 
Objectivo: Recolher os dados de uma amostra de popula	o de So Tom
 e Prncipe, com 
indivduos dos 2 aos 35 anos.   
So realizados testes Audiolgicos: Audiograma Tonal e/ou Potenciais Evocados Auditivos.  
Simultaneamente ao estudo auditivo, ser realizada colheita de 4 gotas de sangue para estudo de 
tra	o de hemoglobinopatia, viral e gen
tico. 
Os testes audiolgicos consistem na apresenta	o de sons, atrav
s de auscultadores e/ou 
el
trodos, que o indivduo dever assinalar, ou sero registadas as ondas el
ctricas 
correspondentes  resposta ao estmulo. Os testes audiolgicos no so invasivos, no requerem a 
administra	o de qualquer frmaco, no provocam qualquer dor ou desconforto ao indivduo 
avaliado. 












Eu, abaixo assinado, declaro que tomei conhecimento dos objectivos do trabalho de investiga	o 
intitulado O que poder  estar associado   surdez neurosensorial na Popula	o de So 
Tom
  e Prncipe?  realizado por Cristina Paiva Chaves Caro	a, que frequenta o Doutoramento 
em Otorrinolaringologia da Universidade Nova de Lisboa. Acrescento que estou informado de que 
todos os dados recolhidos sero tratados de modo estritamente confidencial, aceitando, por isso, 
fazer parte da amostra do referido trabalho.  
 
 Indivduo <18 anos:  
Aps ter sido devidamente informado, ____________________________________, pai/me de 
__________________________________________, declaro que tomei conhecimento dos 
objectivos do estudo e que aceito que o(a) meu (minha) filho(a) colabore no mesmo. 
 
 Indivduo 18 anos: 
Aps ter sido devidamente informado, declaro que tomei conhecimento dos objectivos do estudo e 
que aceito a minha colabora	o no mesmo. 
 
______________________________________(Indivduo / Representante Legal) 
 
________________________________________(Investigadora / Enfermeiro) 
 










Nome:&& & & & & & Nome&de&casa:& & & & &
Idade:& & & Sexo:& !F !M&Data&Nascimento:& & Contacto& & & &
Distrito:& & & Subdistrito:& & & Localidade:& & & & &
 &Estuda&Escola:& & & & & & & Ano&Escolar:& & & &
☐ Trabalha&Profissão& & & & Habilitações& & & & & &
Fala& ☐!Sim!☐!Não!☐!Pouco& História&Familar&Surdez& ☐!Sim!☐!Não!☐!NS/NR&
Cosanguinidade& ☐!Sim!☐!Não!☐!NS/NR&
1
Questionário&São&Tomé&e&Príncipe& & Nº& & &
Gravidez&
Mãe!Gesta!(Gravidezes)! ! Para!(Partos)! !! Idade!da!mãe!no!Parto! ! !
Gravidez!☐!Pré=termo!(<36sem)!☐!Termo!(38sem)!☐!Pós!–termo!(>40sem)!
Local!☐!Casa!☐!Hospital!! Parto!Eutócito!☐!Sim!☐!Não!  Apgar     
TORSH:!☐!Rubéola! ☐!Toxoplasmose! ☐!Herpes! ☐!Citomegalovirus! ☐!Outras!
Complicações!Periparto:! ☐!Icterícia!Neonatal! ☐!Prematuridade! ☐!Anoxia!Cerebral!
Malária/Paludismo!Profilaxia!na!gravidez!! ☐!Sim!(Fansidar!ou!Quinino) ☐!Não!☐!NS/NR!!
Profilaxia!Paludismo!periparto! ☐!Sim!(Fansidar!ou!Quinino) ☐!Não!☐!NS/NR!!
Teve!Paludismo?! ! Idade! ! ! Quanto!tempo!☐!!<6!meses! ☐!>6!meses!
Internamento!por!paludismo!! ☐!Sim! !☐!Não! !☐!NS/NR! Idade! ! ! !
Outros!internamentos:! ! ! ! ! ! ! Idade:! ! ! !
Terapêutica!anti=palúdica!efectuada:!☐!Artenusato/Amodiaquina!☐!Artemeter/Lumefantrine!!
! ! ! ! ! ☐!Quinino!Oral! ☐!Quinino!EV!!! ☐!NS/NR!
Quantas!vezes!teve!Paludismo:! ! ! ! !
História&Pessoal&
Otites!de!repetição:!☐Sim! ☐Não! ☐NS/NR! Otorreia!! ☐Sim! ☐Não! ☐NS/NR 
Fístulas!Préauriculares! ☐!Sim!(Unilateral! ! /Bilateral)! ☐!Não!
Traumatismo!Craneano! ☐!Sim!☐!Não!☐!NS/NR!
Acha!que!ouve!mal?! ☐!Sim!(OD/OE)!! ☐!Não!! ☐!NS/NR!
Observação&
CAE!OD☐!Normal!! ☐!Cerumen!! ☐!Otorreia! ☐!Otorragia!! ☐!Otomicose!!☐!Exostoses!
CAE!OE☐!Normal!! ☐!Cerumen!! ☐!Otorreia! ☐!Otorragia!! ☐!Otomicose!!☐!Exostoses!
Timpano!OD!☐!Normal!☐!Não!visível!☐!OMD! ☐!OMC!! ☐!OMC!Col!! ☐!Disf!TE!
Timpano!OE!☐!Normal!☐!Não!visível!☐!OMD! ☐!OMC!! ☐!OMC!Col!! ☐!Disf!TE!
Exames&Audiométricos&–&Impedanciometria&
OD! Tipo!☐!A!☐!B!☐!C1!☐!C2!! ! ! ! OE! Tipo!☐!A!☐!B!☐!C1!☐!C2!
OD!Reflexos!☐!Presentes!☐!Ausentes! ! ! OEReflexos!☐!Presentes!☐!Ausentes!
Exames&Audiométricos&–&Audiograma&Tonal&
OD! 250! 500! 1000! 2000! ! 4000! ! Média!
VO! ! ! ! ! ! ! ! !
VA! ! ! ! ! ! ! ! !
!
OE! 250! 500! 1000! 2000! ! 4000! ! Média!
VO! ! ! ! ! ! ! ! !
VA! ! ! ! ! ! ! ! !
Exames&Audiométricos&–&Potenciais&Evocados&Auditivos&(PEA)&
Limiar!OD! ! ! ! ! Limiar!OE! ! ! ! ! !
Destino!
☐!Alta ☐!C.!ORL!☐!Cirurgia!☐!C.!Aud!☐!PEA!☐!Próteses!☐!Terapia!Fala!☐!Lingua!Gestual!!
Contribution	to	the	study	of	epidemiological	factors	associated	with		
Sensorineural	hearing	loss	in	the	population	of	São	Tomé	and	Príncipe		
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